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Intestinal immunological environment is shaped by a continuous cross-talk 
involving three major components: intestinal epithelium, immune system and 
local microbiota. This work intended to investigate the role of lympho-epithelial 
interactions in response to food components and microorganisms.  
As part of this work the role of the immune-derived cytokine interleukin (IL)-12 
in development of food allergy has been investigated. It was previously found 
that in peanut-sensitized mice there was decreased level of IL-12 in the 
intestine. We have observed that this is accompanied with increase in thymic 
stromal lymphopoietin (TSLP), a cytokine produced by the intestinal epithelium 
and indispensable for development of allergy. Oral delivery of recombinant 
Lactococcus lactis secreting bioactive IL-12 resulted in amelioration of the 
allergic symptoms and decrease in TSLP, thus suggesting a regulatory 
interaction between these two cytokines. Further investigation of the 
mechanism of this cross-regulation revealed that intestinal epithelial cells 
express incomplete but functional IL-12 receptor. However, mice deficient in IL-
12 signalling displayed normal levels of TSLP implying involvement of other 
factors in the IL-12/TSLP axis.  
In addition, the availability of mice defective in IL-12 associated pathways 
prompted us to test the hypothesis that alteration of the cytokine network in 
the gut may contribute to shape the intestinal microbiota. Thus, by using 16S 
pyrosequencing we have studied the composition of the gut microbiota in mice 
deficient for IL-12p40, IL-12Rβ2, and IFN-γ in comparison to WT mice. In 
parallel, we have monitored the metabolome of the microbiota and the host 
intestinal tissue. 
Finally, we have described a novel pathogen-exclusion mechanism mediated by 
CX3CR1+ cells that migrate into the intestinal lumen upon Salmonella infection. 
This event is orchestrated by a lympho-epithelial crosstalk involving MyD88-
dependant epithelial signal. CX3CR1-dependant migration is vital for pathogen 
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Chapter 1: General introduction 
 
1. Gastrointestinal (GI) tract  
The gastrointestinal (GI) tract with help from the salivary glands, liver, and 
pancreas fulfils ingestion, digestion, absorption and defecation.   
The GI tract can be divided into upper and lower1. The upper GI tract consists of 
mouth, pharynx, oesophagus, stomach, and duodenum. The lower GI tract 
consists of jejunum, ileum, cecum, colon, rectum, and anal canal. This division 
delineates the embryonic origins of the different compartments as being 
foregut or midgut derived. The exact demarcation between the upper and lower 
tracts is the suspensory ligament of the duodenum (also known as the Ligament 
of Treitz) (Mazziotti et al., 1997, AMR, 1991) (Figure 1).  
There is no specific anatomical landmark that divides jejunum from ileum. It is 
accepted that the first 40% of the length are jejunum and the remaining 60% 
are ileum (Seiden et al., 2013).  
Together the duodenum, jejunum, and ileum constitute the small intestine (SI) 
whereas the cecum, colon, rectum, and anal canal2 constitute the large 
intestine (LI) (Figure 1). 
                                                 
1
 Other classifications may refer as lower GI tract only to the colon, rectum, and anal canal. 
2




Figure 1 Anatomy of the human GI tract (Research, 2015). 
Each segment of the GI tract has specific function and its anatomical features 
are suited accordingly but in most broad terms the GI tract is a multilayered 
tube. The series of tissue layers that build the tube are referred to as the GI 
wall. The cavity within the GI tract is called GI lumen. Four general layers 
(ordered from the lumen inward) could be distinguished, namely: mucosa, 
submucosa, muscular layer, and serosa/adventitia (Figure 2). 
For the purpose of this work mucosa of the SI (and to a lesser extend LI) will be 




Figure 2 The four layers of the GI tract are the mucosa, submucosa, muscularis, 
and serosa (John Wiley & Sons, 2011). 
2. Mucosal associated lymphoid tissue (MALT) 
Organs of the immune system are distributed throughout the body such that 
defence can be provided regardless of pathogen entry route. The spleen is the 
main organ involved in generation of response against pathogens that have 
entered the tissues and spread into the blood stream. Equally important site of 
adaptive immune response generation is the mucosal immune system that is 
located near the environmentally exposed and highly vulnerable mucosal 
surfaces of the body. The mucosal surfaces are thin and permeable barriers due 
to their physiological activities such as gas exchange (lungs), nutrient absorption 
(intestine), secretory activities (eyes, nose, mouth), and reproduction (uterus 
and vagina). The mucosal associated lymphoid tissue (MALT) of the body 
include: the gut associated lymphoid tissue (GALT), broncho associated 
lymphoid tissue (BALT), nasal associated lymphoid tissue (NALT), genital 
associated lymphoid tissue (GENALT).  
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All mucosal surfaces are protected by an epithelial layer which is often 
reinforced by mucus and antimicrobial products as well as both innate and 
adaptive components of host defence (Rubtsov et al., 2008). In case of the gut 
and the lung this epithelium consists only of a single layer of cells whereas the 
vaginal and mouth epithelium is stratified. Underneath the epithelium usually 
there is a layer of connective tissue and a muscle layer. In addition, mucosal 
surfaces are heavily populated by immune cells (Chaudhry et al., 2011). Immune 
cells originating from each mucosal site could migrate to anatomically 
associated lymph nodes. For example, the tracheobronchial lymph nodes are 
involved in immune response generation towards antigen encountered in the 
lung mucosa, whereas the mesenteric lymph nodes are part of the GALT 
(Chaudhry et al., 2011). 
3. Intestinal mucosa 
Intestinal mucosa consists of epithelial layer and underlying lamina propria (LP) 
(Figure 3). Intestinal LP is a loose connective tissue, rich in vascular networks 
and lymphatic vessels. A myriad of cells reside within the LP, such as 
myofibroblasts, fibroblasts, mural cells (pericytes), bone marrow–derived 
stromal stem cells (Powell et al., 2011), neural endings (Furuya et al., 2005), and 
numerous lymphoid and myeloid immune cells.  
Essential for the coexistence of commensal microbiota and mucosal immune 
cells is the ability to maintain the separation between host and microorganisms. 
The intestinal epithelium forms a physical and biochemical barrier to both 
commensal and pathogenic microorganisms present in the lumen, thus acting as 
a separator between the external environment and the immune system. 
Moreover, intestinal epithelial cells (IECs) can sense and respond to microbial 
stimuli and are involved in the immune response in both cases of tolerance and 
anti-pathogen immunity. The surface area of the GI mucosa is vast and the 
lumen is inhabited by billions of microorganisms which means that the GI 





Figure 3 Schematic illustration of the intestinal mucosa. The microbes, intestinal 
epithelium and the underlying immune system interact closely to establish and 
maintain intestinal immune homeostasis. The presence of pathogen-associated 
molecular pattern receptors on IECs and antigen transport across follicle-
associated epithelium (FAE) M cells allow the gut immune system to examine 
the luminal contents and to generate appropriate response in case of pathogen 
invasion. After the initial interaction within the Peyer’s patches, the inductive 
sites of mucosal immunity, antigen-specific B and T cells recirculate to the 
effector site, i.e. the LP. A mucus layer produced by the goblet cells protects the 
epithelium; the mucus contains antimicrobial peptides and a large amount of 
secretory IgA the main role of which is to prevent microbes from crossing the 
epithelial barrier. IEC= intestinal epithelial cell; IEL= intra-epithelial lymphocyte; 
DC= dendritic cell; M cell= microfold cell; IgA= immunoglobulin A. 
 
In mammalian gut the intestinal immunological microenvironment is shaped by 
this continuous cross talk involving the intestinal epithelium, the immune 
system and the local microbiota (Figure 4). In order to gain in depth 
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Figure 4 Three-way cross talk in the gut. Homeostasis in the mammalian gut is 
established and kept by an interaction between three components: the host 
immune system, the intestinal epithelium which separates the inner milieu from 
the environment, and the myriad of microorganisms inhabiting the gut. 
 
3.1. Gut-associated lymphoid tissue (GALT) 
The GALT consists of i) secondary lymphoid organs: Peyer’s patches (PPs) and 
mesenteric lymph nodes (MLNs); ii) tertiary organized lymphoid tissues: 
cryptopatches and isolated lymphoid follicles; iii) dispersed cells: intraepithelial 
lymphocytes (IELs), LP immune cells. 
3.1.1. Mesenteric lymph nodes (MLNs) 
Lymph nodes are important immunological structures performing a series of 
vital functions: recruiting large numbers of naїve lymphocytes from the blood; 
collecting antigen and DCs from peripheral tissues; providing environment for 
antigen-specific tolerance; modulating the homing characteristics of effector or 
memory T cells. 
MLNs are lymph nodes located within the layer of mesentery and are 
designated to receive antigen originating from the gut.  
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Two main regions can be distinguished histologically in the MLNs — the cortex 
and the medulla. The cortex itself is composed of paracortex (the T-cell area), 
and a more superficial B-cell area. The B-cell follicles are the main site of 
humoral responses, whereas the paracortex is the site where DC-T cell 
interactions occur. The medulla is a labyrinth of lymph-draining sinuses that are 
separated by medullary cords containing many plasma cells, some macrophages 
and memory T cells (von Andrian and Mempel, 2003).  
In the MLNs, conventional DCs (cDCs) can be generally classified into lymphoid 
tissue resident cDCs, which are believed to originate from circulating precursors 
that enter directly from the blood, and migratory cDCs that arrive in organized 
lymphoid tissues via afferent lymph after acquiring antigen (Ag) in the intestine 
(Persson et al., 2013). 
3.1.2. Peyer’s patches (PPs) 
Peyer's patches (PPs) are macroscopic aggregates of lymphoid follicles (Figure 
3). They are present throughout the small intestines of humans and other 
mammals. Importantly, PPs are considered a gateway through which luminal 
dietary/microbial antigens are sampled by the mucosal immune system. Both 
complex and highly dynamic is the cellular composition of the PP, with at least 
four known major cell types identified as migratory in case of antigenic 
stimulation (Ahlawat et al., 2014) (Figure 3).  
PPs consist of a number of large B-cell follicles intervened by T-cell areas. In the 
core of the follicle is the germinal center (GC) which is surrounded by follicular 
mantle (FM). B-cell activation requires engagement of CD40 on conventional 
IgM+ B cells by CD40 ligand (CD40L) on CD4+ Th cells. Antigen-activated B cells 
differentiate into centroblasts that undergo clonal expansion in the dark zone of 
the GC. During proliferation, the process of somatic hypermutation (SHM) 
introduces base-pair changes into the V(D)J region of the rearranged genes 
encoding the immunoglobulin variable region of the heavy chain and light chain. 
Centroblasts then differentiate into centrocytes and move to the light zone. 
With help from Th and DCs there the modified antigen receptor is selected for 
improved binding to antigen. A subset of centrocytes undergoes 
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immunoglobulin class-switch recombination (CSR). In general, CSR diversifies 
the antibody effector functions by substituting the heavy-chain constant region 
of IgM and IgD with that of IgG, IgA, or IgE (with IgA being favored in the PPs). 
Cycling of centroblasts and centrocytes between dark and light zones seems to 
be mediated by a chemokine gradient, presumably established by the stromal 
cells. Centrocytes that produce an unfavorable antibody are eliminated by 
apoptosis. Antigen-selected centrocytes eventually differentiate into memory B 
cells or plasma cells (Klein and Dalla-Favera, 2008). FM comprises B-cells that 
have not passed through a GC (Isaacson and Du, 2004). The area between the 
follicle and the epithelium is the subepithelial dome (SED). It is a diffuse area 
harboring numerous dendritic cells (DCs). In the SED there are also B cells which 
resemble the marginal zone (MZ) B cells of the spleen. These cells 
spontaneously release antibodies with low affinity and broad specificity (Cerutti 
et al., 2013).   
A single layer of columnar epithelial cells, known as the follicle-associated 
epithelium (FAE) separates the lymphoid areas from the intestinal lumen. The 
FAE differs from the epithelium that covers the villus mucosa by means of less 
digestive enzymes and a less pronounced brush border. The most notable 
feature of the FAE is the presence of specialized enterocytes that have no 
microvilli. Due to their characteristic microscopic appearance those cells are 
called microfold (M). M cells bind invasive pathogens, such as Salmonella, 
Shigella, Yersinia and reoviruses, and other particulate antigens which get 
transported across the epithelium and are then available for sampling by the 
immune system. Up until recently, M cells were considered to provide the main, 
if not the only, way in which complex antigens can gain access to the intestinal 
immune system. Other ways of antigen transport from the lumen are described 
in Chapter 1 section 3.2.2.2 and Chapter 5. The M cells do not process antigens 
themselves and they do not express MHC class II molecules. Instead, they 
provide a route of entry for intact antigen to be uptaken and processed by 
professional antigen presenting cells (APCs) in the dome region (Debard et al., 
2001, Kerneis et al., 1997, Golovkina et al., 1999). 
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3.1.3. Cryptopatches (CP) and isolated lymphoid follicles (ILF) 
In comparison to the PPs and the MLNs these lymphoid structures have been 
studied much less extensively. CP and ILF are relatively small lymphoid 
structures dispersed throughout the SI. They vary in size and cellular 
composition within the individual as well as significant variations is observed 
between species, ages and mouse strains (Pabst et al., 2005).  
CP are numerous small and randomly distributed clusters of lymphoid cells in 
the basal LP of the murine intestine and are predominantly  composed of 
lineage negative (CD3–CD4–CD8–B220–) cells expressing the stem cell factor c-kit 
(CD117) (Kanamori et al., 1996, Saito et al., 1998). 
ILF have been described in human (Moghaddami et al., 1998), mouse (Hamada 
et al., 2002) and some other species (Rosner and Keren, 1984). There are 
approximately 100–150 ILF in the mouse gut. The cellular composition of ILF 
resembles that of PPs: predominantly filled with B cells. In addition ILF may 
possess germinal centers and a FAE containing M cells. Thus, ILF along with PPs 
are assumed inductive sites for intestinal immune reactions. They share 
common developmental traits as assembly of both structures requires IL-7Ra 
and LTa signaling (Pabst et al., 2005). 
According to some authors CP and ILF serve non-overlapping functions and 
differ in localization, size and cellular composition. Therefore, they are usually 
regarded as two genuine and separate types of intestinal lymphoid aggregations 
(Hamada et al., 2002). On the other hand, there are publications suggesting that 
a clear-cut distinction between ILF and CP is not plausible (Pabst et al., 2005). 
3.1.4. Lamina propria (LP) immune cells 
In order to understand the immunological processes in the intestinal mucosa it 
is important not to underestimate its complexity and the numerous interactions 
occurring between the varieties of cell types present. This section does not 
attempt to provide a comprehensive description but is rather a brief account 
acknowledging this complexity. There are recent reviews for the individual cell 




LP Dendritic cells (DCs) and macrophages (MΦs) 
Inducing tolerance to harmless antigens, initiating protective immunity against 
intestinal pathogens, and contributing to intestinal diseases including celiac 
disease and the inflammatory bowel diseases (IBD) are all suggested to be 
mediated by DCs (Persson et al., 2013). 
The characterization of DCs in the intestinal LP has been the subject of intense 
investigation and controversy, mainly due to most of their surface markers 
(including CD11c, CD11b and MHC class II (MHCII)) being shared with the 
macrophages (MΦs) (Persson et al., 2013). 
DCs can be distinguished (but not exclusively) from the MΦs by their lack of 
expression of the high-affinity IgG receptor FcγR1 (CD64) (Tamoutounour et al., 
2012). In addition, MΦs do not express the integrin αE chain CD103. Substantial 
number of the CD64+ appear to be CX3CR1high and there are also some CX3CR1int 
(Tamoutounour et al., 2012). By and large, CD11c+MHCII+CD64− cells are F4/80− 
and the majority of these cells express CD103. These CD103+ DCs are considered 
the prototypic migratory cDCs in the LP and can be divided into two main 
populations differing in their localization, transcription factor requirements, and 
function: CD103+CD11b+ and CD103+CD11b− cDCs (Persson et al., 2013). Further 
discussion of the intestinal DCs and MΦs is provided in a Chapter 5.  
Neutrophils 
Polymorphonuclear leukocytes (PMN), also called neutrophils are a vital 
element of the innate immune system and comprise a critical component of the 
army of first responses to sites of inflammation (Fournier and Parkos, 2012). 
Neutrophils can secrete cytokines such as TNF-α, IL-1β, IL-1ra (Nikolaus et al., 
1998), IL-17 (Ferretti et al., 2003, Zindl et al., 2013), IL-22 (Zindl et al., 2013).  
Unfortunately, clear cut understanding of PMN function in inflammatory 
diseases such as IBD (which is characterized by intestinal infiltration of 
neutrophils) has not yet been achieved (Fournier and Parkos, 2012). A detailed 






Basophils were discovered by Paul Ehrlich in 1879 (Ehrlich, 1879) but still there 
are many unknowns in regards to their function. Basophils constitute less than 
0.3% of leukocytes in the peripheral blood. They are functionally closely related 
to mast cells as both cell types express the high-affinity receptor for IgE and 
produce similar effector molecules, including histamine, lipid mediators (eg, 
leukotrienes and prostaglandins), serine proteases, and interleukins (eg, IL-4, IL-
13, and IL-6) (Falcone et al., 2006).  
Basophils are effector cells of the innate immune system that are associated 
with allergic inflammation and infections with helminth parasites (Ohnmacht 
and Voehringer, 2009). Upon infection with the helminth Nippostrongylus 
brasiliensis increased de novo production in the bone marrow leads to 
basophilia. In such cases basophils are found near the marginal zone in the red 
pulp of the spleen, in the LP of the small intestine, and in the lung parenchyma.  
Basophils are also found in the lungs of patients with allergic asthma 
(Devouassoux et al., 1999). Increased number of basophils is found in the skin of 
contact dermatitis or atopic dermatitis patients during late-phase response 
(Dvorak and Mihm, 1972).  
Eosinophils 
The GI tract is a primary site for normal eosinophil residence. Significant 
progress has been made in elucidating that eosinophils are integral members of 
the GI mucosal immune system. In physiological states, small numbers of 
eosinophils are found throughout the GI tract except the esophagus (Zuo and 
Rothenberg, 2007). 
Mast cells 
Mast cells comprise 2–5% of mononuclear cells in the LP of the normal GI tract. 
Previous studies have documented an increased number of mast cells in 
gastrointestinal mucosa of patients with gastrointestinal diseases such as 
irritable bowel syndrome (Ramsay et al., 2010).  
Mast cells are preferentially located next to nerve terminals in the LP, where 
they are activated by secreted neuropeptides such as substance P. When 
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stimulated by substance P, these mast cells release inflammatory mediators, 
such as serotonin and proteases, as well as proinflammatory cytokines. In 
addition release of histamine and prostaglandin D2 by intestinal mast cells is 
important for chloride and water secretion as well as control of intestinal 
motility (Ramsay et al., 2010). 
Innate lymphoid cells (ILCs) 
Now we had a look at the usual suspects, it is time to introduce some new stars 
of immunology – innate lymphoid cells (ILCs). According to the current 
classification (Spits et al., 2013) the natural killer (NK) cells and the lymphoid 
tissue-inducer (LTi) cells also belong to the ILCs. Indeed, both NK and LTi cells 
have been known for 40 years (Kiessling et al., 1975) but for all that time 
nobody suspected that there will be even more such cells out there.  
Three main features define the ILCs: i) the absence of recombination activating 
gene (RAG)-dependent rearranged antigen receptors; ii) a lack of myeloid cell 
and  iii) dendritic cell phenotypical markers; and their lymphoid morphology 
(Spits and Cupedo, 2012). 
Similarly to NK cells and lymphoid tissue-inducer (LTi) cells ILCs depend on γc 
and ID2  for their development (Boos et al., 2007). In addition, ILCs also require 
signaling through interleukin-7 receptor subunit-α (IL-7Rα) for development and 
maintenance (Spits et al., 2013). Different ILC populations have distinct patterns 
of cytokine production mirroring the cytokine-secreting profiles of Th cell 
subsets (Spits and Di Santo, 2011).  
The proposed classification of ILCs identifies three groups; all based on 
functional criteria. Group 1 ILCs are defined by their capability to produce 
interferon-γ (IFNγ) (NK cell belong to this group). Group 2 ILCs are able to 
produce T helper 2 (Th2) cell-associated cytokines, such as IL-5 and IL-13. Group 
3 ILCs are capable of producing IL-17 and IL-22 (Spits et al., 2013). The 
prototypical Group 3 ILCs are LTi cells, which are crucial for the formation of 
secondary lymphoid organs during embryogenesis (Spits et al., 2013). These 
cells have also been reviewed recently (Spits et al., 2013). 
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ILCs have been appreciated as key orchestrators of immune defenses at 
mucosal surfaces. For example, ILC3s have been shown to mediate intestinal 
epithelial cell (IEC) glycosylation by stimulating Fut2 expression in the 
epithelium. Epithelial fucose is used as a dietary carbohydrate by many of the 
commensal bacteria thus mediating host-microbiota interaction. Fucosylation of 
IECs in response to pathogens such as Salmonella enterica Typhimurium is also 
mediated by ILC3 (Goto et al., 2014).  
Example of the ILC2s (previously referred to as nuocytes) intestinal mucosal 
function is their expansion in vivo in response to the type-2-inducing cytokines 
IL-25 and IL-33. ILC2s represent the predominant early source of IL-13 during 
helminth infection with Nippostrongylus brasiliensis (Neill, 2010). 
T-cells 
The amount of information on systemic and mucosal T-cells is startling. 
Therefore this section is by no means comprehensive. Nevertheless, a short 
outline of the intestinal mucosa T-cells will be provided, just to underline the 
complexity and variety of the intestinal mucosal immune system. The 
intraepithelial lymphocytes (which are also T-cells) are discussed in this section 
despite being located in the intraepithelial region instead of the LP.  
Homing of T-cells in the gut is believed to be mediated by CCL25 (Wurbel et al., 
2007).  
CD8+ T-cells  
LP resident CX3CR1+ cells induce differentiation of precursor cells into CD8+ T-
cells expressing IL-10, IL-13, and IL-9 via antigen presentation. These CD8+ T-
cells are capable of migrating into adjacent compartments (such as the 
intraepithelial) and control the activation of CD4+ T-cells in the small intestine 
(Chang et al., 2013). 
CD4+ T-cells 
Among the intestinal lymphocytes, the CD4+ T cells are key mediators of host 
protective and homeostatic responses. The greatest proportion of CD4+ T cells 
in both small intestine and colon LP express CD44hiCD62L− effector memory 
phenotype of antigen-experienced cells (Targan et al., 1995, De Maria et al., 
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1993). Only a minority of LP CD4+ T cells harbor surface markers associated with 
naїve T cells (Cose et al., 2006). What are the functions of those cells and 
whether they can undergo priming in the LP is not yet studied (Shale et al., 
2013). 
Presumably, priming of CD4+ T cells that populate the LP occurs predominantly 
in the MLN by DCs originating from the intestinal mucosa (Shale et al., 2013, 
Coombes and Powrie, 2008). During the interaction between DCs and naїve 
CD4+ T cells cytokine receptor ligation can modulate the activation of the T cells 
into particular types (also referred to as lineages or subsets). These CD4+ T cell 
subsets can be identified by expression of certain transcription factors and 
effector molecules. There is evidence accumulating that these CD4+ T cell 
subsets are not terminal and their differentiation exhibits a certain degree of 
plasticity (Brucklacher-Walderet et al., 2014; Hooper and Macpherson, 2010). 
The most widely recognized subsets are Th1, Th2, Th17, and Treg (Brucklacher-
Waldert et al., 2014) (Figure 5).  
DCs’ production of IL-12 is essential for Th1 differentiation. IL-12 effects are 
mediated via STAT4 and along with T-bet and H2.0-like homeobox 1 are 
deemed essential for Th1 IFNγ production (Heufler et al., 1996, Lugo-Villarino et 
al., 2003). IL-18 is a cytokine that has been described to amplify the effects of IL-
12 (Vossenkamper et al., 2004). Th1 responses are essential for the elimination 
of intracellular pathogens (Jong et al., 1998). Liu et al. (2014) have shown that 
TGFβ, IL-6, and IL-2 can drive Th1 to Th17 conversion in the intestine (Liu et al., 
2015, Lee et al., 2009).  
Development of Th2 requires IL-4 (Swain et al., 1990); in addition IL-13, which 
has partially overlapping functions with IL-4, can independently drive Th2 
polarization (Punnonen et al., 1993), whereas IL-12 is a potent Th2 inhibitor 
(Gavett et al., 1995). The actions of IL-4 and IL-13 are mediated by the 
transcription factor STAT6 (Kaplan et al., 1996). Another transcription factor 
required for the Th2 effector properties, such as IL-3 and IL-13 secretion, is 
GATA-3 (Kitamura et al., 2005). It exerts STAT6 independent auto-activation 
creating a feedback mechanism that stabilizes the Th2 commitment (Ouyang et 
al., 2000). Th2 responses are essential for protective immunity against intestinal 
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helminths (Turner et al., 2003) whereas their inappropriate exacerbation has 
been associated with allergic hypersensitivity (Deu et al., 2010; Licona-Limon et 
al., 2014). Initially linked to Th2 phenotype, IL-9 production is now attributed to 
a separate class of CD4+ T helper cells - Th9, which are also expressing the 
transcription factor PU.1 (Gessner et al., 1993, Veldhoen et al., 2008, Gerlach et 
al., 2014). TGF-β is essential for Th2 to Th9 reprograming (Veldhoen et al., 
2008).  
Cytokines implemented in the differentiation of Th17 include IL-23, IL-6 (Zhou et 
al., 2007) and to some extent TGF-β (Ghoreschi et al., 2010; McGeachy et al., 
2007). IL-6 induces expression of IL-21 that amplifies an autocrine loop leading 
to enhanced expression of IL-21 and IL-23 receptors, where IL-21 and IL-23 
stimulate IL-17 production. STAT3 is required for mediating IL-6 and IL-21 
signaling and along with RORγt promote IL-17 upregulation (Zhou et al., 2007). 
It has been suggested that adenosine 5’-triphosphate derived from the gut 
microbiota activates CD70high CD11clow DCs to produce IL-6, IL-23p19 and TGF-β-
activating integrin-αV and -β8 thus driving Th17 differentiation (Atarashi et al., 
2008). Another microbiota-induced, intestine-specific factor involved in Th17 
response is IL-1β (Show et al., 2012). IL-10 and IL-2 have been shown as 
negative Th17 regulators (Huber et al., 2011; Yang et al., 2011). MLNs rather 
than intestinal tissue are essential for generation of gut homing Th17 cells 
(Kawabe et al., 2013). Th17 cells are important for the defense against 
extracellular bacteria such Citrobacter rodentium and Klebsiella pneumoniae, as 
well as other pathogens of fungal (Candida albicans) and viral (influenza H1N1) 
origin (Conti et al., 2009; Huang et al., 2004; Ye et al., 2001; Crowe et al. 2009). 
A number of pathologies have been associated with aberrant Th17 response, 
one example being IBD (Fujino et al., 2003; Seiderer et al., 2008). Th17 are 
enriched at mucosal sites and produce IL-17A, IL-17F, and IL-22 (Littman and 
Rudensky, 2010). However, not all Th17 secrete IL-22; what is more, there are 
IL-17 negative CD4+ helper T cells that secrete IL-22 which are referred to as 
Th22 (Duhen et al., 2009, Basu et al., 2012). Citrobacter rodentium infection 
induces IL-22 in ILCs and CD4+ T cells. IL-22 production by ILCs is heavily 
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dependent on IL-23 whereas Th22 development occurs via IL-6 dependent 
mechanism. CD4+ T cells, differentiated to Th22 (but not Th17) in the presence 
of IL-6 and absence of TGF-β, when transferred to infected IL-22-deficient mice 
are able to establish protection against Citrobacter rodentium (Basu et al., 
2012). 
Compared to the systemic immune system, the intestinal mucosa is enriched for 
Treg cells (Uhlig et al., 2006a). Characteristic for those is the expression of the 
transcription factor Foxp3 and secretion of IL-10. A number of small intestinal LP 
IL-10 producing T cells are Foxp3 negative and are classified as Tr1 (Maynard et 
al., 2007). LP DCs promote Treg differentiation by TGF-β and retinoic acid 
secretion (Sun et al., 2007). Treg cells, after their generation in the MLN, home 
to the gut where they undergo local expansion which is important for oral 
tolerance (Hadis et al., 2011a). Mice with Treg specific ablation of IL-10 show 
that IL-10 production by Treg cells is not required for the control of systemic 
autoimmunity but is critical for maintaining homeostasis at mucosal sites such 
as colon and lungs (Rubtsov et al., 2008). In addition, mice with Treg-specific 
deletion of IL10Ra and STAT3 also exhibit severe colitis (Chaudhry et al., 2011). 
The Treg-derived cytokine IL-35 has been recently identified as a contributor to 






Figure 5  There are four widely recognized CD4+ T cell subsets. They are 
characterized by expression of certain transcription factors and secretion of 
effector molecules. The cytokines positively regulating each subset 
differentiation are in green and the negative regulators are in red. 
 
Intraepithelial lymphocytes (IELs) 
IELs comprise antigen-experienced T cells belonging to both the T cell 
receptor-γδ (TCRγδ)+ and TCRαβ+ lineages. Particular IEL subsets are found in 
the epithelium of the small and large intestine (Cheroutre et al., 2011). The 
small intestinal IELs could be up to 60% TCRγδ+ antigen-experienced cells, 
expressing activation markers, such as CD44 and CD69 (Cheroutre, 2004). These 
cells are tissue associated and are not recirculating. On average for every five 
IECs there is one intestinal IEL (Hershberg and Mayer, 2000). Effector cytokines 
expressed by IELs include IFNγ, IL-2, IL-4 or IL-17 (Offit and Dudzik, 1989, Guy-
Grand, 1991, Guy-Grand et al., 1991, Roberts et al., 1993, Chardes et al., 1994, 
Muller et al., 2000, Shires et al., 2001, Tang, 2009).  
IELs interact with IECs via the constitutively expressed CD103 (also known as the 
αE integrin). CD103 binds E-cadherin on IECs (Kilshaw and Murant, 1990, Cepek, 
1994). 
Activated small intestinal IELs tend to express CD8αα homodimers (Leishman, 
2002, Denning, 2007). CD8 exists on the T-cell surface in two isoforms, CD8αα 
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and CD8αβ. CD8αβ is a much stronger co-receptor for MHC-I than CD8αα, the 
expression of CD8β enhances TCR sensitivity about 100-fold compared to 
CD8αα (Yachi et al., 2005). CD8αα might be a negative regulator of MHC-I T-cell 
activation (Cheroutre and Lambolez, 2008). The thymus leukaemia antigen (TLA) 
is a non-classical MHC class I molecule that is widely expressed by mouse small 
intestinal ECs and is ligand for the CD8αα. Some TCRαβ IELs along with CD8αα 
also express CD4 or CD8αβ, but very few of the IELs are CD4+ compared to the 
LP lymphocytes (Cheroutre et al., 2011).  
IELs can be divided in two subsets depending on how they have acquired their 
antigen-experienced phenotype. The first subset are the thymus activated (also 
called ‘natural’/type b) IELs that have maturated during development in the 
thymus in the presence of self-antigens. They are either CD8αα+ or CD8αα− T 
cells that express TCRγδ or TCRαβ but do not express CD4 neither CD8αβ  
(Cheroutre et al., 2011). Natural IELs are the first type of antigen-experienced T 
cells to populate the gut, even before birth. 
The second subset (also known as ‘induced’/type a) derive from conventional 
CD4+ or CD8αβ+ TCRαβ+ T cells, that have been activated post-thymically in 
response to peripheral antigens (Cheroutre et al., 2011). They typically express a 
'memory-like phenotype' (CD2+ CD5+ CD44+ LFA1+ THY1+), and are CD8αα 
positive. The conventional T cells in the periphery have polyclonal origin, 
whereas induced IELs are found oligoclonal based on their TCR diversity. At birth 
there are barely any induced IELs, but their population grows with age as the 
organism encounters more and more exogenous antigens. The small intestine 
contains at least ten times more IELs than the colon (Cheroutre et al., 2011). 
B-cells 
The traditional view about the intestinal immune system is that it includes an 
immunoglobulin (Ig)A-inductive site represented by the PPs and an IgA effector 
site represented by the LP (Figure 3). As described above, B cells undergo IgM to 
IgA class switch in the PPs but recently studies have shown the presence of 
active IgA class switching also in the LP (Cerutti, 2008). 
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3.2. Intestinal epithelial cells (IECs) 
Intestinal epithelium is formed by a single layer of cells, held tightly together by 
specialized proteins. Four cell lineages: absorptive enterocytes, which make up 
most IECs, mucus-producing goblet cells, hormone-producing enteroendocrine 
cells, and Paneth cells, which produce antimicrobial peptides or lectins, could be 
found in the intestinal epithelial layer.  
Intestinal epithelium is simultaneously a link and separator between the luminal 
content and the immune system. It is no longer just a nutrient transporter, now 
we know that it is also capable of fine-tuning the immune response and breach 
of this epithelial function might be cause of disease. Before looking into the 
immunological “vocabulary” of the IECs we will first have a glance at the 
intricate lifecycle of these cells and their constant renewal occurring with 
remarkable speed and precision. 
3.2.1. Life and death of the IECs 
Mammalian intestinal epithelium is renewed every 3 to 5 days (Creamer et al., 
1961) with up to 1011 IECs (~200 g) being lost every day in humans (Barker, 
2014). This process of renewal must be tightly regulated in order to ensure 
continuous integrity of the epithelial layer where the epithelial cells are tightly 
attached to each other without any gaps that might compromise the barrier.  
In the small intestine each villus is “fed” with cells by at least six crypts of 
Lieberkühn, which house dedicated populations of LGR5+ (Leu-rich repeat-
containing G protein-coupled receptor 5-expressing) crypt base columnar 
(CBC) stem cells that divide and produce all the cell types present in the 
epithelium. Stem cell activity is strictly regulated during homeostasis by a 
complex array of signals delivered by neighbouring cells, such as Paneth cells, 
which are found in close association with the stem cells at the crypt base and 
are an important source of various niche factors, including epidermal growth 
factor (EGF), WNT3A, and Notch ligand. In addition Paneth cells enable 
adequate response to change of nutrient availability. In case of calorie 
restriction Paneth cells reduce mTOR complex 1 (mTORC1) signalling, thus 
resulting in a rapid reduction of the LGR5+ stem cell pool (Barker, 2014).  
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The colonic stem cell niche is less well defined. Since Paneth cells are generally 
absent from the colon it is believed that CD24+ and KIT+ goblet cells that are 
located in close proximity to LGR5+ stem cells at the crypt base are instead 
involved in the steam cell niche (Rothenberg et al., 2012). 
The small populations of adult stem cells regularly divide to produce highly 
proliferative progenitors known as transit-amplifying cells. After 2 – 3 divisions 
transit-amplifying cells gradually commit to terminal differentiation and migrate 
upwards towards the beginning of the villus (Rothenberg et al., 2012). Despite 
the outlined above findings there is still no consensus on the true identity 
(transit-amplifying versus LGR5+) of adult intestinal epithelial  stem cells. It is 
likely that the niche harbours a lot of plasticity and the dedicated active stem 
cells (LGR5+) are responsible for daily epithelial homeostasis but in case of injury 
the more quiescent ‘reserve’ stem cells (the transit-amplifying cells) can be 
activated in order to facilitate repair. 
With the recent advance of molecular biology several signalling pathways 
involving WNT, bone morphogenic protein (BMP) (He et al., 2004), and Notch 
(VanDussen et al., 2012) have been identified as involved in maintaining the 
stem cell niche and driving intestinal epithelial differentiation.  
WNT signals are important to maintain a proliferative, undifferentiated 
environment for the LGR5 stem cells, as well as driving Paneth cell maturation.  
The seven transmembrane segment receptor LGR5, which is used as a stem cell 
marker, is itself linked to stem cell homeostasis. Conditional epithelial deletion 
of LGR5 and its close homologue LGR4 results in the suppression of WNT 
signalling and stem cell death (de Lau et al., 2011). LGR5 at the plasma mem-
brane recruits roof plate-specific spondin (R-spondin)-a WNT agonist, thus 
amplifying WNT signalling and ensuring stem cell homeostasis in vivo (Glinka et 
al., 2011) (Carmon et al., 2011).  
Intestinal cell differentiation is additionally controlled by Notch which maintains 
the undifferentiated proliferative state of crypt progenitors and also controls 
the differentiation of the transit-amplifying cells into absorptive enterocytes or 
secretory cells (Fre et al., 2005). Notch inhibition induces the expansion of 
secretory cell populations, mainly goblet cells, at the expense of enterocytes. 
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Understanding of these interactions enabled in 2014 a homogenous niche-
independent culture of LGR5+ stem cells to be maintained (Yin et al., 2014).  
Notch and WNT signalling just build a general scaffold of intestinal stem cell 
renewal and differentiation but it is likely that other pathways are also involved 
and allow for fine-tuning and adjustment to the environmental changes such as 
calorie restriction (as already described) or pathogenic challenge. It has been 
found that Lgr5+ stem cells constitutively express the intracellular receptor 
Nod2. Nod2 stimulation by muramyl-dipeptide (MDP), a peptidoglycan motif 
common to all bacteria, prompts stem cell survival and protection against 
oxidative stress-mediated cell death (Nigro et al., 2014).  
Whereas WNT signalling is characteristic of the crypt region, BMP signalling is 
active in the villi and antagonizes WNT-induced crypt formation and stem cell 
renewal, limiting crypt expansion. Noggin and Chordin1 are BMP antagonists 
expressed in the crypt base and prevent BMP-induced WNT inhibition (He et al., 
2004) (Kosinski et al., 2007).  
Epithelial BMP signalling plays an important role in the terminal differentiation 
of the intestinal secretory cell lineage (Auclair et al., 2007). BMP receptors 
(BMPR) Ia, BMPR Ib, and BMPR II are all expressed in colonic epithelial cell lines 
(HT29, Caco-2, DLD-1, SW480, HCT116, and LS174-T). In vitro BMP2 promotes 
apoptosis, differentiation and supresses cell growth. BMP2, BMPRIa, BMPRIb, 
BMPRII, phosphorylated Smad1, and Smad4 are expressed predominantly in 
mature colonocytes at the epithelial surface in normal adult human and mouse 
colon (Hardwick et al., 2004). 
Studies on IECs differentiation have identified 1113 genes differentially 
expressed between the crypt and villus (Mariadason et al., 2005). For example, 
villus cells have increased cell surface membrane protein glycosylation (Weiser, 
1973). MHCI is found in villus and crypt IECs independent of the inflammatory 
state of the mucosa. In contrast, MHCII in the non-inflamed mucosa of healthy 
controls and CD patients in remission is restricted to the villi whereas during CD 
ileitis, both villus and crypt IECs show staining for MHCII (Hundorfean et al., 
2007). Yet another example is IL-32 being largely expressed in the differentiated 
colon epithelial cells but not in the colonic crypts (Netea et al., 2005).  
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Once the IECs reach the villus tip they undergo shedding. Mathematical 
modeling suggests that in the mouse, 1400 mature enterocytes are likely to 
shed from a single villus tip daily (Williams et al., 2014). Regardless of the high 
rate of physiological IEC loss from individual villi, shedding events are observed 
relatively rarely in fixed specimens due to the very short time it takes for each 
cell to be extruded. Examination of hematoxylin and eosin (HE)–stained sections 
of human small intestine reveals shedding cell in less than 6% of villus sections 
(Bullen et al., 2006). 
Pathological shedding has been observed in humans with inflammatory bowel 
disease (IBD) (Kiesslich et al., 2012), in mice following systemic tumor necrosis 
factor (TNF) administration (Watson and Hughes, 2012), and during acute 
murine endotoxic shock (Williams et al., 2013). 
3.2.2. Immunological properties of the IECs 
This section outlines some of the immunological properties of the IECs and aims 
to show that IECs are as important for the maintenance of immune homeostasis 
as are any of the hematopoietic derived immune cells.  
Our research group has focused its attention on the cross talk taking place 
between gut epithelium and cells of the underlying immune system. Indeed, in 
the past few years it has emerged that lympho-epithelial cross talk plays a key 
role in the control of inflammation in the gut by shaping the appropriate 
immunological microenvironment (Swamy et al., 2010). It is well documented 
that IECs signal to the immune system via the secretion of regulatory cytokines. 
In the presence of non-invasive commensal bacteria, intestinal epithelial cells 
secrete molecules such as thymic stromal lymphopoietin (TSLP) (Taylor et al., 
2009) and TGF-β (Barnard et al., 1989); in contrast, pathogens cause epithelial 
cells to release pro-inflammatory factors, such as IL-8 (CXCL-8), MCP-1 (CCL2) 
and MIP-3α (CCL20) (Jung et al., 1995) (Izadpanah et al., 2001). 
3.2.2.1. IECs interaction with the commensal microbiota and pathogens 
A layer of mucus protects the epithelium. In the LI the mucus layer is thick and 
at its closest to the epithelium is considered to be microbe free. In the SI the 
mucus is thinner and more loose which is suggested to provide more 
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opportunities for microbe-epithelium interaction. Nevertheless, antimicrobial 
peptides are produced by the Paneth cells of the SI which aim at reducing the 
microbial load reaching the IECs (Atuma et al., 2001, Bevins and Salzman, 2011).  
Despite these lines of protection microbes or microbial products do reach the 
epithelium. IECs possess a range of receptors evolved to recognise those 
microbes and their products. IECs are structurally and functionally polarized, 
with an apical surface facing the intestinal lumen and a basolateral surface 
facing the underlying basement membrane and LP. Some of the membrane 
bound microbe associated molecular patters (MAMPs) recognition receptors 
are expressed apically, others basolaterally, and some could be both. Additional 
clarification that should be made is that these receptors are often referred to as 
pathogen-associated molecular patterns recognising but in case of the gut - 
commensal microorganisms are also recognised therefore here the term 
MAMPs will be used (Abreu, 2010). Finally, MAMPs receptors are by no means 
restricted to the IECs; many other immune and nonimmune cells are capable of 
expressing MAMPs receptors.  
Toll-like receptors (TLRs) are probably the most studied of all MAMPs 
receptors. In mice and humans combined there are 13 paralogs (TLR10 is only 
present in humans and TLR11–13 is only present in mice). TLRs are single-pass 
(Type I) transmembrane proteins characterized by multiple extracellular 
leucine-rich repeats (LRRs).  TLRs possess a single intracellular Toll/interleukin-1 
(IL-1) receptor (TIR) domain (Moresco et al., 2011). 
TLR2 in conjunction with either TLR1 or TLR6 recognises lipopeptides and other 
components of Gram-positive bacterial cells. TLR4 is the receptor for 
lipopolysaccharide (LPS). There are additional molecules involved in TLR4-LPS 
binding and signalling, namely CD14, MD-2 and sometimes β2 integrins 
(Fitzgerald et al., 2004).  
TLR5 recognizes flagellin. TLR3 is implicated in the recognition of viral dsRNA 
(usually in vitro activated with the synthetic analogue poly I:C), whereas TLR7 
and TLR8 are implicated in ssRNA recognition. Unmethylated DNA and CpG-
oligodeoxynucleotides (CpG-DNA) are detected by TLR9 (Moresco et al., 2011). 
Up until 2014, TLR10 was orphan but now it is suggested that it is a modulatory 
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receptor with mainly inhibitory effects. The modulatory effects of TLR10 seem 
to be determined by competition for ligands or by the formation of heterodimer 
receptors with TLR2, and also PI3K/Akt-mediated induction of the anti-
inflammatory cytokine IL-1Ra (Oosting et al., 2014). 
TLR11 and TLR12 recognise the profilin from Toxoplasma gondii (Koblansky et 
al.). And finally, bacterial 23S rRNA is ligand for TLR13 (Oldenburg et al., 2012). 
Apart from the TLRs there are other membrane bound MAMP receptors. For 
example, C-type lectins, such as DC-SIGN (CD209), Dectin-1 (CLEC7A), Dectin-2, 
Mincle (CLEC4E), Mannose receptor (CD206) have been shown to participate in 
microbe recognition and immune response (Cunha et al., 2012). Other examples 
include Galectin-3, CR3 (CD11b/CD18), CD36 (Cunha et al., 2012).  
In terms of intracellular receptors, the nucleotide-binding oligomerization 
domain receptors, in short NOD-like receptors (NLRs), also called the 
CATERPILLAR family, have been most widely studied. At present they comprise 
more than 20 different mammalian proteins which mostly contain three distinct 
domains: a carboxy terminal ligand recognition (LRR) domain, a centrally 
located nucleotide binding domain (NBD), and a structurally variable amino 
terminal effector binding domain (Cario, 2005). Research has mostly focused on 
two cytosolic receptors of this family, NOD1 (also designated CARD4) and NOD2 
(CARD15), which sense the cytosolic presence of bacterial peptidoglycan 
fragments and their activation leads to phosphorylation of mitogen-activated 
protein kinase (MAPK) and the transcription factor NF-κB. A different set of 
NLRs induces caspase-1 activation through the assembly of large protein 
complexes named inflammasomes (Kanneganti et al., 2007). 
NOD1 recognizes the dipeptide γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP) 
(Chamaillard et al., 2003), which is produced by most Gram-negative and certain 
Gram-positive bacteria (Hasegawa et al., 2006). Muramyl dipeptide (MDP), 
which is peptidoglycan motif common to all bacteria, is the ligand for NOD2 
(Girardin et al., 2003). 
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3.2.2.1. Cytokine signalling and the IECs 
IECs are capable of producing a myriad of cytokines. For example, IECs regulate 
colonic CD4+ T-cell function through production of IL-18. Under homeostatic 
conditions, IL-18R1 signalling limits colonic Th17 cell differentiation, whereas 
during inflammation, Foxp3 Treg cell expression of IL-18R1 is critical for 
prevention of experimental colitis (Harrison et al., 2015). 
Another cytokine form the IECs’ arsenal is IL-15 which is closely relate to IL-2 
sharing similar four-helix bundle structure. IL-15 is found to activate natural 
killer (NK) cells and induce B cell proliferation and differentiation in vitro. Both 
IL-2 and IL-15 require IL-2Rβ and γc for signalling which are found on IECs 
surface (Reinecker et al., 1996). In contrast to IL-2, which is produced by 
activated T cells, IL-15 seems to be expressed by a variety of cell types. It has 
been shown that both human and rodent IECs can express IL-15, particularly in 
the terminal ileum and the colon (Reinecker et al., 1996). Human colon 
intestinal epithelial cell lines (Caco-2, HT-29, and T84) constitutively express IL-
15 (Reinecker et al., 1996). Within 4 h of stimulation with IFNγ Caco-2 cells up-
regulate IL-15 mRNA expression  which slightly drops after 12 h and is almost 
back to normal at 18 h (Reinecker et al., 1996). Interestingly IECs not only 
produce IL-15 but are also capable of responding to it. Upon stimulation with IL-
15 within minutes STAT3 phosphorylation is observed (Reinecker et al., 1996). In 
addition IL-15 treatment induces cell proliferation in Caco-2 (Reinecker et al., 
1996). 
Other epithelial derived cytokines include IL-25 and IL-33 which are produced 
during helminth infection and facilitate ILC2s expansion and IL-13 production 
necessary for parasite expulsion (Neill, 2010). IL-33 has also been implicated in 
IBD where increased expression of full-length IL-33, representing the most 
bioactive form, is detected in UC epithelium, while elevated levels of cleaved IL-
33 are present in IBD serum. Infliximab (anti-TNF) treatment of UC decreases 
circulating IL-33, whereas stimulation of HT-29 IEC confirms IL-33 and sST2 
regulation by TNF (Pastorelli et al., 2010).  
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IECs also secrete IL-7 (Watanabe et al., 1995), IL-6 (McGee et al., 1993), IL-8 
(Steiner et al., 2000), IL-10 (Hyun et al., 2015, Dvorak et al., 2003), IL-26 
(Dambacher et al., 2009), IL-32 (Netea et al., 2005), IL-37 (Imaeda et al., 2013) 
Factors produced by the IECs such as TSLP, TGFβ and retinoic acid condition the 
nearby DCs towards more tolerogenic phenotype (Peterson and Artis, 2014) 
(Mosconi et al., 2013). The production of TSLP has been identified as critical to 
the maintenance of intestinal immune homeostasis. On one hand, the 
constitutive low level production by IECs of this cytokine ensures that the 
immunological environment of the gut is polarized towards a T helper-2 (Th2) 
anti-inflammatory response. On the other hand, over-expression of TSLP is 
linked to the genesis of allergic responses both in the respiratory (Li et al., 2011) 
and gastrointestinal (Blázquez et al., 2010) tract.  
The work described in Chapter 2 and 3, shows that the mouse model of food 
allergy is characterized by reduced levels of IL-12 in the gut and overexpression 
of TSLP. Oral delivery of Lactococcus lactis engineered to secrete bioactive IL-
12p70 resulted in a reduction of TSLP. The mechanisms involved in this 
regulatory interplay between the epithelium-derived TSLP and the lymphoid-
derived IL-12 have been one of the main objectives of this thesis. 
3.2.2.2. Further immunological roles of the IECs 
IgA transport 
Immunoglobulin (Ig)A constitutes the most abundant antibody in the gut, where 
it provides immune protection through both high- and low-affinity binding 
systems. While high-affinity IgA neutralizes toxins and pathogens, low-affinity 
IgA blocks the adhesion of commensal bacteria. Epithelial cells express a 
polymeric Ig receptor that shuttles IgA oligomers secreted by B cells from the LP 
into the lumen. Recent findings indicate that epithelial cells function not only as 
IgA transporters, but also as IgA inducers (Cerutti, 2008). He et al. (2007) have 
found that TLR stimulation prompts colonic epithelial cells to secrete BAFF and 




Antigen sampling/presentation by IECs 
As mentioned previously (section 3.1.2), specialised type of epithelial cells (M 
cells) associated with the PPs transport particulate antigens originating in the 
lumen. It has also been suggested by Karlsson et all. that supra-molecular, 
exosome-like structures assembled in and released by the small intestinal 
epithelial cells are also involved in antigen transport. Those vesicles were 
named “tolerosomes” because when isolated from serum shortly after antigen 
feeding or from an in vitro pulsed intestinal epithelial cell line they were fully 
capable of inducing antigen specific tolerance in naїve recipient animals. These 
structures carry MHC class II with bound antigenic peptides sampled from the 
gut lumen (Karlsson et al., 2001). Yet another way of antigen transport via the 
small intestine goblet cells delivering low molecular weight soluble antigens 
from the intestinal lumen to the underlying CD103+ DCs is also likely to take 
place (McDole et al., 2012). Mouse IECs likewise express CD1d and are capable 
of lipid antigen presentation. Reduction of the epithelial CD1d has been 
implicated in colitis (Olszak et al., 2014).  
4. Immunological processes of the GI tract 
Mammalian digestive tract is populated by numerous and complex microbial 
community. The number of microbial cells can reach 1010-1012 cell/ml, which 
outcompetes any other known microbial ecosystem. Hundreds of species 
comprise these communities, the diversity and metabolic properties of which 
vary from host to host and are also dependant on the gut segment. At birth the 
digestive tract is sterile but gets rapidly colonized. Most of the gut associated 
microbes are not pathogenic and are even beneficial for the host. On the other 
hand, many could cause serious illness. The gastrointestinal part of the immune 
system has the intricate duty of creating tolerance towards the food antigens 
and the mutualistic bacteria whilst combating against invading pathogens. Here 
it will be discussed how the anatomical and cellular characteristics of the GI 
tract outlined in the previous sections interact in order to serve both functions. 
Processes of both steady state and disease will be conferred. 
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4.1. Defence against intestinal pathogens 
Intestinal mucosa is exposed to billions of antigenic molecules. The majority of 
those belong to harmless commensal microorganisms or are food derived and 
therefore the immune system remains unresponsive to them and is even 
tolerised as discussed in section 4.2. On the other hand many pathogens make 
their invasive way via the oral root. Those include bacteria such as Salmonella 
species, certain Escherichia coli serotypes, certain Vibrio spp, certain Clostridium 
spp, Campylobacter spp, etc.; viruses, protozoans and multicellular parasites. 
Several layers of innate and adaptive immune defence are in place to protect 
the GI tract.  
As mentioned previously, a layer of mucus protects the epithelium form 
mechanical, chemical and microbial stress. In the SI the mucus is thinner and 
more loosely attached. In the LI the mucus consists of two layers – upper loose 
and inner dense and microbe free. A range of antimicrobial peptides are 
secreted by the epithelium and released into the mucus layer (Tollin et al., 
2003).  
It has recently been shown that extrusion of infected enterocytes is a way of 
reducing pathogen load. This mechanism is advantageous in case of acute 
insults such as Salmonella Typhimurium that can invade and breach the mucous 
and epithelial barrier. The epithelium-invading Salmonella Typhimurium initially 
replicate within the infected IECs, expulsion of the infected enterocytes into the 
lumen limits this stage of the infection. Epithelium restricted deletion of  
inflammasome components (NAIP1-6, NLRC4, caspase-1/-11) results in more 
than 100-fold higher intraepithelial loads and faster lymph node colonization 
(Sellin et al., 2014) suggesting that these inflammasome mediators are 
important players in this pathogen-protection mechanism.  
Another early infection defence mechanism first documented by our group is 
described in Chapter 5.  It involves migration of macrophages into the lumen 
after Salmonella challenge.  
Copious amounts of immunoglobulin A (IgA) are produced by B cells residing in 
the LP and then transported/released in the lumen by the IECs. IgA interferes 
with the earliest steps in the infection process by blocking toxins and pathogens 
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adherence to the intestinal epithelium (Mantis et al., 2011). Approximately 25% 
of intestinal IgA and IgG antibodies are polyreactive but the majority are 
antigen-specific. Specificity is not only directed against enteropathogenic but 
also against commensal microbes and self-antigens. Regardless of their 
reactivity, all intestinal antibodies are somatically mutated and are likely to be a 
result of antigen-mediated selection (Benckert et al., 2011). 
Craig and Cebra were the first to show that PPs are a source of IgA precursor 
cells (Craig and Cebra, 1971). They demonstrated that cells derived from PPs 
were able to replenish lethally irradiated rabbits with IgA-producing cells. They 
clearly showed that the intestinal LP of recipient animals was repopulated with 
IgA-producing cells of donor origin after transfer of PPs, but not of popliteal LN 
cells. The cellular organisation of the PPs is described in section 3.1.2.  
TGF-β cooperates with CD40 ligand (CD40L, also known as CD154), a tumour 
necrosis factor (TNF) family member expressed by CD4+ T cells, to trigger IgA 
class switch recombination (CSR) and generate antigen-specific IgA+ B cells, 
which represent nearly 70% of germinal center B cells in the PPs. B cell-specific 
TGF-β-receptor-deficient mice are severely impaired in their steady-state and 
antigen-induced IgA responses. In addition to TGF-β, IL-4, IL-6, and IL-10 also 
facilitate the expansion and differentiation of B cells to IgA-secreting plasma 
cells (Cerutti and Rescigno, 2008). 
Although important, PPs and MLNs are not essential for intestinal IgA 
production. Severe IgA deficiency in lymphotoxin-deficient (LT-/-) mice could be 
restored by reconstitution with LT-expressing bone marrow, despite the 
absence of both LNs and PPs. IgA deficiency in LT-/- mice is reversed by the 
transplantation of a segment of RAG-1 (recombination-activating gene I)-
deficient intestine, which confirms the dispensability of the MLNs and PPs and 
the sufficiency of the LT-mediated gut microenvironment for IgA production 
(Kang et al., 2002).  
Immunoglobulin E (IgE) has been implicated in the clearance of intestinal 
parasites. For example, rapid worm expulsion is impaired in IgE-deficient but 
not in IgG1-deficient mice. IgE mediates activation of basophils promotes the 
recruitment of other effector cells into the small intestine and induces 
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expression of antihelminthic proteins resistin-like molecule β and mucin 5ac. 
Selective deletion of IL-4/IL-13 in basophils results in impaired worm expulsion. 
Therefore IgE-mediated activation of basophils and the release of basophil-
derived IL-4/IL-13 are critical steps in protective immunity against helminths 
(Schwartz et al., 2014).  
IgE is believed to be one of the major mediators of immediate hypersensitivity 
reactions that underlie atopic conditions such as urticaria, allergic rhinitis, 
asthma and anaphylaxis.  
Location and kinetics of class switching to IgE are still not fully understood. 
Further advances in understanding IgE+ B cells have been hindered by their 
small numbers under physiological conditions. Relevant findings have been 
reviewed by (Akdis and Akdis, 2012). 
4.2. Oral tolerance  
The mammalian immune system has extraordinary potential to combat an array 
of pathogens with constantly evolving invasion strategies. But even more 
astonishing is its capacity of distinguishing between friends and foes. Non-
responsiveness towards body’s own antigens is maintained by the means of 
systemic tolerance, whereas non-responsiveness against foreign innocuous 
antigens, such as food and commensal microbiota, is perpetuated by peripheral 
tolerance.  
Essential for systemic tolerance is the negative selection of the newly 
developed B and T cells occurring in the bone marrow and the thymus 
respectively. If the B cells are found to be highly reactive to self, three 
mechanisms can occur in order to preserve self-tolerance: receptor editing, 
clonal deletion or anergy (Sandel and Monroe, 1999). Auto-reactive T cells are 
either eliminated, become anergic or they start expressing the transcription 
factor forkhead box P3 (Foxp3) and become natural regulatory T cells (nTregs). 
Both deletion of self-reactive T cells and differentiation of nTreg require the 
interaction of the T-cell receptor with its cognate antigen in the thymus. The 
promiscuous expression of tissue-restricted self-antigens by medullary thymic 
epithelial cells ensures that all possible self-antigens are available during the 
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selection process (Kyewski and Klein, 2006). However, these mechanisms are 
not suitable for preventing responses against food and commensal microbiota 
antigens that have not been found at the sites of lymphocyte differentiation, 
therefore additional layers of peripheral tolerance must exist (Pabst and 
Mowat, 2012). 
Oral tolerance represents a state of local and systemic immune 
unresponsiveness that is induced by oral administration of harmless antigen 
such as food components. It is disputed that similar but not identical 
mechanisms account for the toleration of the intestinal microbiota. Tolerance 
induction at the mucosal surface of the gut is believed to prevent intestinal 
disorders such as food allergy, celiac disease, and inflammatory bowel diseases 
(Pabst and Mowat, 2012). Systemic delayed-type hypersensitivity, T-cell 
proliferation, and cytokine production as a result of mucosally induced 
tolerance are common measures of this process. Serum antibody levels can also 
be suppressed (particularly IgE and Th1-dependent IgG2a) as well as the 
mucosal T-cell and IgA responses. Furthermore, oral tolerance has been shown 
to suppress immunopathology in experimental models of autoimmune 
encephalitis (Higgins and Weiner, 1988), collagen-induced arthritis (Nagler-
Anderson et al., 1986), and type 1 diabetes (Zhang et al., 1991). 
Oral tolerance varies with age. For example, B6D2F1 mice, are very susceptible 
to tolerance induction by a single gavage with 20 mg of ovalbumin (OVA) at age 
8 weeks, but as they age the degree of tolerance induction declines and at age 
70 weeks could no longer be achieved. However, 70-week-old mice may be 
rendered tolerant by repeated ingestion of OVA. Mice orally exposed to OVA at 
age 8 weeks remain tolerant at age 70 weeks which suggest that only the 
induction but not the maintenance of tolerance is impaired in ageing (de Faria 
et al., 1998). On the other hand, neonatal and new born immune system is also 
incapable of mounting oral tolerance (Strobel and Ferguson, 1984).  
In order to understand the molecular and cellular basis of oral tolerance it is 
vital to identify which anatomical locations, apart from the intestinal mucosa, 
are involved in the process. Several studies indicate that the liver is a major 
organ involved in the induction of oral tolerance. Injection of antigen into the 
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portal vein, which drains blood from the intestine to the liver, is known to 
induce antigen specific tolerance (Goubier et al., 2008).  In addition, generation 
of oral tolerance can be prevented by diverting the blood flow away from the 
liver by portocaval shunting (Callery et al., 1989). It has been also established 
that MLNs are required for oral tolerance whereas PPs are dispensable (Spahn 
et al., 2002) (Kraus et al., 2005), in particular, CCR7-dependant transport of 
antigen from the LP into the MLNs by CD103+ DCs is the key event for inducing 
the systemic consequences of oral tolerance. Thus, genetic deficiency in CCR7 
prevents T cells recognition of the fed antigen in the MLNs and impairs the 
induction of oral tolerance (Worbs et al., 2006). Limited number of papers have 
looked at the involvement of thymus in oral tolerance. According to (Song et al., 
2004) (Song et al., 2006) thymectomised adult mice are not protected from 
experimental autoimmune encephalomyelitis (EAE) after myelin basic protein 
feeding. On the other hand, Mattingly and Waksman (1978) observe similar 
responses to orally fed sheep erythrocytes in normal and thymectomised adult 
rats (Mattingly and Waksman, 1978).  
One may question whether any food antigens endure the acidic environment of 
the stomach and the enzymatic digestion in the small intestine in order to 
trigger mucosal immune response. It has been demonstrated that orally 
administered antigen within 30 min enters the intestinal epithelium. After 6 h it 
appears in the intestinal LP, and disappears at 24 h (Goubier et al., 2008).  In 
healthy adult humans within 2-3 h after a test meal there are up to 10.5 ng 
ovalbumin (OVA)/ ml serum; the OVA being intact and unbound or present as 
part of the immune complexes (Husby et al., 1985, Husby et al., 1987). How the 
intact OVA makes its way into the blood stream remains largely unknown and 
the biological significance of this phenomenon is questionable.  
Specialised methods of antigen transport take place at the mucosal surface and 
they are believed to functionally contribute in the establishment of oral 
tolerance. Material of low molecular weight, such as haptens and polypeptides, 
may pass directly across the epithelium by paracellular diffusion through pores 
in the epithelial cells tight junctions (Pabst and Mowat, 2012). The importance 
of M cell antigen transport for the induction of oral tolerance is unclear. First, M 
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cells are inefficient at uptake of soluble protein antigens. They are specialized to 
take up particulate antigens or those antigens for which these cells express 
receptors (eg, poliovirus) (Chehade and Mayer, 2005). Second, as already 
mentioned, PPs are not essential for oral tolerance; therefore the M cell antigen 
transport might contribute but is likely to be secondary to oral tolerance 
induction. Though, on the other hand, there are studies demonstrating that 
targeting protein antigen directly to the M cells facilitates tolerance induction 
(Suzuki et al., 2008), and one study observed that inhibition of PP development 
during gestation reduced oral tolerance to protein but not haptens in adult mice 
(Fujihashi et al., 2001). Other routes of antigen transport - “tolerosomes” and 
small intestine goblet cells have been described in section 3.2.2.2. Finally, most 
popular around the mucosal immunologists’ community in the recent years way 
of antigen transport from the lumen to the LP is the so called DC/macrophage 
“sampling” (Rescigno et al., 2001).  More detailed information regarding its 
mechanism and its significance is presented in Chapter 5. Mice that lack 
CX3CR1+ macrophages and are incapable of antigen sampling but have fully 
functional CD103+ DCs cannot mount oral tolerance against OVA (Hadis et al., 
2011b).  
Before proceeding further with the cellular mechanism of oral tolerance here 
we should spend a moment on the antigen’s role in the process. Amongst the 
most widely used “model” oral tolerance antigens are: egg or egg derived 
proteins such as OVA and hen egg lysozyme; cow’s milk and proteins derived 
from it such as β-lactoglobulin and α-casein. Some other antigens capable of 
inducing oral tolerance are: heat shock protein 65 (Harats et al., 2002); collagen 
(Trentham et al., 1993); keyhole limpet hemocyanin (used as novel antigen); 
myelin basic protein (Khoury et al., 1992). Example of proteins that cannot 
induce oral tolerance and indeed abrogate it are cholera toxin (CT) (Elson and 
Ealding, 1984) which will be further discussed in Chapter 2 and 3, and heat-
labile enterotoxin (Clements et al., 1988). There is dearth in the literature 
regarding the antigens’ capabilities and properties enabling oral tolerance 
induction. From the examples listed above one could see that generally soluble 
globular proteins tend to mount oral tolerance. Little is known about the role of 
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protein glycosylation in this case or whether non-proteinaceous antigens have 
the same effect. In addition, there is lack of evidence whether/how antigens 
originating from the commensal flora may induce oral tolerance.  
Many different doses and regimens of single and multiple feeds induce oral 
tolerance successfully. There is limited evidence that single administration of 
high dose of antigen (> approximately 0.5 mg/g body weight in mice) induces 
clonal deletion or anergy (Garside et al., 1995) (Melamed and Friedman, 1994) 
whereas multiple low doses (< approximately 0.1 mg/g body weight in mice) are 
more likely to generate regulatory cells (Strobel and Mowat, 1998).  
Intestinal microbiota is a constant participant in the maintenance of 
gastrointestinal immune homeostasis and is expected to affect most if not all 
associated regulatory pathways. Germ free (GF) mice fed with OVA seem to 
mount oral tolerance, but the difference between fed GF and non-fed GF 
animals is smaller than that observed between fed and non-fed conventional 
mice (Walton et al., 2006). Monocolonisation of germ free mice with certain 
probiotic strains can modulate oral tolerance. For example mice 
monoassociated with Lactobacillus paracasei (NCC 2461) but not Lactobacillus 
johnsonii (NCC 533) or Bifidobacterium lactis Bb12 (NCC 362) develop higher 
tolerance against β-lactoglobulin (Prioult et al., 2003).  
A recent study implicates mucus as modulator of tolerance. Antigen sampling 
cells from the small intestine can uptake MUC2 (major component of gut 
mucus) which drives their anti-inflammatory properties. Muc2–/– mice gavaged 
with OVA cannot mount intestinal or systemic tolerance. The impairment of 
tolerance in Muc2–/– mice is not due to bacteria-induced inflammation. Germ 
free Muc2–/– do not attenuate OVA-specific delayed type hypersensitivity, IgG, 
and IgE responses after gavage with OVA. Interestingly, oral tolerance induction 
is restored in Muc2–/– if gavaged with a combination of OVA and MUC2 (Shan et 
al., 2013). Thus, mucus is much more than a nonspecific physical barrier and it is 
also capable of limiting the immunogenicity of gut antigens by delivering 
tolerogenic signals. 
The evidence outlined above hopefully demonstrates the multitude of factors 
influencing oral tolerance. Since major focus of this dissertation is the lympho-
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epithelial cross-talk regulating the immune homeostasis, it is ought to discuss 
the epithelial contribution to the phenomenon of oral tolerance. For example, 
supernatants from IECs from antigen fed animals exert a dramatic inhibitory 
effect on the proliferative reaction of antigen-primed T cells in response to the 
antigen presented by syngenic spleen cells. This inhibitory effect can be 
reversed by neutralising anti- TGFβ antibodies (Galliaerde et al., 1995). Serum 
TGFβ levels increase after oral administration of TGFβ. Balb/c mice treated orally 
with OVA and TGFβ show enhanced reduction of OVA-specific IgE and IgG1 
antibodies, T-cell reactivity, and immediate-type skin reactions when compared 
with the mice treated orally with OVA alone (Ando et al., 2007). Epidemiologic 
studies suggest that TGFβ in breast milk provides protection against allergic 
disease during infancy. Cytokines in milk, such as IL-10, IL- 4 and TGFβ influence 
antigen priming. The importance of neonatal exposure to TGFβ in breast milk is 
highlighted by TGFβ knockout mice which do not survive after weaning due to 
an uncontrolled inflammatory state unless suckled on TGFβ producing mothers 
(Letterio et al., 1994). It is suggested that the anti-inflammatory action of TGFβ is 
mediated by modulation of IL-18, IL-6, IFNγ, IL-1β, and IL-1Rα mRNA expression 
and active protein secretion in the intestine (Penttila et al., 2003).  
On the other hand, overexpression of certain cytokines by the epithelium has 
been shown to have negative effect on tolerance. For example, mice genetically 
engineered to overexpress IL-7 in the intestinal epithelium develop chronic 
colitis (Watanabe et al., 1998). Increased production of epithelia IL-18 has been 
associated with Crohn’s disease (Pizarro et al., 1999) and exogenous application 
of this cytokine has been found to prevent induction of oral tolerance (Eaton et 
al., 2003). 
4.3. Food allergy 
Under certain circumstances dysregulation of the immune response can result 
in significant tissue damage and even death. This inappropriate immune 
response is termed hypersensitivity and includes allergies and autoimmunity.  
Depending on whether the symptoms of hypersensitivity develop instantly or 
after certain time post antigen exposure the hypersensitivity reactions could be 
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accordingly classified as “immediate” or “delayed”. In the first instance, 
different antibody isotypes drive the aberrant reaction, for example, IgE 
antibodies induce mast-cell degranulation and release of histamine. IgG and IgM 
antibodies induce hypersensitivity by activating complement (membrane-attack 
complex and split products such as C3a, C4a, and C5a). T cells secrete various 
cytokines acting as effector molecules in the delayed-type hypersensitivity 
reactions (Table 1) (Kindt et al., 2007). 
Food allergy presumably occurs when oral tolerance fails to develop normally or 
breaks down and involves an abnormal response to otherwise harmless orally 
acquired antigen. Food hypersensitivity develops in genetically predisposed 
individuals (Sicherer et al., 2000). Depending on the effector molecules/cells 
involved, IgE-, cellular-, or mixed food hypersensitivity disorders have been 


















Table 1 The four types3 of hypersensitivity responses according to Coombs and 











    
Type I Type II Type III Type IV 
Ag induces crosslinking of 
IgE bound to mast cells 
and basophils with release 
of vasoactive mediators 
Ab directed against cell 
surface antigens; meditates 
cell destruction via 
complement activation or 
antibody-dependent cell-
mediated cytotoxicity  
(ADCC) 
Ag-Ab complexes 
deposited in various 
tissues induce 
complement activation 
and an ensuing 
inflammatory response 
mediated by massive 
infiltration of neutrophils 
Sensitized Th1 cells release 
cytokines that activate 
macrophages or TC cells 




anaphylaxis and localized 
anaphylaxis such as hay 
fever, asthma, hives, food 
allergies, and eczema 
Typical manifestations 
include blood transfusion 
reactions, erythroblastosis 
fetalis, and autoimmune 
haemolytic anemia 
Typical manifestations 
include blood transfusion 
reactions, erythroblastosis 
fetalis, and autoimmune 
haemolytic anemia 
Typical manifestations 
include contact dermatitis, 













                                                 
3
 Recently a fifth type has been added to this classification. It is also considered to be a subclass 
of Type II RAJAN, T. V. 2003. The Gell–Coombs classification of hypersensitivity reactions: a 
re-interpretation. Trends in Immunology, 24, 376-379.   
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Table 2  Food hypersensitivity disorders adapted from (Sampson, 2004) 
IgE mediated 
 
 Gastrointestinal Oral allergy syndrome, gastrointestinal anaphylaxis 
 Cutaneous Urticaria, angioedema, morbilliform rashes and flushing 
 Respiratory Acute rhinoconjunctivitis, bronchospasm (wheezing) 
 Generalized Anaphylactic shock 
Mixed IgE and cell mediated 
 Gastrointestinal Allergic eosinophilic esophagitis, allergic eosinophilic gastroenteritis 
 Cutaneous Atopic dermatitis 




Food protein–induced enterocolitis, food protein–induced proctocolitis, food 
protein–induced enteropathy syndromes, celiac disease 
 Cutaneous Contact dermatitis, dermatitis herpetiformis 
 Respiratory 
Food-induced pulmonary hemosiderosis (Heiner syndrome) 
 
According to recent estimates IgE-mediated food allergies affect 3.5% to 4% of 
Americans and most importantly this number has been increasing (Sampson, 
2004). The prevalence of food hypersensitivity is higher in children; in some 
cases allergy could be outgrown (Hourihane et al., 1998). A variety of foods can 
cause IgE-mediated reactions but most studies have focused on cow’s milk, 
hen’s egg, peanut, tree nut, wheat, soya, fish and shellfish since they are the 
most common triggers (Gray et al., 2015). Allergies to ovalbumin and cow's milk 
are most common among children, whereas peanuts induce the most severe 
form of the food allergy (Lack, 2008). Comprehensive list of plant-derived 
allergens and discussion of their structural characteristics contributing to 
allergenic properties are summarised elsewhere (Breiteneder and Ebner, 2000).  
Depending on the anatomical location of sensitization induction food allergies 
could be divided in two groups. In class 1 the sensitization occurs in the 
gastrointestinal tract and it is more likely to affect young children. On the other 
hand, class 2 is mainly observed in adults and sensitization takes place in the 
respiratory mucosa (Breiteneder and Ebner, 2000).  
Interestingly, not all individuals that produce food-specific IgE will have 
symptomatic reaction when the food in question is consumed. Unfortunately, 
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the mechanisms underlying this difference between food allergic and food 
sensitized individuals are not completely understood (Dang et al., 2013, Sicherer 
and Sampson, 2007). Higher plasma levels of IL-4, IL-13, IL-12p70 and lower IL-
10 are present in food-sensitized compared to nonsensitized infants. IL-10 and 
IL-6 are lower in allergic compared to sensitized infants. Interestingly, higher IL-
13 and IL-12p70 were found in egg-allergic compared to peanut-allergic patients 
(Dang et al., 2013).  
IL-4, IL-13 and IL-5 are some of the cytokines most commonly studied in allergy. 
The importance of IL-4 in allergy has been confirmed in a series of experiments 
involving wild type and IL-4 deficient Balb/c mice sensitized with OVA. Increased 
level of IL-4 was measured in spleen and MLN cells of WT mice after 
sensitization and continuous oral rechallenge. In addition, these animals had 
high anti-OVA IgE and IgG1 in the serum and lost body weight. In contrary, IL-4 
deficient mice failed to develop symptoms (Dourado et al., 2010). In the blood 
of allergic patients increased IL-4 expression has been detected in CD25 (IL-2 
receptor alpha)+ population. Further studies indicate that within this population 
it is the basophils, NK, and NK-T cells rather that the CD4+ T cells that exhibited 
positive intracytoplasmic staining for IL-4. Allergic basophils express higher 
levels of MHCII and CD25 (Caubet et al., 2014). IL-4 is also essential for intestinal 
mast cell expansion in the case of food allergy (Burton et al., 2013). The role of 
IL-13 and IL-5 in allergy has been primarily studied in the context of airway 
hypersensitivity (Rael and Lockey, 2011, Kouro and Takatsu, 2009). Association 
studies have shown that certain IL-13 variants could possibly contribute to 
elevated IgE in atopic children and are strongly associated with sensitization to 
food allergens (Zitnik et al., 2009). In eosinophilic esophagitis IL-5 facilitates 
eosinophil trafficking, growth, activation and survival (Stein et al., 2006).  
What factors contribute to the production of those pro-allergic cytokines is still 
not fully understood. Since the epithelial cells are located at the site of allergen 
entry it is likely for them to also be some of the primary responders and 
initiators of the allergic cascade. The role of the lympho-epithelial crosstalk in 




5. Summary  
Accumulating evidence suggests that lympho-epithelial interactions in the 
intestine help to promote mucosal homeostasis. In addition, the epithelium is 
an important player that also mediates cross-talk with the commensal 
microbiota as well as gastrointestinal pathogens. IECs contribute to the innate 
defense mechanisms by producing antimicrobial peptides and mucus (Dahan et 
al., 2007). What is more, the epithelium is also involved in establishment and 
modulation of adaptive immune responses. For example, factors produced by 
the epithelium such as TSLP, TGFβ, and retinoic acid can promote IL-10 
production by DC hence contributing to maintenance of tollerogenic state (Man 
et al., 2008, Liu et al., 2007). IECs are capable of producing a number of other 
cytokines upon bacterial invasion, some examples being IL-8, monocyte 
chemotactic protein 1, and macrophage inflammatory protein 3α (Dahan et al., 
2007). In addition to secretion of signaling molecules IECs have been 
implemented in cell-to-cell interactions with macrophages (Rescigno et al., 
2001) and T cells (Gonnella and Wilmore, 1993).  
On the other hand, immune cell derived mediators can affect the epithelium. 
One example is the macrophage migration inhibitory factor (MIF) which is 
produced rapidly after in vivo bacterial challenge by CD11c+ cells. It has been 
shown to act on IECs and induce M-cell like phenotype thus facilitating antigen 
transport (Man et al., 2008). Another example is the induction of epithelial 
cyclooxygenase-2 by inflammatory mediators which is essential for epithelial 
repair (Subbaramaiah et al., 2004). Macrophages have been shown to interact 
with the epithelial stem cell progenitors in the colon and facilitate repair of the 
injured epithelium (Pull et al., 2005).  
These are just a few examples of the myriad of interactions occurring at the 
lympho-epithelial interface in the gut. Chapter 2 and 3 will discuss further how 
the epithelial-derived cytokine TSLP participates in sensitization to food 
components and its potential cross-regulation with IL-12, a cytokine produced 
by the lymphoid compartment. Chapter 4 explores the intestinal microbiota and 
metabolic status of mice deficient in IL-12 signaling. Finally, Chapter 5 will focus 
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on a defense mechanism occurring in the gut early during bacterial infection. Of 
great importance for this mechanism is the capability of the IECs to send 



























Chapter 2: Lympho-epithelial crosstalk in the 
gut plays a major role in food allergy, IL-12 and 
TSLP  
 
1. Introduction  
Aberrant response to food components is termed food allergy. Depending on 
the effector molecules/cells involved food hypersensitivity can be classified as 
IgE-, cellular-, or a combination of those two (examples are provided in Chapter 
1 section 4.3.). Both IgE- and cytotoxic-dependant reactions can cause 
anaphylaxis though the term “anaphylaxis” usually applies for IgE-dependant 
events and the IgE-independent are classified as “anaphylactoid” but are 
otherwise clinically similar. Allergen-specific IgE could bind to FcεRI receptors on 
mast cells and basophils, subsequent interaction with the antigen is central to 
the initiation and propagation of the immediate hypersensitivity reactions. 
Degranulation of mast cells and basophils leading to release of biologically 
active mediators such as histamine, tryptase, chymase, heparin, prostaglanding 
D2, leukotriene B4, platelet-activating factor, and cysteinyl leukotrienes drives 
the pathologic symptoms of anaphylaxis (Kemp and Lockey, 2002). Activation of 
histamine receptor H1 results in pruritis (itchy skin), rhinorrhea (nasal mucus 
overproduction), tachycardia (rapid heartrate), and bronchospasm.  
Engagement of both H1 and H2 receptors leads to headache, flushing, and 
hypotension (Kaliner et al., 1981). Activation of complement and blood clotting 
could also occur during anaphylaxis (Kemp and Lockey, 2002). 
Normally serum IgE has short lifespan and its concentration is low (lowest 
among the five immunoglobulin subtypes). During childhood serum IgE levels 
increase up to 10-15 years of age and then gradually decline throughout 
adulthood. Environmental factors (such as pollen exposure), genetics, immune 
status can influence total IgE levels (Smith P, 2009). Class switching to IgE is 
tightly regulated and requires two signals the first being IL-4 and IL-13. The 
second signal is ligation of CD40 on B cells with T cell CD40L (Gould and Sutton, 
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2008, D., 2009, Stutz and Woisetschlager, 1999). Several additional mechanisms 
of IgE class switch recombination control have been described and it is likely 
that further are yet to be discovered (Geha et al., 2003). Prior to the B-T cell 
interaction the T cells acquire polarisation signals and are primed to the specific 
antigen by DCs (Kawabe et al., 2013). A large body of evidence, part of which 
collected in Nicoletti’s lab suggested that dendritic cells with their ability to 
direct immune responses play an important role in the generation of adverse 
reaction to food. 
1.1. Work leading to the project 
In our laboratory the role of DCs in the early stage of allergic sensitization has 
been studied in detail and several allergy-related immunoregulatory features of 
DCs observed and reported. First, we described evidence showing that 
production of allergen-specific IgE and IgG can be provoked by DCs isolated 
from cow’s milk (CM)-allergic mice when passively transferred into naïve 
syngeneic mice, even in the absence of antigen exposure (Chambers et al., 
2004). Regardless of the allergic status and differences in potential to regulate 
antibody responses, the DC population analysed from both PPs and spleen from 
all groups of mice (allergic and non-allergic) was characterised with low 
expression of regulatory molecules, such as CD40, CD80, CD86 and CD8a, 
indicating a low degree of maturation of these CD11c+/hi B220– DCs. Moreover, 
the level of MHC II was not significantly different between PP- and splenic DCs 
and was not affected by the allergic sensitization. Furthermore, it was observed 
that both systemic and gut-derived DCs from allergic mice showed an increased 
resistance to T cell–mediated cell death compared with DCs from control 
donors (Man et al., 2004). Additional experiments have demonstrated that in 
both allergic and control mice, T cell– mediated DC apoptosis is dependant on 
the presence of the specific antigen, requires MHC II, and is only partially CD95-
CD95 ligand dependent. This demonstrated that the reciprocal, finely balanced 
regulation between DCs and T cells, which plays a central role in controlling 
immune responses, is altered in allergy. The biological relevance of increased 
DC resistance to T-cell mediated apoptosis was ultimately confirmed by 
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experiments of adoptive transfer of “apoptosis-resistant” DC from OVA-
sensitized into naïve mice (Arques et al., 2008). After isolation surviving 
apoptosis-resistant DCs were subsequently co-cultured with OVA-specific 
CD62LhiCD44low naïve T cells or passively transferred into naïve syngenic 
recipients and the in vitro profile of DC and T cell lymphokine production, 
chemokine receptors expression and in vivo, post- DC transfer T helper (Th) and 
IgE responses were assessed. Naïve OVA-specific T cells, when co-cultured with 
apoptosis-resistant DCs from either OVA-sensitized or immunized mice, 
produced increased levels of IL-4 and reduced levels of IFNγ and showed 
increased expression of Th2 related CCR4 and CCR8 chemokine receptors. 
Finally, in the absence of antigen challenge, higher levels of OVA-specific IgE 
were elicited by adoptive transfer of apoptosis-resistant DC compared to freshly 
isolated DCs from both sensitized and immunized donors. These findings 
suggest that increased numbers of apoptosis-resistant T cell-activating DCs is 
associated with sensitization. The apoptosis-resistant DCs are likely to 
contribute to the generation/maintenance of IgE-mediated allergic reaction.   
In another study of peanut food allergy it was found that CD11c+ B220- cells 
isolated from PPs of peanut-allergic C3H/HeJ mice are unable to produce 
sufficient IL-12p70 upon stimulation with IL-4 compared to Balb/c (Temblay et 
al., 2007). In vivo data confirmed this insufficiency to be restricted to the gut 
immune system, and not to be associated with reduced expression of IL-4 
receptor or the lack of functional TLR4. Instead, a pathway critically involved in 
IL-4–dependent production of IL-12p70 was dysregulated since IL-4 failed to 
inhibit IL-10 production by PP-DCs. Importantly, neutralization of IL-12 within 
PPs by oral delivery of microencapsulated anti-IL-12 antibody during antigen 
presentation significantly augmented Balb/c susceptibility to food allergy. Thus, 
reduced intestinal level of IL-12 is a hallmark of allergic sensitization to food 
components. IL-12 is a typical T helper type 1 cytokine and its role in the genesis 
and as potential therapeutic in the treatment of allergy has been suggested 
(Hogan et al., 1998). However, although the potential of IL-12 in suppressing 
allergic reactions has been reported (Lee et al., 2001, Hogan et al., 1998), how 
this is brought about and its mechanism of action remained to be determined. 
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1.2. Strategic approach 
In collaboration with the laboratory of Dr. Arjan Narbad at IFR a strategy was 
devised for restoring physiological levels of IL-12p70 in mice undergoing allergic 
sensitization based on oral delivery of Lactococcus lactis engineered to produce 
biologically active IL-12p70 (Fernandez et al., 2009). This approach provided us 
with a reliable delivery tool to test the hypothesis that restoring levels of IL-12 
in the gut immune system at the time of antigen presentation might prevent 
allergic sensitization to an orally delivered allergen and possibly to identify 
cytokine regulatory pathways affected. 
1.3.  The IL-12 cytokine family and its role in allergy  
IL-12 was identified as a natural killer stimulating factor (NKSF) in 1989 
(Kobayashi et al., 1989) and was the first known cytokine with heterodimeric 
structure where two independently transcribed and translated protein subunits 
are covalently linked by a disulphide bond (Palmer and Weaver, 2010). Since 
then other cytokines with analogical architecture have been discovered, namely 
IL-23, IL-27, and IL-35. These cytokines are classified as the IL-12 family and are 








According to the generally accepted view, IL-12 consist of p40 and p35 protein 
subunits (together making p70) and its receptor is formed by IL-12Rβ1 and IL-
12Rβ2 (Palmer and Weaver, 2010). It is suggested that p40 is important for 
receptor binding, while p35 is responsible for the biological activity (Ling et al., 
1995), however there is evidence that both subunits are needed for binding and 
intracellular responsiveness (Chua et al., 1995b). 
Within the IL-12 family many structural components are shared. The IL-12Rβ1 
subunit is part of both IL-12 and IL-23 receptors (Trinchieri et al.). Similarly, the 
IL-12Rβ2 subunit is part of IL-12 and IL-35 receptors (Collison et al., 2012b). 
Despite sharing structural features and intracellular signalling pathways the 
overall biological activity of these cytokines is very diverse (Vignali and Kuchroo, 
2012). For example, IL-35 is produced by regulatory T-cells and is suppressive, 
while IL-12 is involved in initiation of Th1 differentiation (Collison et al., 2012b, 
Uhlig et al., 2006b). 
The gp130 that is involved in IL-35 and IL-27 signalling provides a crosslink with 
other cytokines families as it is a component of receptors for IL-6, IL-11, 
leukocyte-inhibitory factor, oncostatin M, ciliary neurotrophic factor, 
cardiotrophin 1 and cardiotrophin-like cytokine (Silver and Hunter, 2010). In 
addition to their canonical function as heterodimers, some members of the IL-
12 family can function autonomously as monomers or homodimers. For 
example, p28 alone, in the absence of its regular partner Ebi3, has been shown 
to bind to the receptor chain gp130 without provoking further signalling and 
thereby antagonizing IL-6 and IL-27, limiting the production of IL-17 and IL-10, 
respectively (Stumhofer et al., 2010). Similarly, p40 has been shown to form 
homodimers (p40)2 antagonising IL-12 driven responses (Gately et al., 1996). In 
contrast, there is no clear evidence suggesting that p19 or p35 can be secreted 
without a partner and although Ebi3 is autonomously secreted it is not 
confirmed to have biological function (Vignali and Kuchroo, 2012). 
Some of the receptors in the IL-12 family were also found to function not only 
as heterodimers but as homodimers and/or monomers. For example, 
CD4+CD45RBhiCD25− naive T cells lacking just one chain of the putative IL-35R 
are partially resistant to IL-35, which suggested that signalling can occur with 
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the expression of only one chain of IL-35R. It should be noted that whereas 
some biological functions are partially affected others are completely abolished 
(Collison et al., 2012a). If expressed individually, human IL-12Rβ1 and IL-12Rβ2 
bind to IL-12p70 with low affinity and when they are coexpressed both low and 
high affinity binding is observed accompanied with IL-12 responsiveness (Presky 
et al., 1996). In contrast, mouse IL-12Rβ1 is the primary binding component 
conferring both low and high affinity sites (Chua et al., 1995a) but IL-12Rβ2 is 
required for biological activity of IL-12p70 (Wu et al., 2000). Interestingly, 
(p40)2 signals via IL-12Rβ1 (Jana and Pahan, 2009). In a study by Collison et al. 
(2012) IL-12p70 triggered formation of IL-12Rβ2 homodimers even though at a 
very low level (Collison et al., 2012a). 
Antigen presenting cells (APCs) are considered to be the main source of IL-12 
(Liu et al., 2006). IL-12 drives Th1 polarisation, secretion of IL-2 and IFNγ 
(Collison et al., 2012b, Uhlig et al., 2006b), where IFNγ is part of synergistic loop 
(Snijders et al., 1998) upregulating expression of both IL-12 (Liu et al., 2003) and 
its receptor subunits (Kano et al., 2008). A potent stimulator of IL-12 expression 
is the interaction between CD40 on DCs with its ligand (CD40L) on the T cell 
surface (Cella et al., 1996). In addition to IFNγ another cytokine synergising with 
IL-12 is IL-18, also contributing to development of Th1 cells and capable of 
upregulating IL-12 receptor subunits (Sinigaglia et al., 1999). 
An important function of IL-12 is linking the early innate responses with 
subsequent antigen specific immunity (Chehimi and Trinchieri, 1994). This 
cytokine is vital for combating intracellular infections of viral and bacterial origin 
such as influenza A (Hama et al., 2009), norovirus (Fang et al., 2013), 
Staphylococcus aureus (Hultgren et al., 2001), and Mycobacterium spp. (McNab 
et al., 2014). Evidence has accumulated that TLR engagement can play an 
important role in the balance between production of IL-12 and other members 
of the family. Simultaneous activation of more than one TLR has been shown to 
produce much stronger IL-12 activation (Gautier et al., 2005). Most importantly, 
selective activation of TLRs can discriminate between stimulation of different IL-
12 family members. For example, TLR4 engagement can drive production of IL-
12 and IL-23, whereas activation of TLR2 stimulates only IL-23 (Re and 
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Strominger, 2001). A number of microorganisms have been shown to modulate 
IL-12 production by DCs. For example, Lactobacilllus acidophilus NCFM is 
promoting, whereas Lactobacillus reuteri 5289 is supressing (Amar et al., 2015).  
Cytokines such as IL-10 (Aste-Amezaga et al., 1998) and TGFβ (Pardoux et al., 
1997) have been demonstrated to downregulate IL-12. Complex regulatory 
interactions link IL-4 and IL-13 with IL-12. Interestingly, addition of IL-4 and IL-13 
to peripheral blood mononuclear cells (PBMCs) inhibits IL-12 induced by LPS or 
Staphylococcus aureus when all the stimuli are applied simultaneously, 
however, if the PBMCs are pre-treated with IL-4 or IL-13 for more than 20 h, 
exactly the opposite effect is observed (D'Andrea et al., 1995). A detailed study 
of IL-12 p40, p70 and (p40)2 production of freshly isolated mouse and human 
DCs have revealed that IL-4 inhibits (p40)2 and increases p70. Dual application 
of IFNγ and IL-4 produces strong synergism and leads to optimal production of 
p70 with minimal (p40)2 (Hochrein et al., 2000).  
While stimulating Th1 polarisation and secretion of IFNγ, IL-12 supresses Th2 
responses (Davidson et al., 1998, Lee et al., 2001). For example, infection with 
Leishmania major initiates strong Th2 response which leads to eosinophilic 
inflammation, airway hyperresponsiveness and release of IgE. This exacerbated 
Th2 reaction can be reversed by intraperitoneal administration of IL-12 (Nabors 
et al., 1995). Allergic asthma, known to be characterised by exacerbated Th2 
response, is also linked to reduced IL-12 levels (van der Pouw Kraan et al., 1997) 
which if restored by gene delivery lead to significant amelioration of the allergic 
symptoms (Hogan et al., 1998). Similarly to asthma, food hypersensitivity has 
been established as a Th2 associated condition. Lee et al. (2001) investigated 
the effects of oral IL-12 treatment in a murine model of peanut allergy and 
found that supplementation of IL-12 could both prevent and reverse 
hypersensitivity (Lee et al., 2001).   
Intracellular pathways associated with IL-12 and IL-12R 
Canonical IL-12 signalling activates the intracellular mediators Janus kinase 
(JAK2) and tyrosine kinase 2 (TYK2) ultimately leading to phosphorylation of a 
number of signal transducer and activator of transcription (STAT) proteins. 
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Highest activation is reported for STAT4 but other members such as STAT1, 
STAT3, and STAT5 are also phosphorylated (Watford et al., 2004). Another 
cytokine from the IL-12 family capable of eliciting phosphorylation of the same 
STAT proteins is IL-23 but major difference is that in the latter case it is STAT3 
that achieves highest activation (Teng et al., 2015). Phosphorylation of STAT4 is 
not mediated by extracellular signal-regulated kinase (ERK) or c-Jun N-terminal 
kinase (JNK) in T cells and NK cells. Instead, it has been shown that IL-12 
stimulation leads to mitogen activated protein kinase (MAPK)p38 activation via 
MAP kinase kinase MKK6 (Visconti et al., 2000). Interestingly, an alternative IL-
12Rβ1- and STAT4- independent pathway of IL-12 signalling exists. T cells 
deficient in IL-12Rβ1 could still respond to IL-12 by increased IFNγ; this process 
requires MAPKp38 and MKK1/2 (Verhagen et al., 2000). 
1.4. Mouse model of peanut allergy 
For a first time mouse model of food allergy was described by Li et al. (1999). 
They have utilised intragastric administration of cow’s milk (CM) along with 
cholera toxin (CT) to sensitize C3H/HeJ mice. This treatment required several 
boosts at weekly intervals that ultimately resulted in increased CM-specific IgE 
at 3 weeks which reached maximum at 6 weeks after the first sensitization 
dose. Systemic anaphylaxis was provoked after intragastric challenge with CM 
at week 6. Most importantly, this mouse model successfully recapitulated 
symptoms associated with food hypersensitivity in human. In addition to the 
production of allergen-specific IgE, the anaphylactic reaction elicited with the 
recall CM challenge at week 6 was associated with vascular leakage, elevated 
plasma histamine, and increased intestinal permeability to casein. It was also 
evident that the IgE production was likely to be a result of excessive Th2 
polarisation since in vitro stimulation of splenocytes from allergized mice 
induced significant increase in IL-4 and IL-5 but not IFNγ (Li et al., 1999).  
A year later Li et al. (2000) demonstrated successful sensitization of C3H/HeJ 
mice with crude peanut extract (CPE) (Li et al., 2000) (Error! Not a valid 
bookmark self-reference.). Again CT was applied as an adjuvant alongside the 
food antigen. In this case two doses were administered within seven day 
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interval and then three weeks after the first sensitization the animals were 
rechallenged with peanut protein alone. Similarly to the CM allergy model, this 
treatment resulted in increased antigen-specific IgE production and 
anaphylactic reaction after peanut protein challenge accompanied by increased 
mast cell degranulation and plasma histamine. The allergen-specific B- and T-
cell responses provoked by the sensitization in this model were similar to those 
observed in patients with peanut hypersensitivity.  Interestingly, in both CM and 
CPE sensitization the lower dose of allergen administered for sensitization 
resulted in higher IgE and more severe anaphylactic reaction (Error! Not a valid 
bookmark self-reference. A).  
Some of the questions this work provokes are whether other mouse strains 
could be sensitized in a similar fashion and whether the C3H/HeJ malfunctioned 















Figure 7 Original protocol for the mouse model of peanut allergy (Li et 
al., 2000). The model was described by Li et al. (2000) for low (A) and 
high (B) dose of allergen. This model has been used by many laboratories 
(including Nicoletti’s) to study variety of aspects of food allergy. Indeed 
this model fatefully replicates the type I hypersensitivity reaction 
observed in human (see text for details). 
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Strain-specific susceptibility to food allergy 
In another paper by the same group (Morafo et al., 2003) the authors mention 
that according to unpublished data the above described protocol (Error! Not a 
valid bookmark self-reference.) did not induce anaphylactic reactions in Balb/c 
mice but did induce peanut-specific IgE. Even when a more severe protocol for 
peanut sensitization involving increased CT dose and number of boosts 
alongside NaHCO3 was used, no hypersensitivity reactions were detected in 
Balb/c mice, despite the presence of significant serum peanut-specific IgE levels 
(Morafo et al., 2003). Other studies argue that Balb/c mice are not only capable 
of producing peanut-specific IgE and IgG1 but also exhibit anaphylactic reaction, 
however with lesser severity (Adel-Patient et al., 2005, Jhaveri and Bonfield, 
2015, Husain et al., 2011, Mondoulet et al., 2012). A study by Smit et al. (2011) 
compared sensitization in C3H/HeOuJ, Balb/c and C57BL/6 mice. They used 
relatively rigorous sensitization scheme involving CT and CPE intragastric 
administration at days 0, 1, 2, 7, 14, 21 and 28 followed by CPE rechallenge at 
day 35 (Smit et al., 2011). This protocol resulted in CPE-scpecific T cell 
responses, IgE, IgG1 and IgG2a and mast cell degranulation that differed in their 
levels between the three mouse strains. Most importantly, anaphylactic 
symptoms after systemic challenge were high in C3H/HeOuJ and C57BL/6 but 
were absent in Balb/c. 
Studies that looked at the effects of the genetic make-up of the host in the 
development of food allergy also brought about the notion that specific genes, 
involved in microbial recognition may play significant role in the sensitization 
process. Indeed, although still a matter of debate it has been suggested that 
Toll-like receptor-4 (TLR4) might be involved in determining susceptibility to 
food allergy. Bashir et al. suggested that the lack of a functional TLR4 is what 
renders C3H/HeJ mice susceptible to Type I allergic reaction. What is more, they 
also show that removal of the intestinal flora with antibiotics in TLR4 sufficient 
animals can also lead to exacerbated anaphylactic reaction and increased 
splenocyte production of IL-5 and IL-13 upon stimulation with peanut (Bashir et 
al., 2004). Using the mouse model of cow’s milk allergy it has been shown that 
germ free (GF) animals are more susceptible to allergy as indicated by the lower 
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rectal temperature after sensitization and have increased allergen-induced 
degranulation of mast cells (mMCP-1 release). Despite the fact that GF mice also 
score higher anaphylactic scores they are not significantly different from those 
of conventional mice (Rodriguez et al., 2011). In another study response 
towards peanut allergen similar to that of C3H/HeJ mice was seen in congenic 
TLR4+ C3H/HeOuJ mice, suggesting that genetic susceptibility to food allergy 
does not depend solely on the presence of a functional LPS (TLR4) receptor 
(Temblay et al., 2007).  
2. Hypothesis 
Previous studies done in the Nicoletti lab prompted us to test the hypothesis 
that replenishing the levels of IL-12 via oral administration of genetically 
engineered L. lactis secreting the biologically active variant of the cytokine IL-12 
(IL-12p70) could prevent allergic sensitization. Also, we hypothesized that the 
significant decline of IL-12 in allergic mice might lead to alteration of the 
intestinal immunological homeostasis by triggering the production of pro-
allergic cytokine(s) by the intestinal epithelial cells. 
3. Methods 
Animals 
C3H/HeJ mice were purchased from Harlan (Shardlow, UK). Balb/c mice were 
purchased from Disease Modelling Unit, UEA. Experiments were approved by 
the University of East Anglia Welfare and Ethical Review Body (AWERB; ref: 
70/7582) and conducted under the guidelines of Animals Scientific Procedures 
Act (1986) of the United Kingdom. Also, experimental protocols were approved 
by the Animal Care and Use Committee of the University of Siena (no. 
G2007/11/2) under the “Guiding Principles for Research Involving Animals and 
Human Beings”. 
Recombinant Bacterial strains 
The heterologous Lactococcus lactis strains FI5876/pTG262 empty vector 
(FI10632) (LAB) and FI5876/pFI2596 secreting IL-12p70 (FI10611) (rLAB-IL12) 
were used. L. lactis strains were grown in M17 medium (Oxoid) supplemented 
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with 0.5% (wt/vol) glucose (GM17 medium) at 30° C without agitation. For 
experimentation L. lactis strains were grown to an OD600 of approximately 1.0. 
The recombinant bacterial strains were generated by Dr. A. Fernandez-Dumont 
in Dr. Narbad’s laboratory at IFR. Description of the WT strain, generation of the 
recombinant strain, levels of IL-12p70 secreted and its biological activity have 
been described in detail elsewhere (Fernandez et al., 2009). 
Mouse model of food allergy and administration of rLAB-IL12   
Five weeks old female C3H/HeJ mice were sensitized according to an 
established protocol (Li et al., 2000). Briefly, mice received intragastric 
administration of 1 mg/mouse of ground crude peanut extract (CPE) together 
with 10 g of cholera toxin List Biological Laboratories)in PBS on days 0, 7, 14, 
21, 28. On day 35 all mice were challenged by intragastric gavage with CPE (10 
mg/mouse divided into 2 doses at 30 min intervals). To assess the role IL-12 in 
suppressing food allergy three groups of animals were intragastrically gavaged 
with PBS (control group), L. lactis FI10632 (LAB) and L. lactis FI10611 secreting 
mIL-12 (rLAB-IL12) (8-10 mice/group). Details of the administration regimen are 
shown in Figure 8 A below. Bacterial cell pellets were collected, washed with 
PBS and resuspended in 2% NaHCO3. A suspension of 100 l containing 10
9 
colony-forming units/ml was administrated by oral gavage in a single dose to 
the mice 24 h and 2 h before administration of the sensitizing mixture. Parallel 
experiments assessed the role of TSLP in the development of food allergy in the 
same mouse model. Animals were gavaged with CPE+CT, CT alone, or PBS; 
where the mice receiving CPE+CT were either administered with rLAB-IL12 or 
PBS before each sensitization as already described. Intestinal tissue for gene 
expression analysis and microscopy was collected within an hour of CPE 
restimulation. Further experiments assessing the role of TSLP included groups of 
mice injected i.p. with two doses of 0.5 mg/mouse of anti-TSLP blocking 
antibody (clone M702, Amgen) 12 h and 3 h prior to the delivery of each 
sensitizing dose (Figure 8 B). In all these experiments the percentage of mice 
that developed type I hypersensitivity reaction was assessed using a scoring 
system previously described (Jong et al., 1998). Serum levels of CPE-specific IgE, 
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IgG1 and IgG2a antibody were determined by ELISA in all groups of sensitized 
and control mice (see below). Plasma levels of histamine were detected by 
using an enzyme immunoassay kit (Immunotech S.A.S.) whereas vascular 
leakage was monitored by injecting Evans blue dye solution (100 l of 0.5% w/v) 
(Sigma) into the tail vein to three animals from each group and footpads were 
examined 40 minutes after the dye injection. Body temperature was monitored 
using a rectal probe (Kent Scient. Corp.). Finally, levels of the cytokines IL-4, IL-5 
and IFN- produced by splenocytes in vitro following antigen (CPE 10 g/ml) 
recall challenge were determined in culture supernatant by ELISA kits 
(Biolegend) following 72 h challenge. For isolation of splenocytes, spleens were 
treated with 400 U/ml collagenase D (Roche) in RPMI 1640 (Sigma) and 
incubated at 37° for 10 min and were afterwards gently dispersed with glass 
homogenizer. Cells were spun at 400 g for 5 min and red blood cells were 
removed by addition of 1 ml/spleen Red Blood Cell Lysing Buffer (Sigma) after a 
minute incubation the cells were washed with 20 volumes of medium. Cells 
were grown in RPMI 1640 (Sigma) with 10% FCS, penicillin (final conc. 100 U/ml) 
and streptomycin (final conc. 100 µg/ml) (Invitrogen). 
 
Figure 8 Peanut sensitization scheme. To assess the effect of IL-12 
reconstitution on the development of allergy (A) five sensitization doses of CPE 
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and CT were intragastrically administered at seven day intervals. Twenty-four 
and two hours before each sensitization a group of animals received gavage 
with L. lactis FI10611 secreting  bioactive mouse IL-12p70 (rLAB-IL12), 
alternatively* another group received L. lactis FI10632 (LAB) or PBS (control 
group). Blood was withdrawn from tail vein on days 7, 21 and 35 for evaluation 
of plasma CPE-specific antibodies. On day 35 the animals from all groups were 
recall challenged with CPE alone and within 1 h blood for measurement of 
histamine and spleens were collected. Alternatively* mice were not recall 
challenged with CPE and intestinal tissue was collected for evaluation of IFNγ. 
To assess the role of TSLP in the development of food allergy (B) again mice 
were sensitized with CPE and CT as before. In this instance anti-TSLP blocking 
antibody was administered twelve and three hours before each sensitization. 
Tissue and blood collection was performed as described in A).  
 
Effect of CT gavage on IECs IL-12Rβ2 expression 
Mice (4 animals per group) were intragastrically administered with 10 µg CT in 
300 µl PBS or only 300 µl PBS as a control. After 48 h small intestine was 
collected for IECs isolation for flow cytometry. Faecal material and fat were 
removed and intestinal tissues were washed in 25 ml PBS with 0.1% (vol/vol) 
sodium azide, 2% (vol/vol) FCS and 4mM EDTA (PBSAFE) which contained 0.05% 
(vol/vol) of protease inhibitor cocktail (Sigma Aldrich) (per 6 cm intestine) and 
subsequently washed twice into 25 ml PBSAFE containing 0.8 mM DTT (Sigma 
Aldrich). IECs were detached by incubation in PBS containing 10% FCS, 1 mM 
EDTA at 37 °C for 20 min and vigorously shaken 20 times. This step was 
repeated until no more IECs were detaching and visual inspection showed bare 
villi. Cells were filtered through 40 µm ø strainers, spun (10 min at 300g) and 
washed once in PBSAFE, resuspended appropriately and counted. For flow-
cytometry analysis 1x106 cells were stained in 100 µl final volume with APC anti-
mouse E-cadherin, Clone: 114420 (1:10; R&D Systems); APC rat IgG2a, Clone: 
54447 (1:10; R&D Systems); FITC rat anti-mouse CD45, Clone: 30-F11 (1:20; 
Caltag laboratories); PE anti-human/mouse IL-12Rβ2, Clone: 305719 ( 1:10; R&D 
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systems); PE mouse IgG1, Clone: 11711 (1:10; R&D systems). After one wash 
with PBSAFE samples were fixed by adding equal volume 2% formalin and 
analysed with EC800 (Sony Technologies), software version 1.3.6 (Sony 
Technologies). 
Effect of CT gavage on intestinal IL-12 and TSLP expression 
Mice (5 animals per group) were intragastrically administered with 10 µg CT in 
300 µl PBS or only 300 µl PBS as a control. Small intestinal tissues for protein 
and mRNA analysis were collected 6 h, 16 h, and 72 h post gavage. 
ELISA assay for serum and fecal peanut-specific IgE, IgG1, and IgG2a 
On days 7, 21 and 35 following initial sensitisation and before each sensitisation 
process, tail vein blood extraction was performed. Sera were collected and 
stored at –70 C. Levels of peanut-specific IgE antibody were determined by 
ELISA as described in detail previously (Chambers et al., 2004). Serum levels of 
peanut-specific IgG1 and IgG2a were measured as follows (Lee et al., 2001). 
Briefly, Nunc-Immuno 96 Maxisorp plates (Fisher scientific) were coated with 
300 l per well with CPE or dinitrophenyl-albumin (DNP-albumin) (Calbiochem) 
at a concentration of 1 g/ml in coating buffer at pH 9.6. As previously 
illustrated by Lee et al., 2001 due to the fact that there is a lack of commercially 
available anti-peanut antibody the levels of IgE, IgG1 and IgG2a were 
determined by comparison with a reference curve created with DNP-albumin 
and its correspondent anti-DNP IgE (Sigma), IgG1 and IgG2a (Biocytex) mouse 
monoclonal antibodies. After two hours at room temperature the plates were 
washed six times with PBS with 0.05% Tween-20 (PBST). To generate the 
standard curve, 100 l of anti-DNP IgE, IgG1 and IgG2a at dilutions of 106 pg/ml 
per well to 1 pg/ml per well were loaded in one half of the plates. Mouse sera 
(100 l) were added at dilutions from 1:10 to 1:100 for IgE and from 1:1000 to 
1:10000 for IgG1 and IgG2a to the other half of the plates.  Plates were 
incubated for 90 min at room temperature, washed in PBST six times and then 
anti-mouse IgE-HRP (Serotec), anti-mouse IgG1 and anti-mouse IgG2a (Sigma) 
from goat was incorporated. In the case of IgG1 and IgG2a a second step was 
included by the incubation with anti-goat IgG-HRP (Sigma). Enhanced K-blue 
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TMB substrate (100 l) (Skybio) was added and incubated for 10 min. 
Afterwards, the reaction was stopped with 50 l of 2M sulphuric acid. 
Protein isolation for cytokine measurement 
Protein was extracted by running samples in tubes with acid washed 3 mm ø 
glass beads (VWR) on fast prep (6x 1 min with rest on ice inbetween, speed 4 
m/s) in CelLytic MT (Sigma) containing 1% (vol/vol) protease inhibitor cocktail 
(Sigma). Samples were centrifuged (800 g for 5 min), transferred and 
centrifuged again (100 g for 10 min) and supernatants were collected and 
protein concentration determined with Nanodrop ND-1000 Spectrophotometer. 
Intestinal levels of TSLP (pg/ml) were measured by using ELISA MAX Deluxe set 
(Biolegend) according to the manufacturer’s description. 
Immunohistochemistry 
Frozen sections (8 m) were fixed with 10% buffered formalin for 30 minutes 
and endogenous peroxidases were quenched with 0.3% hydrogen peroxide for 
1 hour and stained with biotinylated goat anti-mouse TSLP (R&D Systems) and 
then treated with Vectastain Elite ABC kit (Vector Laboratories). Fluorescein 
deposit was achieved on the site of the immunoreaction with the TSA Plus 
fluorescence system (Perkin-Elmer). Sections were counterstained with mouse 
anti-β-actin Mab (Sigma-Aldrich) followed by TRITC-conjugated donkey anti-
mouse IgG antibody (Jackson ImmunoResearch Lab-Starfish, Milan, Italy). 
Q-PCR  
RNA extraction was carried out using RNeasy Mini Kit (Qiagen) according to 
manufacturer’s instructions with additional RNase-free DNase set (Qiagen) 
treatment.  Quantity and purity of each RNA sample extracted was determined 
with Nanodrop ND-1000 Spectrophotometer. The mRNA (300 ng/reaction) was 
reverse transcribed into cDNA with the QuantiTect Reverse transcription Kit 
(Qiagen). Q-PCR was performed with ABI 7500 or ABI 7300 sequence detection 
systems (Applied Biosystems) and mRNA expression of IL-12p40 and TSLP was 
measured using the following primers from QuantiTect primer Assay (Qiagen): 
Mm IL12b_1_SG; Mm Tslp_1_SG. Gapdh and 18S mRNA were used as -
endogenous controls and quantified with QuantiTect primers (Qiagen) Mm 
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GAPDH_3_SG and Mm Rn18s_3_SG. SYBR GREEN Mastermix contained 10% 
(vol/vol) of 20 mg/ml BSA (Biolabs new England); 1% (vol/vol) 50 mg MgCl2 
(Bioline); 2% (vol/vol) ROX reference Dye (Invitrogen); 10% (vol/vol) of 
Quantitect primer Assay; 0.6% (vol/vol) of 100x SYBR Green nucleic acid staining 
(Invitrogen); 1,4% (vol/vol) water; 50% (vol/vol) 2x Immomix (Bioline); 25% 
(vol/vol) cDNA. Real-time PCR reactions were performed, using a 10 min hot 
start at 95 °C, followed by 50 cycles of denaturing at 95 °C for 30 s, annealing at 
60 °C for 30 s and extension at 72 °C for 35 s.  Reactions were carried out using 
three technical replicates for every biological replicate. All samples were 
normalized to 18S expression using the ΔΔCT method. 
4. Results 
4.1. Oral delivery of L. lactis secreting IL-12p70 suppresses 
food allergic reaction to peanuts. 
L. lactis producing bioactive IL-12p70 (Fernandez et al., 2009) was delivered 
prior the administration of the sensitizing mixture and its effects on food 
allergic reaction were monitored. First, mice treated with rLAB-IL12 showed a 
significant decline of allergen-specific IgE compared to sensitized control mice 
or LAB-treated over the observation period (Figure 9 A). Also, in agreement with 
a previous report (Swain et al., 1990) reduced levels of IgE, although not 
statistically significant were observed in mice treated with the wild type (WT) 
bacterial vector L. lactis, suggesting that this bacterial strain has intrinsic anti-
allergic properties. Levels of plasma histamine were significantly reduced by 
treatment with rLAB-IL12. In sensitized untreated mice levels reached 2023+307 
ng/ml and were reduced to 1670+450 (p<0.65) and 515±120 ng/ml (p<0.01) in 
LAB and rLAB-IL12-treated mice respectively (Figure 9 B). Treatment with rLAB-
IL12 also affected cytokine production following in vitro recall antigen challenge 
of splenocytes. Increased vascular permeability leakage is an additional feature 
of type I hypersensitivity reaction; indeed, this was reduced in mice treated with 
rLAB-IL12 compared to sensitized mice (Figure 9 C). In addition, levels of IgG1 
and IgG2a were monitored at the end of the observation period (day 35 post 
initial sensitization) (Figure 9 D); levels of IgG1 ranged between 66.2±21 µg/ml 
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in sensitized mice and 51±12 µg/ml and 14.9±4.7 µg/ml in LAB and rLAB-IL12-
treated mice respectively; also the visual recording of the overall anaphylaxis 
score showed that mice treated with rLAB-IL12 exhibited an overall reduction of 
allergy-related symptoms (Figure 9 G).  Levels of both IL-4 and IL-5 in culture 
supernatants were significantly reduced (p<0.01) while the production of IFN 
was significantly increased (p<0.01) only in rLAB-IL12-treated mice (Figure 9 E, 
F). Furthermore, repeated delivery of IL-12 could affect the inflammatory status 
of the gut; however, quantification of the pro-inflammatory cytokine IFNγ the 
production of which is directly up-regulated by IL-12 (Liu et al., 2015), showed 
that repeated delivery of IL-12 via rLAB does not induce local long-lasting 
inflammation as determined six days after the termination of the treatment 






Figure 9 Prior to sensitization mice were intragastrically delivered L. lactis 
FI10632 (LAB), L. lactis FI10611 secreting mIL-12 (rLAB-IL12) or PBS. The group 
receiving rLAB-IL12 showed significant reduction in serum IgE (A), plasma 
histamine (B), vascular leakage (C), IgG1 but not IgG2a (D), and exhibited 
ameliorated anaphylactic symptoms (Jong et al., 1998) (G). Splenocytes from 
mice receiving rLAB-IL12 produced significantly lower levels of IL-4 and IL-5 (E), 
and more IFNγ (F) after in vitro CPE restimulation. Finally rLAB-IL12 treatment 
did not induce long-term local inflammation since 6 days after the last 
application there was no significant increase in intestinal IFNγ (H). (Experiments 
performed in triplicate, n=8 to 9 mice/group; two-way ANOVA in A, one-way 
ANOVA in B, D, E, F, G, H; error bars represent standard error of the mean 
(SEM))  
4.2. Oral delivery of IL-12 down-regulates allergy-associated 
increase of IEC-derived TSLP 
Several reports have indicated TSLP as a key cytokine in allergic response (Han 
et al., 2012, Liu et al., 2007, Soumelis et al., 2002).  Therefore the production of 
TSLP during sensitization in the presence or absence of oral administration of 
rLAB-IL12 was investigated. First, quantitative PCR analysis showed that TSLP 
gene expression was significantly up-regulated in sensitized mice as well as in 
mice treated with CT alone, compared to control non-sensitized (PBS-treated) 
mice (Figure 10 A). This suggested that CT is required to induce a strong TSLP-
mediated Th2 polarized immune response. Next, we observed that 
administration of rLAB-IL12 prior to the delivery of the sensitizing dose 
significantly suppressed the expression of TSLP. The regulatory effect of IL-
12p70 on IEC-derived TSLP was further confirmed by immunohistochemistry 
analysis (Figure 10 B-E). The latter approach did not detect TSLP neither in PBS 
nor rLAB-IL12 treated mice (Figure 10 B, C) but only in sensitized mice (Figure 
10 D, E). These results demonstrated the existence of a regulatory effect 
exerted by IL-12p70 on the production of TSLP by IEC and, thus concurring with 
several reports (Han et al., 2012, Liu et al., 2007, Soumelis et al., 2002) 




Figure 10 TSLP in the intestine is upregulated as a result of sensitization and 
treatment with rLAB-IL12 supresses TSLP overproduction. Application of CPE 
antigen (Ag) in combination with cholera toxin (CT) or CT on its own lead to 
significant increase in TSLP expression. When rLAB-IL12 was applied before each 
sensitizing dose there was no increase in TSLP (A). (Experiment performed in 
triplicate, n=7-9 mice/group); fold change difference >2 is considered 
significant, error bars represent SEM) Immunohistochemistry of small intestinal 
tissue sections form PBS (B) and rLAB-IL12 (C) groups showed no detectable 
TSLP whereas there was enhanced signal in the epithelium of sensitized mice 
(D) and higher magnification (E).  
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4.3. Requirement for TSLP in the sensitization process 
It remained to be determined as to whether down-regulation of TSLP is directly 
linked to suppression of allergic reaction. To this end, mice were injected i.p. 
with two doses of anti-TSLP blocking antibody prior to the delivery of each 
sensitizing dose. In contrast to what has been observed by others (Chu et al., 
2013) administration of anti-TSLP antibody prior sensitization in C3H/HeJ mice 
had a significant reduction effects on allergic reaction to peanuts. Levels of 
allergen specific IgE were significantly reduced in mice treated with anti-TSLP 
antibody (Figure 11 A) compared to sensitized control mice; this was 
accompanied by significant decrease in the production of both IL-4 and IL-5 
during in vitro antigen recall challenge (Figure 11 E) as well as of plasma 
histamine (Figure 11 B). Of note is the observation that in contrast to rLAB-IL12 
the administration of anti-TSLP antibody suppressed allergic reaction without 
affecting levels of IFN produced in an in vitro antigen recall challenge (Figure 
11 F). This further highlighted the existence of multiple pathways that can 
trigger/regulate allergic immune responses.  Furthermore administration of 
anti-TSLP antibody induced a significantly suppressed vascular leakage (Figure 
11 C) and allergen-specific IgG1 antibody but did not affect antibody of IgG2a 
isotype (Figure 11 D). Finally, lack of decrease in body temperature (Figure 11 
G) and lower anaphylaxis score (Figure 11 H) were observed in mice treated 







Figure 11 Mice were injected i.p. with two doses of anti-TSLP blocking antibody 
prior to the delivery of each sensitizing dose. A number of parameters were 
measured including serum IgE (A), plasma histamine (B), vascular leakage (C), 
serum IgG1 and IgG2a (D), and rectal temperature (G). Anaphylactic score was 
assigned as previously described (Jong et al., 1998) (H). Splenocytes isolated 
from the sensitized animals were re-stimulated with allergen and IL-4, IL-5 (E) 
and IFNγ (F) were assessed by ELISA. (Experiments performed in triplicate, n=7-9 
mice/group; t-test in B, D, E, F; two-way ANOVA in A and G; error bars represent 
SEM)  
 
4.4. Kinetics of TSLP and IL-12 production in the gut following 
oral administration of CT  
Oral administration of CT, either alone or in combination with antigen, induced 
a significant increase in TSLP gene expression (Figure 10). This observation, 
along with the notion that CT directly suppressed the production of IL-12 and its 
specific receptor (IL-12R) (Braun et al., 1999) prompted us to determine the 
levels of TSLP, IL-12 and IL-12R over time following a single oral delivery (10g) 
of CT. Levels of TSLP were not affected during the first 16 h post oral 
administration of CT; however expression of TSLP significantly increased at 72 h 
after CT treatment. The pattern of the IL-12 (p40 subunit) expression showed 
different kinetics. Indeed, a significant decline of IL-12 expression in the gut 
tissue was detected already at 16 h post-treatment and remained lower at 72 h. 
Thus, oral delivery of CT initially suppressed the expression of IL-12 and 
subsequently up-regulated the production of TSLP by IEC (Figure 12). 
Interestingly we observed, for the first time that a substantial percentage of 
IECs in the small intestine expressed the IL-12R2 chain; however, we also 
observed that its constitutive expression on IECs (Figure 13 A) was not 







Figure 12 TSLP protein (A) and IL-12p40 (IL-12B) mRNA (B) were measured in 
mouse small intestine after intragastric administration of a single dose of CT. 
Reduction in IL-12p40 mRNA expression preceded overexpression of TSLP 
protein. Decrease in IL-12p40 mRNA was evident as early as 16 h post CT 
administration while at this early time points TSLP protein levels remained 
unchanged and increased only after 72 h. (n=5; one-way ANOVA, Bonferroni 








Figure 13  Effect of CT on IEC IL-12R2 expression. Mice were gavaged with PBS 
(A, B) or CT (C, D) for 48 hours before sacrifice. Isolated IECs were stained with 
PE-coupled isotype control immunoglobulin (A, C) or anti-IL-12R2-PE antibody 
(B, D). IL-12R2 expression was compared between the treatments after data 
acquisition by flow cytometry. (This experiment was performed three times, 












The main finding of this work is that oral delivery of recombinant Lactococcus 
lactis secreting the bioactive form of IL-12 (IL-12p70) prior the administration of 
allergen in a mouse model of food allergy prevented allergic sensitization to 
food components (peanuts) by possibly down-regulating the production of the 
pro-allergic cytokine TSLP by the intestinal epithelial cells. The importance of 
this finding is twofold. First, we have identified a novel regulatory loop that 
appeared to be important for the intestinal immune homeostasis based on the 
reciprocal control and regulation between the immune derived IL-12p70 and 
the epithelium-derived TSLP. Second, we have further shown the biological 
importance of a finely tuned interaction between the gut epithelium and the 
underlying immune system. TSLP is a critical cytokine in establishing and 
maintenance of the intestinal immune homeostasis; it has been shown that the 
production of (TSLP) plays a major role regulating the generation of non-
inflammatory DCs and regulatory T cells (Ito et al., 2005, Rimoldi et al., 2005). 
However, overproduction of this cytokine is essential for development of food 
hypersensitivity. 
This work further highlights the importance of lympho-epithelial cross talk at 
mucosal interface in the gut in maintaining health. However, although it is well 
known that epithelium-derived cytokines such as, TSLP, IL-25 and IL-33 have an 
impact on the function of cells of the immune system, much less is known about 
immune cell-derived cytokines that participate in the cross-talk between the gut 
epithelium and the immune cells and their regulatory function on IECs.  It has 
been previously shown that following microbial challenge the cytokine 
Macrophage-Migration Inhibitory Factor (MIF) produced by CD11c+ cell in the 
subepithelial area of the specialized follicle-associated epithelium of the Peyer’s 
patch up-regulate microfold (M) cell transport of luminal antigen; thus playing 
an important role in initial steps of mucosal immune responses (Man et al., 
2008). The current work provides an additional example of how an immune-
derived factor controls critical features of IECs.  
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The IL-7-like cytokine TSLP is an epithelial-derived soluble factor with the ability 
to shape the immunological microenvironment of both respiratory and 
intestinal mucosae. TSLP is produced by epithelial cells, stromal cells, and 
basophils and acts on DCs, mast cells, T cells, and B cells (Takai, 2012). TSLP 
signals by binding to a heterodimeric receptor consisting of the IL-7 receptor α-
chain and the low affinity TSLP receptor chain (TSLPR). The IL-7Rα is required for 
the generation of a high affinity binding site and for signalling (Pandey et al., 
2000). Exposure of ECs to viral, bacterial, and parasitic pathogens, as well as to 
various cytokines can induce TSLP expression (Takai, 2012). It promotes Th2-
type intestinal immunity against helminthic infections. This cytokine negatively 
regulates production of IL-12/23 p40 by DCs in vivo and in vitro and suppresses 
Th1 responses (Taylor et al., 2009). Interestingly, mRNA expression of TSLP is 
significantly reduced in patients with CD, whereas TSLP is overexpressed in 
patients with UC (Rimoldi et al., 2005, Tanaka et al., 2010). TSLPR−/− mice have 
pronounced Th1 and Th17 responses that lead to worsened DSS colitis and 
pathologic Th1-mediated inflammation in Trichuris muris infection (Taylor et al., 
2009). Critically, TSLP has been identified as a mediator of allergic reactions 
including atopic dermatitis, asthma and gastrointestinal allergy (Zhou et al., 
2005, Ziegler, 2012, Blázquez et al., 2010). In addition to this, here we describe 
that the production of TSLP by IEC is possibly regulated by IL-12p70 and that this 
regulatory pathway has a critical role in shaping intestinal immunity.  It has 
been shown previously that TSLP supresses  the production of IL-12 in DCs 
(Rimoldi et al., 2005); our study suggest that in turn IL-12 possibly controls the 
production of TSLP by IEC in a regulatory feedback loop that contributes to 
maintaining the intestinal immune homeostasis. In our opinion this observation 
shows interplay between these two cytokines produced by the intestinal 
epithelium and the immune system that is central in the control of intestinal 
immunity. 
It has been previously shown that different mouse strains exhibit variable 
degree of susceptibility to sensitization. For example the C3H/HeJ mice are 
highly susceptible whereas Balb/c under the same sensitization regimen and 
although producing a significant amount of IgE antibody do not develop type I 
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hypersensitivity reaction. Using this model it has been demonstrated that 
reduced levels of IL-12 in the gut, but not systemic, immune system is critical for 
the development of food hypersensitivity (Temblay et al., 2007). The availability 
of this model provided us with the possibility to test the biological relevance of 
the TSLP/IL-12 cross regulation and its implication in health and disease.  We 
observed that by restoring levels of IL-12 in the gut we could abolish the 
expression of TSLP by IEC and in so doing suppressing food allergy to peanut. 
This demonstrates that lack of IL-12 and the subsequent over-expression of 
TSLP play a major role in shaping the proper immune response to food 
components.  Interestingly, it has been previously shown in the same mouse 
model of food allergy that oral delivery of a similar bacterial vector secreting IL-
10 suppressed food allergy. The notion that cytokines with very different 
biological activity, such as the anti-inflammatory IL-10 and the pro-inflammatory 
IL-12 both have the ability to suppress IgE-mediated allergy illustrates the 
complexity of the cytokine network involved in the regulation of immune 
response to food components. In addition, although the possibility of using 
recombinant bacterial vector to deliver IL-12 to treat allergy will require further 
investigation it is worth noticing that, at least in mice repeated delivery of rLAB-
IL12 did not compromise the inflammatory status of the gut and no side effects 
were detected. However, in the case of IL-12 it was still plausible that restoring 
the balance between TSLP and IL-12 did not have a direct effect on peanut 
allergy in our experimental model. To address this we administered anti-TSLP 
blocking antibody prior to each sensitization dose in mice. This step was 
necessary since it has been suggested that TSLP is not central to peanut allergy 
while IL-33 plays a more critical role (Vossenkamper et al., 2004). Although we 
have not addressed the role of IL-33 we have observed that in contrast to what 
was previously reported specific blocking antibody to TSLP suppressed allergic 
reaction as monitored by a variety of immunological and visual parameters. This 
discrepancy may reflect the different genetic make-up of the host and its effect 
on susceptibility/resistance to peanut allergy; however at this stage we are not 
in the position to reconcile these discordant observations. In addition, our 
findings are in agreement with a number of studies that prescribe TSLP an 
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essential role in allergy. For example, application of anti-TSLP antibody in 
asthma reduces allergen-induced bronchoconstriction (Gauvreau et al., 2014). 
Furthermore, skin-specific overexpression of TSLP has been reported to result in 
atopic dermatitis associated with pronounced increase in Th2 CD4+ cells homing 
to the skin and elevated serum IgE (Yoo et al., 2005). Similarly, lung-specific 
TSLP overexpression is sufficient to elicit severe airway allergic inflammation 
and development of asthma-like phenotype, accompanied with Th2 CD4+ 
infiltrates, eosinophilia and increased serum IgE (Zhou et al., 2005).  
The regulatory effects of IL-12 on the production of TSLP were further 
supported by the observation that oral delivery of CT differentially affected the 
kinetics of the TSLP and IL-12 production in the gut. Indeed, CT-mediated down-
regulation of IL-12 production was already evident at 16 h following the delivery 
of CT while expression of TSLP was unaffected at 16 h but showed a significant 
up-regulation at 72 h post-administration; thus further suggesting that reduced 
production of IL-12 plays an important role in TSLP overexpression in allergy.  
Overall, these data showed that the production of TSLP by IECs is under the 
control, either directly or in-directly by IL-12 and that this regulatory mechanism 













Chapter 3: IL-12-mediated regulation of TSLP 




The way we look at the intestinal epithelium has dramatically evolved in the 
past few years. Although the main task of the epithelium overlying mucosal 
surfaces of the GI tract is to provide an effective barrier to the vast majority of 
macromolecules and microorganisms present in the intestinal lumen; it has 
become evident that the signals originating from the variety of cells forming the 
intestinal epithelium contributes to shape the immunological environment of 
the gut. The role of this selective barrier is achieved by several means. Firstly, 
the epithelium is composed of cells joined by tight junctions allowing passage of 
water and ions but providing an effective mechanical barrier to macromolecules 
(Duffey et al., 1981). Secondly, local secretions of mucus, secretory IgA 
antibodies, and a thick glycocalix cover the mucosal surfaces (Maury et al., 
1995, Frey et al., 1996, Kett et al., 1995, Johansson et al., 2011). In addition to 
this vital function, the intestinal epithelium plays a key role in shaping mucosal 
immune responses by creating the appropriate immunological 
microenvironment described in detailed in Chapter 2. Indeed, IECs are capable 
of producing a number of cytokines upon bacterial invasion, some examples 
being IL-8, monocyte chemotactic protein 1, and macrophage inflammatory 
protein 3α (Dahan et al., 2007). In addition to secretion of signaling molecules 
IECs have been implicated in cell-to-cell interactions with macrophages 
(Rescigno et al., 2001) and T cells (Gonnella and Wilmore, 1993). However, the 
cytokine traffic is not by all means unidirectional and although this part of the 
lympho-epithelial cross talk has received less attention by the scientific 
community immune-derived factors can have an impact on the IECs function.  
One of the first studies that addressed the role of immune–derived signals in 
shaping regulatory features of the IEC was carried out by Haller et al. (2000). 
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Their work has first shown that the presence of lymphocytes is essential to 
impart IEC (human Caco2 cells) the ability to respond to bacterial challenge 
(Haller, 2000). It is to be noted that the IEC and PBMC were co-cultured using 
Transwell culture devices and were not in direct cell-to-cell contact (Parlesak et 
al., 2004). Although the soluble factors responsible and the overall mechanism 
underlying these events were not identified it became clear that cytokine-
mediated cross talk between immune cells and IECs is an important part of 
regulatory network operating at the mucosal interface in the gut. Another 
important example of the impact of immune-derived factors that contribute to 
shape the function of the epithelial cells is represented by macrophage 
migration inhibitory factor (MIF). Indeed, MIF is produced by CD11c+ cell 
present in the SED area of the PPs rapidly after in vivo bacterial challenge. It has 
been shown to act on IECs and induce M-cell like phenotype thus facilitating 
antigen transport (Man et al., 2008). To these examples we can now add our 
finding that IL-12 regulates the production of TSLP from IECs. However, despite 
the fact that the latter observations pertain to events that participate in 
important aspects of intestinal immunity the mechanism of action and the way 
immune-derived cytokines interact with IECs remained to be determined.  
2. Hypothesis  
In Chapter 2 we have reported that a substantial percentage of IECs did express 
the β2 subunit of the IL-12R. This prompted us to investigate the role of IL-
12Rβ2 on IECs. There were several possible scenarios for IL-12-mediated 
regulation of TSLP. One possibility was that IL-12, either on its own or in synergy 
with unknown partner, could regulate TSLP directly by binding the IL-12R. 
Alternatively, IL-12 action could take place indirectly by inducing the production 








Female mice from B6.12931-IL12btrn1Jm/J (IL-12p40 knockout) and B6.12931-
IL12Rβ2trn1Jm/J (IL-12Rβ2 knockout) strains, along with the appropriate wild type 
C57BL/6J controls, were purchased from Jackson Laboratories. Balb/c and 
C57BL/6 mice were purchased from Disease Modelling Unit, UEA. All 
procedures were carried out in accordance with U.K. Home Office regulations, 
license conditions and University of East Anglia guidelines on animal welfare 
and the current Italian law for animal experimentation.  
MODE-K cells cultures 
Mode-K cells (Vidal et al., 1993) originally isolated from the same mouse strain 
used for the in vivo study on food allergy (C3H/HeJ) were cultured either alone 
or co-cultured in the presence of gut (Peyer’s patch-derived) lymphocytes. 
A-MODE-K cells were washed with Hank’s Balanced Salt solution (HBSS Gibco) 
and detached with 1 ml TrypLE (Gibco) per 25 cm2 and incubated for 10-15 
minutes at 37° C. The cells were transferred into Falcon tubes containing 6 
volumes of HBSS and spun down (300 g for 10 min). After counting the cells 
were seeded into 12-well plates, 25cm2 or 75 cm2 T flasks at 2.5 x 104 cells/cm2 
and incubated at 37° C, 5% CO2. Growth media for MODE-K: high glucose DMEM 
medium (Invitrogen), 10% (vol/vol) heat-inactivated FCS, penicillin (final conc. 
100 U/ml) and streptomycin (final conc. 100 µg/ml) (Invitrogen). For flow 
cytometry, cells were washed with and PBS with 0.1% (vol/vol) sodium azide, 
2% (vol/vol) FCS and 4mM EDTA (PBSAFE). Subsequently, the cells were 
detached with a cell scraper (Griener Bio-one), resuspended by pipetting, 
passed through a needle (0.3 mm x 0.13 mm) and filtered with a cell strainer (ø 
40 µm BD falcon). 
B- MODE-K cells were seeded in the top compartment of 12 mm ø Transwells, 
pore size 3 µm ø (Costar) at 1x105/well. After four days of growth PPLs were 
added to the culture. First, media was exchanged with fresh DMEM (Invitrogen), 
10% (vol/vol) heat-inactivated FCS, penicillin (final conc. 100 U/ml), 
streptomycin (final conc. 100 µg/ml) (Invitrogen) and gentamycin (final conc. 50 
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µg/ml). PPLs were isolated from PPs by mashing between frost edged sterile 
glass slides and filtered through strainer (ø 40 µm BD falcon). Washed with 
media once and resuspended to 1x106/ml. 5x105 PPLs were added in the top 
compartments of the Transwells and the MODE-K layer was scraped to ensure 
appropriate contact. For non-contact co-culture 1x106 PPLs were added to the 
bottom compartments, MODE-K layer was scraped to ensure that the 
conditions the same among all treatments. After three days expression of IL-
12Rβ2 was examined by flow cytometry.  
Antibodies  
The following specific antibodies and isotypes were used for flow cytometry: 
Alexafluor 488 goat anti-rat IgG2b, Clone: poly4054 (1:50; Biolegend); anti-
mouse CD130 (GP130), Clone: 4H1B35 (1:50; Biolegend); Rat IgG2b, Clone: 
RTK4530 (1:50; Biolegend); APC anti-mouse E-cadherin, Clone: 114420 (1:10; 
R&D Systems); APC rat IgG2a, Clone: 54447 (1:10; R&D Systems); FITC rat anti-
mouse CD45, Clone: 30-F11 (1:20; Caltag laboratories); PE anti-human/mouse 
IL-12Rβ2, Clone: 305719 ( 1:10; R&D systems); PE mouse IgG1, Clone: 11711 
(1:10; R&D systems); PE anti-mouse IL-12Rβ2, Clone REA200 (1:20; Miltenyi); PE 
Isotype (A3) REA293 (1:20; Miltenyi); PE anti-mouse CD212 (IL-12Rβ1), Clone: 
114 (1:20; BD Pharmigen); PE mouse IgG2a, Clone: G155-178 (1:20; BD 
Pharmigen) 
Flow cytometry  
For detection of extracellular markers 1x106 cells were stained in 100 µl final 
volume. For intracellular detection of phosphoproteins cells were fixed with 
equal volume of 8% buffered formalin. After 10 minutes at 37° C, fixed cells 
were washed once with PBSAFE and allowed to cool on ice followed by 
permeabilisation on ice for at least 30 minutes with Perm Buffer III (BD 
Biosciences). Permeabilised cells were washed twice with PBSAFE and stained 
for 30 minutes at room temperature. For intracellular detection of cytokeratin 
cells were washed once with 1% Saponin Buffer (SB; 1% Saponin in PBSAFE), 
resuspended in SB and incubated with anti-cytokeratin FITC (Beckman Coulter) 
for 1 hour on ice followed by one wash in SB and a second wash in PBSAFE. 
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Samples were fixed by adding equal volume 2% formalin and analysed with 
EC800 (Sony Technologies), software version 1.3.6 (Sony Technologies).  
Isolation of primary intestinal epithelial cells for flow cytometry 
Faecal material and fat were removed and intestinal tissues were washed in 25 
ml PBSAFE which contained 0.05% (vol/vol) of protease inhibitor cocktail (Sigma 
Aldrich) (per 6 cm intestine) and subsequently washed twice into 25 ml PBSAFE 
containing 0.8 mM DTT (Sigma Aldrich). IECs were detached by incubation in 
PBS containing 10% FCS, 1 mM EDTA at 37 °C for 20 min and vigorously shaken 
20 times. This step was repeated until no more IECs were detaching and visual 
inspection showed bare villi. Cells were filtered through 40 µm ø strainers, spun 
(10 min at 300g) and washed once in PBSAFE, resuspended appropriately and 
counted.  
Isolation of primary intestinal epithelial cells for functional studies  
The following protocol was used to extract IECs from the small intestine of 2 
mice, volumes and amounts were scaled according to number of mice used for 
experiments.   
Mice were sacrificed by cervical dislocation; small intestines were removed, 
dissected longitudinally and washed with sterile PBS.  Tissue was cut into 0.5 cm 
pieces and washed with sterile PBS. To remove mucus, the tissues were first 
washed in 20 ml PBS containing 10% FCS and 1 mM DTT. Subsequently IECs 
were detached by incubation in 20 ml PBS containing 10% FCS, 15 mM EDTA at 
37 °C, 250 rpm for 15 and 20 minutes, respectively.  Before and after each 
incubation, tissue-buffer mix was vortexed for 1 minute.  Cells were filtered 
through a 70 µm ø cell strainer and the filtrate was centrifuged at 300 g, 7 
minutes at 4° C.  The resultant pellets from each wash were pooled, 
resuspended in PBS containing 10% FCS and stored on ice. CD45+ cells were 
removed from crude IEC preparations using magnetic labelling with anti-CD45 
Microbeads (Miltenyi Biotec) and magnetic separation with LD MidMACS 





Testing functional integrity of IL-12Rβ2 through MAPKp38 phosphorylation  
Mouse IEC were washed twice in DPBS (Sigma-Aldrich) then placed in a 37° C 
water bath in the presence of 500 µM H2O2 or 2 µg/ml IL-12p70 (Biolegend) for 
various times. Control cells were left untreated. At the end of the incubation 
period and while the cells were still in the water bath, an equal volume of 8% 
buffered formalin was added. After 10 minutes fixed cells were washed once 
with PBSAFE and allowed to cool on ice followed by permeabilisation on ice for 
at least 30 minutes with Perm Buffer III (BD Biosciences, UK). Permeabilised cells 
were washed twice with PBSAFE and stained for 30 minutes at room 
temperature with rabbit anti-phospho-MAPKp38 (Cell Signaling, USA) or normal 
rabbit IgG (Santa Cruz Biotechnology, USA). After one wash with PBSAFE cells 
were incubated for further 30 minutes with donkey anti-rabbit IgG-FITC (Santa 
Cruz) and washed once with PBSAFE. Data were acquired by flow cytometry. For 
viability assessments cell were washed and resuspended in 1ml PBS. Dead cells 
were stained using Live/Dead Fixable Violet Dead Cell Stain Kit (Life 
Technologies, UK) according to the manufacturer’s instructions. Surface staining 
was performed before and intracellular staining after treatment with viability 
dye. 
Transmission electron microscopy 
Small fragments of gut were fixed in 4% paraformaldehyde and, following 
dehydration, embedded in Epon 812. After cutting and mounting on Formvar-
coated grids, unspecific binding sites on sections were quenched with 1% 
ovalbumin dissolved in PBS. Then, sections were incubated overnight at 4° C 
with rabbit anti-IL12Rβ2 (Bioss Inc.) followed by 15 nM gold-conjugated anti-
rabbit IgG (BB International). After washing, sections were air-dried, stained 
with uranyl acetate, and later examined with a 201 Philips transmission electron 
microscope. 
Organoid isolation and culture 
Small intestine was flushed with DPBS (Sigma-Aldrich), cut longitudinally and 
the villi were scraped off with a glass coverslip. Mucus was washed off three 
times with cold DPBS 2mM EDTA. Tissues were incubated for 30 minutes at 4° C 
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in DPBS 2mM EDTA. The incubation step was repeated into fresh DPBS 2mM 
EDTA for another hour at 4°C. Remaining villi were filtered out with 70 µm ø cell 
strainers. Pelleted crypts were resuspended in Matrigel matrix (Corning) and 20 
µl was seeded per well of a pre-heated (37° C) 48-well tissue culture plate 
(Breiner Bio One). The plate was incubated for 5 minutes (37° C) before adding 
0.25 ml media. Organoids were grown at 37° C and 5% CO2 and media was 
renewed daily. After 7 days organoids were passaged by dissociating from the 
matrix by pipetting with a 200 ml pipette, spun down (600 rcf for 5 min), and 
resuspended into fresh Matrigel (ratio 1:3). Media: advanced DMEM/F12 
(Invitrogen), 1% (vol/vol) Glutamax 100x (Invitrogen), 5mM HEPES (Invitrogen) 
and 100 U/ml penicillin and 100 µg/ml streptomycin (Invitrogen), 0.02% 
(vol/vol) B27 supplement (Invitrogen), 0.01% (vol/vol) N2 supplement 
(Invitrogen),  1.25 mM n-Acetylcysteine (Sigma-Aldrich), 50 ng/ml recombinant 
mouse epidermal growth factor (EGF) (Invitrogen), 4 ng/ml mouse Noggin 
(Peprotech), 500 ng/ml recombinant mouse R-spondin (R&D) and 10 µM ROCK 
kinase inhibitor (Sigma-Aldrich).  
Q-PCR  
RNA extraction was carried out using RNeasy Mini Kit (Qiagen) according to 
manufacturer’s instructions with additional RNase-free DNase set (Qiagen) 
treatment.  Quantity and purity of each RNA sample extracted was determined 
with Nanodrop ND-1000 Spectrophotometer. The mRNA (300 ng/reaction) was 
reverse transcribed into cDNA with the QuantiTect Reverse transcription Kit 
(Qiagen). Q-PCR was performed with ABI 7500 or ABI 7300 sequence detection 
systems (Applied Biosystems) and mRNA expression of TSLP and IL-12Rβ2, was 
measured using the following primers from QuantiTect primer Assay (Qiagen): 
Mm Tslp_1_SG; Mm IL12Rb2_1_SG. Gapdh and 18S mRNA were used as 
endogenous controls and quantified with QuantiTect primers (Qiagen) Mm 
GAPDH_3_SG and Mm Rn18s_3_SG. SYBR GREEN Mastermix contained 10% 
(vol/vol) of 20 mg/ml BSA (Biolabs new England); 1% (vol/vol) 50 mg MgCl2 
(Bioline); 2% (vol/vol) ROX reference Dye (Invitrogen); 10% (vol/vol) of 
Quantitect primer Assay; 0.6% (vol/vol) of 100x SYBR Green nucleic acid staining 
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(Invitrogen); 1,4% (vol/vol) water; 50% (vol/vol) 2x Immomix (Bioline); 25% 
(vol/vol) cDNA. Real-time PCR reactions were performed, using a 10 min hot 
start at 95° C, followed by 50 cycles of denaturing at 95° C for 30 s, annealing at 
60° C for 30 s and extension at 72° C for 35 s.  Reactions were carried out using 
three technical replicates for every biological replicate. All samples were 
normalized to 18S expression using the ΔΔCT method. 
Protein isolation for cytokine measurement 
Protein was extracted by running samples in tubes with acid washed 3 mm ø 
glass beads (VWR) on fast prep (6x 1 min with rest on ice inbetween, speed 4 
m/s) in CelLytic MT (Sigma) containing 1% (vol/vol) protease inhibitor cocktail 
(Sigma). Samples were centrifuged (800 g for 5 min), transferred and 
centrifuged again (100 g for 10 min) and supernatants were collected and 
protein concentration determined with Nanodrop ND-1000 Spectrophotometer. 
Intestinal levels of TSLP (pg/ml) were measured by using ELISA MAX Deluxe set 
(Biolegend) according to the manufacturer’s description. 
4. Results 
4.1. IL-12R expression and function on primary IECs 
In the previous chapter we have shown that a substantial percentage of IECs 
constitutively expressed the 2 chain of the IL-12R (IL-12R2). This prompted us 
to determine whether IL-12 directly controlled the production of TSLP by 
binding to the receptor or whether the action of IL-12 is mediated by additional 
immune mediator(s) produced by IECs following interaction with IL-12p70. First, 
we used flow cytometry analysis to characterize the IL-12R.  
Expression of IL-12Rβ2 was observed on approximately 58% of intestinal (ileum) 
CD45- cells and in a small proportion (>1%) of CD45+ cells (Figure 14 A); the 
epithelial nature of these cells was confirmed by monitoring the expression of 
IL-12Rβ2 on E-cadherin+ cells (Figure 14 E). However, the expression of IL-12Rβ2 
on these cells was not paralleled by the expression of the complementary 




Figure 14 Intestinal epithelial expression of IL-12R. IL-12R2 was detected on 
approximately 50% of intestinal (ileum) CD45- cells and in a small proportion 
(>1%) of CD45+ cells (A), appropriate isotype control (B). The majority of the IL-
12R2+ cells were also E-cadherin+ (E), where appropriate isotype control is 
shown in C and single E-cadherin staining in D. However, despite the presence 
of IL-12R2 on these cells no corresponding IL-12R1 chain could be detected 




Expression of the IL-12R2 chain was further confirmed in IECs following 
immuno-gold staining in the Golgi area (Figure 15 A), in the proximity of the 
basolateral membrane (Figure 15 B) and most important at the interface 
between IEC and lymphoid cells (Figure 15 C). 
 
Figure 15 TEM of mouse small intestine showing that IL-12Rβ2 in IECs is found 
in the Golgi (A) as well as the basolateral membrane (B) and in the interface 
between IECs and lymphoid cells (C). EC=epithelial cell, LC=lymphoid cell, 









IL-12Rβ2 is not only capable of associating with IL-12Rβ1 to form IL-12R but also 
it has been reported to interact with CD130 (gp130) as part of the IL-35 receptor 
(Collison et al., 2012a).Therefore, in order to better characterize the IL-12Rβ2 
the presence of CD130 on IECs was also investigated. However, flow cytometry 
showed that gp130 was not expressed by freshly isolated IECs (Figure 16).  
 
 
Figure 16 E-cadherin+ IECs from mouse jejunum were positive for IL-12Rβ2 (B) 
where the appropriate isotype control is displayed in (A). IECs did not express 
CD130 (D); the appropriate isotype control is displayed in (C). (This experiment 





4.2. Investigating the functionality of IL-12Rβ2 on primary 
IECs 
We then asked the question whether the IL-12Rβ2 chain expressed on freshly 
isolated primary IECs retained the ability to respond following the engagement 
with IL-12p70.  MAPKp38 has been previously shown to participate in 
alternative IL-12Rβ1-independent IL-12 signalling cascade (Verhagen et al., 
2000). Thus, to assess the function of IL-12Rβ2, freshly isolated IECs were 
cultured in the presence of IL-12p70 or hydrogen peroxide (H202) a non-specific 
activation stimulus. Rapidly, after the application of the stimuli, significant 
increase of phospho-MAPKp38 levels was observed following challenge of IECs 




Figure 17 Ex vivo stimulation with IL-12p70 lead to increase in intracellular 
phosphorylation of MAPKp38 in primary small intestinal epithelial cells. 
Stimulation with H2O2 was used as a positive control that produced gradual 
increase in phospho-MAPKp38 with time.  (Experiment performed three 





4.3. Levels of TSLP did not increase in IL-12Rβ2-/- mice 
The expression of a functional, albeit incomplete form of the IL-12R raised a 
series of questions, the most notable being: does IL-12p70 suppress the 
production of TSLP by IECs directly by binding the IL-12R2 chain on IECs or 
indirectly via the production of intermediate soluble factors? To start answering 
this complex question we determine the levels of TSLP in IL-12Rβ2-/- mice. Both 
levels of TSLP gene expression and tissue protein in the intestine were assessed 
by Q-PCR and ELISA.  We observed that the production of TSLP was not 
significantly different when compared to WT controls (Figure 18 A, B). Similarly, 
no change in TSLP mRNA was detected in knockout mice lacking IL-12p40 
(Figure 18 C). This result showed that IL-12 controlled the production of TSLP 
indirectly and strongly suggested that other immune mediator(s) that remain to 
be identified participate in the IL-12/TSLP regulatory loop.  
 
Figure 18 No change was observed in the intestinal TSLP protein (A) and mRNA 
(B) levels in IL-12Rβ2 knockout mice. In addition, mice deficient in IL-12 
signalling due to gene knockout of IL-12p40 had intestinal TSLP mRNA levels 
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similar to those observed in WT (C). (n=6 to 7; comparison between WT and KO 
gut, thymus measurement used as positive control but not included in the 
analysis, fold change difference >2 is considered significant; error bars represent 
SEM) 
 
4.4. Developing models to study the function and expression 
of IL-12Rβ2 on IECs: 
4.4.1. Intestinal organoids  
Parallel experiments were devised to investigate the expression and function of 
IL-12β2 on IECs. Fragile when separated from each other, the poor survivability 
of IECs ex vivo/in vitro prohibits investigation of the long term response to IL-
12p70 stimulation. In order to overcome this problem we adopted organoid 
culture (Figure 19 A) as a method of keeping IECs ex vivo/in vitro for a period of 
time sufficient to observe change in mRNA and protein after stimulation with IL-
12p70. First step in validating this model was to monitor whether the IECs retain 
their expression of IL-12Rβ2 (Figure 19 B). Flow cytometry analysis performed 
on mouse small intestine organoids cultured for 7 days showed that, although 
the organoids expressed E-cadherin, a canonical marker for mature IECs (Figure 
19 B), these cells were characterized by the lack of expression of both IL-12Rβ2 






Figure 19 Mouse small intestinal organoids. A) Representative light microscopy 
image after five days of growth. B) Expression of specific surface markers on the 
organoids after seven days of growth. Data is pooled from two independent 
experiments. (This experiment was performed two times, each time n=4 wells 
of organoids) 
 
4.4.2. MODE-K cell line as a model for studying IECs responses to IL-12 
The lack of expression of the IL-12Rβ2 on organoid-associated IECs prompted us 
to investigate the expression of the receptor on mouse small intestine cell line 
MODE-K (Vidal et al., 1993). Incidentally, this cell line had the benefit of 
originating from the same mouse stain (C3H/HeJ) used for the work on food 
allergy described in Chapter 2. In addition to this, the cell lines are easy to 
culture for long period of time and significantly less expensive compared to the 
intestinal organoids. However, given that they have been immortalized by SV40 
large T gene transfer through a murine ecotropic virus, these cells cannot be 
considered as fully “normal” IECs. First, we compared the expression of the IL-
12Rβ2 on freshly isolated IECs and MODE-K cell line. We observed that the 
expression of the latter was negligible (Figure 20).Data collected from primary 
IECs, intestinal organoids and MODE-K raised an important question. Does the 
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expression of IL-12Rβ2 on IECs require immune-derived signals? To answer this 
question we adopted the strategy based on the use of well-established models 
of cell culture that allows the co-culture of IECs and gut-derived lymphocytes. 
MODE-K cells were grown either in contact with gut (PP)-derived lymphocytes 
or on Transwell polycarbonate membrane in the presence of lymphocytes 
seeded on the bottom chamber (Figure 21 B). It appeared that both soluble and 
physical (cell-to-cell) mediated signals from immune cells play a role in the 
regulation of the expression of IL-12Rβ2. Indeed, the expression of the receptor 
was significantly higher in both co-culture models compared to control culture 
although its expression reached its peak in the presence of cell-to-cell signals 
(Figure 21 A). These results taken together demonstrated once again the 
biological importance of lympho-epithelial cross talk in the gut. 
 
Figure 20 MODE-K expression of IL-12R2. Quantitative PCR analysis showed 
that the expression of IL-12R2 was significantly higher on freshly isolated 
primary IECs compared to three day old intestinal epithelial cell line MODE-K. 
(Experiment performed three times, each time n=2 mice donors of IECs; fold 





Figure 21 Co-culture with Peyer’s patch derived lymphocytes (PPLs) led to an 
increased expression of the IL-12R2 in MODE-K. (A) The levels of IL-12R2 
were assessed by flow cytometry. (B) Schematic representation of the culture 
conditions: in the left the MODE-K cells were in a cell-to-cell (c-t-c) contact with 
the PPLs, on the right the MODE-K cells were cultured in the top compartment 
of the Transwell and the PPLs at the bottom so that no contact (n-c) occurs 
between the cells and only soluble mediators participate in the cross-talk. 
Higher expression of IL-12R2 was seen when PP-lymphocytes were seeded in 
the bottom compartment of the Transwells culture system not in contact with 
MODE-K cells (1.5 fold) (n-c); however, a more pronounced increase (3.2 fold) 
was seen when PP-lymphocytes were allowed cell-to-cell interaction with the 
MODE-K cells (c-t-c). (Experiment performed three times, each time n=3 







The main finding of this part of the work is that IECs do express a functional, 
although incomplete form of the IL-12R (IL-12Rβ2 chain only) that is likely to 
play an important role in the control and regulation of TSLP production in the 
intestinal epithelium by IL-12. Further experiments have shown however, that 
IL-12 does not directly regulate TSLP and that other factor(s) participate in the 
IL-12/TSLP axis. The pro-allergic (Th2) TSLP and anti-allergic (Th1) IL-12 seemed 
to be part of immune-regulatory feedback loop. It has been shown that TSLP 
directly suppressed the production of IL-12 by DCs and mice lacking TSLP 
receptor (TSLPR) showed very high level of IL-12 (Massacand et al., 2009). We 
have now demonstrated that IL-12 in turn keeps the production of TSLP by IECs 
under control and that deviation from this pattern is likely to lead to alteration 
of the intestinal immune homeostasis as in the case of allergic response to food 
components as reported in Chapter 2. The latter arm of the regulatory loop has 
been demonstrated by several converging pieces of evidence. First, as shown in 
Chapter 2 allergic mice displayed a significant reduction of IL-12 and a parallel 
increase of TSLP; the supplementation of IL-12p70 by recombinant L. lactis 
restored physiological levels of TSLP and led to suppression of the allergic 
symptoms. Subsequent experiments also showed that following oral 
administration of CT, either alone or in combination with the allergen, levels of 
IL-12 in the gut declined before upregulation of the TSLP production by IECs 
could be detected. The latter data lead to two different conclusions. Firstly, CT 
does not directly induce the production of TSLP by IECs (also confirmed in vitro 
by challenging MODE-K epithelial cells with CT, data not shown) and secondly 
that CT-mediated up-regulation of TSLP possibly depends on its ability to 
suppress the production of IL-12.  
Interestingly, mice deficient for either IL-12p40 subunit or IL-12Rβ2 showed 
normal levels of TSLP in the gut. This experiment brought about a series of 
important considerations. The use of p40-deficient mice in combination with 2 
chain-deficient mice was required to ascertain whether IL-12 could down-
regulate TSLP expression bypassing the need for a specific receptor. Indeed, 
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although the conventional mechanism of action of cytokine include its binding 
to specific receptor, in some case it has been observed that a cytokine can 
actually activate the target cell by entering the cells via micropinocytosis and 
initiate the intracellular signalling cascade by binding to transcription factors. A 
typical example is the intracellular action of the cytokine MIF to modulate AP-1 
activity and the cell cycle through Jab1 (Kleemann et al., 2000). More 
importantly, the absence of increased expression of TSLP in IL-12Rβ2- and p40-
deficient mice raised the fundamental question about the mechanism 
underlying IL-12-mediated suppression of TSLP. 
One possible explanation of the discrepancy observed between the CT 
sensitization model and the knock-out mice is that in addition to the 
downregulation of IL-12 a second signal is required to drive the overproduction 
of TSLP. Although the nature of the second signals remains to be determined it 
is possible to hypothesize that CT treatment provides both signals thus leading 
to the up-regulation of TSLP production; in IL-12Rβ2 and p40-deficient mice only 
the signal provided by IL-12 pathway is missing while the remaining one is still in 
place to regulate TSLP production.  
There are numerous examples of crucial immunological processes requiring 
secondary signal. For instance, T cell activation requires two events: TCR 
engagement with MHC accompanied with CD28 ligation to CD80. There are also 
cytokines whose expression requires dual input, one example being IL-13. Neill 
et al. (2010) have shown that ILC2 require both IL-33 and IL-7 stimulation in 
order to express IL-13.  The fact that TSLP is a critical cytokine essential for the 
control of intestinal immune homeostasis suggests that a tight regulatory 
mechanism is in place to control its production thus making the hypothesis of 
the double signal-dependent regulation plausible. Experiments are now in 
progress that include the monitoring of global gene expression (microarrays) 
and proteomics analysis in peanut-sensitized and IL-12-treated mice. In order to 
identify the missing pieces of the IL-12/TSLP regulatory pathway the 
development of appropriate experimental models is necessary. One of the main 
technical difficulties encountered in this work is the fragility and short ex-vivo 
life spun of primary IECs. We have started to address the issue by using mouse 
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small intestine organoids and intestinal epithelial cells lines.  The approaches 
undertaken showed, once more that a finely tuned dialogue between IECs and 
immune cells is required for the expression of molecules critical in immune 
regulation. We observed that both intestinal organoids and cell line originating 
from the intestinal epithelium lacked the expression of the IL-12Rβ2. This, 
however, was significantly up-regulated by the presence of both soluble and 
cell-to-cell immune-derived signals. This finding will provide an important tool 
to address the regulatory events in IECs that follow the engagement of IEC-
associated IL-12Rβ2 and its ligand. Experiments are now in progress in the lab to 
study global gene expression in epithelial cells expressing IL-12Rβ2 following 





















Chapter 4: Lympho-epithelial cross talk in the 
interaction with the gut microbiota 
 
1. Introduction to the gut microbiota 
Since the microbiome field's inception some 15 years ago thousands of research 
papers have been published on the subject with the microbiota craze peaking in 




Figure 22 Number of publications as determined by search in Google Scholar for 
“intestinal microbiota”. 
It has been established that diet and host genetics as well as other host-
associated factors can influence the microbial composition of the gut. On the 
other hand, change in the microbial community can have profound effects on 
the host. So far microbiota research has given a lot of evidence for this two-way 
interplay but little understanding of the mechanisms that drive it. Currently, 
more and more mechanistic studies are emerging which imply a vast number of 




1.1. Composition of the gut microbiota 
The microorganisms that live in coexistence with their host are referred to as 
the microbiota, microflora, or normal flora. They are found on most 
environmentally exposed surfaces (such as the skin, mouth, gut and vagina), but 
the majority of them live in the gut. Mammalian large intestine harbours around 
1013 bacteria and is the most densely populated ecosystem (Peterson et al., 
2014). Bacteria of the mammalian gut are known to provide some beneficial 
functions to the host: they supply essential nutrients, metabolize indigestible 
compounds, defend against colonization by pathogens and are also involved in 
contributing to the intestinal architecture (Round and Mazmanian, 2009). The 
composition and roles of the bacteria that are part of this community have been 
studied most. However, the roles of viruses, archaea, and unicellular eukaryotes 
that inhabit the mammalian digestive tract are less well known.  
Currently (2014), there are around 80 bacterial phyla described in the 
Greengenes database (Youssef et al., 2014). Only two of which - the 
Bacteroidetes and the Firmicutes comprise the majority of human gut 
microbiota. Proteobacteria, Verrucomicrobia, Actinobacteria, Fusobacteria, and 
Cyanobacteria are also present but less abundant (Eckburg et al., 2005). As in 
humans, the two bacterial divisions with highest relative proportion in mouse 
gut are the Firmicutes (60-80% of sequences) and the Bacteroidetes (20-40%) 
(Ley et al., 2005). Of the Firmicutes more than 75% are in Clostridium cluster 
XIVa, which is a clade also present in human and includes butyrate producers. 
The majority (>88%) of the Bacteroidetes belong to Bacteroidetes 4b 
Proteobacteria and Actinobacteria (Ley et al., 2005). 
Estimates of the number of bacterial species present in the human gut vary 
widely between different studies, but it has been generally accepted that it is 
somewhere between 500 to 1000 species (Xu and Gordon, 2003). Analysis 
involving multiple subjects has predicted that the collective human gut 
microbiota is composed of at least 1,800 genera and ≈15,000–36,000 species of 
bacteria, depending on whether species are conservatively (97% OTUs) or 
liberally (99% OTUs) classified (Frank et al., 2007). It is also suggested that the 
so far sampled sequences represent around 50% of the predicted species-level 
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diversity, thus promising an overwhelming microbial diversity yet to be 
characterized within the human gut (Frank et al., 2007). 
Intestinal microbiota is not homogenous. For example, bacterial load, species 
richness and relative distribution in the small intestine are different from that in 
the large intestine (Sekirov et al., 2010). What is more, microorganisms in the 
intestinal lumen differ significantly from those attached and embedded in the 
mucus layer or those present in the immediate proximity of the epithelium. For 
example, Bacteroides, Bifidobacterium, Streptococcus, members of 
Enterobacteriacea, Enterococcus, Clostridium, Lactobacillus, and Ruminococcus 
are present in faeces, but only Clostridium, Lactobacillus, and Enterococcus are 
found in association with the mucus layer within crypts of the small intestine 
(Swidsinski et al., 2005).  
Age, diet, host physiology can all affect the microbial composition of the gut at 
species level but it remains fairly stable at the phylum level. The major groups 
that dominate the human intestine are conserved between all individuals, 
although the proportions of these groups can vary.  
Within phyla, the inter-individual variation of species composition is high. This 
may indicate that although there is a selective pressure for the maintenance of 
certain microbial groups (phyla), the functional redundancy within those groups 
allows for differences in the composition of the microbiota between individuals 
without compromising the maintenance of adequate function. However, this 
hypothesis remains to be further investigated (Sekirov et al., 2010). 
1.1.1. Of mice and men 
Unravelling the mechanisms by which gut microbiota contributes to human 
health and disease requires use of animal models. The work described in this 
chapter utilizes mice as experimental organisms and therefore this section 
reflects the essential similarities and differences that exist between the mouse 
and human digestive tract and their microbiota.  
One of the reasons why mouse models are so widely used is that mouse and 
human share anatomical and physiological features. In particular, the 
gastrointestinal tract in both species is composed of anatomically similar 
109 
 
organs. The differences between murine and human GI tract are possibly 
evolutionary consequences of their distinct diets, body sizes and metabolic 
features. 
The relative proportions in terms of length of the small and large intestines are 
similar in humans and mice (approximately 80% and 20%) (Casteleyn et al., 
2010) whereas, the proportion of surface area of the small and large intestines 
is different. In humans, the surface area of the large intestine is approximately 
400 times smaller than that of the small intestine but this is only 18 times in 
mice (Casteleyn et al., 2010). What is more, the mouse cecum is also relatively 
larger and has important role for fermentation of plant materials as well as for 
the production of vitamin K and B. Those nutrients are later reabsorbed through 
coprophagy. On the contrary, the human cecum is relatively small, anatomically 
similar to the colon and is of unknown function.  
Generally, the gut microbiota of human and mice are dominated by two major 
phyla, Bacteroidetes and Firmicutes, however, on a deeper taxonomic level 85% 
of bacterial genera found in the mouse gut microbiota are not present in human 
(Ley et al., 2005). Use of different research techniques imposes difficulties in 
comparing murine and human microbiome. First, in human studies usually the 
analysis is performed on faecal samples whereas work done in mice most often 
assesses the cecal microbiota. It is only longitudinal studies in mice that sample 
faecal pellets. Looking at five murine faecal 16S rDNA studies and four public 
16S rDNA healthy adult human datasets Nguyen et al. (2015) estimated that 
there are 79 genera occurring in both human and mouse intestinal microbiota 
(Nguyen et al., 2015). They have also found that genera highly abundant in 
human gut microbiota, as compared to mouse, include Prevotella, 
Faecalibacterium and Ruminococcus, whereas Lactobacillus, Alistipes and 
Turicibacter are more abundant in mouse gut microbiota. Clostridium, 
Bacteroides and Blautia are similarly abundant in both organisms (Nguyen et al., 
2015). Though, much larger sample size is needed to validate those findings.  
When assessing the effect of high fat diet it seems that both mouse and human 
microbiota behave similarly. For instance, mice fed on a high animal-fat diet 
show a decrease in Bacteroidetes to Firmicutes ratio (Murphy et al., 2010) 
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which is in compliance with observations of human dietary studies (Le Chatelier 
et al., 2013).  
Up until recently it was believed that presence of community clusters 
characterized by differences in the abundance of signature taxa, referred to as 
enterotypes are found only in human and some primates populations but not in 
mice. A study by Wang et al. (2014) suggests that the wild domestic mouse 
population also experience enterotype-like clustering (Wang et al., 2014). 
Human enterotypes were first described in 2011 in a study investigating the 
phylogenetic composition of 39 faecal samples from 6 nationalities, where 
metagenomic reads were mapped, using DNA sequence homology, to 1,511 
reference genomes. Multidimensional cluster analysis and principal component 
analysis (PCA) revealed that the samples formed three distinct clusters that 
were designate as enterotypes. These enterotypes could be identified by 
variation in signature genera: Bacteroides (enterotype 1), Prevotella (enterotype 
2) and Ruminococcus (enterotype 3) (Arumugam et al., 2011). In contrary only 
two enterotypes were evident when cecal microbiota of wild mice was analysed 
(Wang et al., 2014). The signature taxa of the two mouse enterotypes are 
Bacteroides as the largest contributor (31.68%) to dissimilarity between groups 
and similarity within enterotype 1 (77.78%) and the second largest contributor 
(8.59%) to dissimilarity between groups is Robinsoniella, which contributes 
14.04% to similarity within enterotype 2 and is also the most abundant genus in 
this group (average 13.6%) (Wang et al., 2014). In both mouse and man dietary 
history is suggested to play a role in the establishment of enterotypes. In 
contrary to this view are the findings by Hildenbrand et al. which suggest that 
strain-independent murine enterotypes are associated with the inflammation 
marker calprotectin (Gerlach et al., 2014).  
Segmented filamentous bacteria (SFB) interact closely with mouse intestinal 
epithelium and modulate mucosal immunity (for more information see Chapter 
4 section 1.2.). There are only sporadic reports (Klaasen et al., 1993, Jonsson, 
2013) about presence of SFB in man. It is still not known whether SFB or any 
other members of the human intestinal microbiota are capable of such a close 
interaction with the epithelium and immune modulation.  
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1.1.2. Of time and space 
Space/cage effect 
At birth mammalian gut is sterile but it soon gets colonised by a simple 
microbial community which undergoes a succession with increasing complexity 
reaching climax in early childhood when the composition is thought to then 
remain relatively stable (Palmer et al., 2007).  
The composition of the microbiota could be shaped by both environmental and 
stochastic factors. Family members are likely to share more similar microbiota 
than unrelated individuals (Turnbaugh et al., 2009). This could be due to either 
close genetic relatedness or common environment. Similarly, mice that share 
cage are likely to have related microbiota. Early studies on the intestinal 
microbiota done with denaturing gradient gel electrophoresis (DGGE) to profile 
PCR-derived amplicons from bacterial 16S rRNA genes have shown that 
genotype has a strong influence on the community structure, whereas 
environmental factors are contributing to a much lesser extent. Work done by 
Hufeldt et al. (2010) have shown that neither sex or individually ventilated cage 
effect are significant contributors to the composition of murine cecal microbiota 
(Littman and Rudensky, 2010). On the contrary, later studies by Campbell et al. 
(2012) show that along with the genotype, cohabitation and litter also have 
detectable, although reduced effect (Campbell et al., 2012). Instead of DGGE 
this later study utilizes pyrosequencing for analysis which might explain higher 
sensitivity. 
A study by McCafferty et al. (2013) suggests that cage effects are driven by 
stochastic differences that occur over time within each cage, rather than the 
composition of the initial microbial community (McCafferty et al., 2013). It is 
also suggested that cage effects show higher variation explained (above 31%) at 
OTU level and the effect is smaller (22.6%) at the phylum level. It is suggested 
that genotype and cage conditions have independent effect on the microbiota 
composition (Gerlach et al., 2014). When Balb/c, C57B/6, FVB and non-obese 
diabetic (NOD) mice are cohoused for 3 weeks in terms of alpha diversity cage 
effect has no impact (Gerlach et al., 2014). In addition, cage effects in the 
Hildebrand et al. study are attributed to Helicobacter infections (Gerlach et al., 
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2014). Removal of the Helicobacter OTUs from the dataset results in the 
difference between cages at OTU level to be no longer significant (Gerlach et al., 
2014). It remains to be further confirmed whether Helicobacter is responsible 
for cage effects in experiments done in other mouse facilities.  
Maternal influence on the microbiota composition 
A study by Ley et al. (2005) suggests that kinship has effect over the gut 
microbiota. For the purpose of their work Ley at al. (2005) describe three 
C57BL/6J ob/+ matings. The microbiota of all offspring as well as that of the 
three mothers has been analysed. The new-born mice have been raised 
together with their mother and littermates until weaning and then housed 
individually in microisolator cages until 8 weeks of age, when they have been 
killed. The results reveal that mothers and their offspring share cecal microbiota 
with similar community membership at the level of genera (Ley et al., 2005). 
However, regardless of family membership, the obese (ob/ob) genotype is 
associated with a large shift in the relative abundance of specific taxa present 
(Ley et al., 2005), which indicates that even if the maternal influence has an 
effect on the microbiota it cannot mask stronger effects such as the ob/ob 
genotype in this case. What is more, the maternal effect observed could be 
simply a random drift in the microbiota. Mice are coprophagic and if they share 
a cage they are likely to acquire each-other’s microbiota. In this case, the 
offspring is initially housed with their mother, which allows for them to acquire 
the same microbiota. Then the animals are housed individually and this 
prevents acquisition/exchange of further species. It is intriguing whether the 
same effect would be observed if after weaning all three litters were housed 
together for a sufficient period of time before testing. It should be noted that a 
maternal effect is not always evident. For example, a study by Kovacs et al. 
(2011) concluded that whilst microbiota is substantially different in different 




1.2. Role of the gut microbiota in shaping the host 
Experiments with reciprocal transplantation of mouse and zebrafish microbiota 
suggest that mouse host is affected in a similar manner by both mouse and 
zebrafish microbiota despite the different bacterial composition (Rawls et al., 
2006). It has been found that similar number of mouse host genes change in 
response to the native mouse microbiota (500) and to the zebrafish microbiota 
(525) (Rawls et al., 2006). However, only half of the genes are responsive to 
both microbial communities; the majority of those genes (96.4%) are also 
regulated in the same direction. Shared enrichment of genes involved in (1) 
biosynthesis and metabolism of fatty acids; (2) metabolism of essential amino 
acids (valine, isoleucine, and lysine); (3) metabolism of amino acids that contain 
the trace element selenium; (4) metabolism of butyrate; and (5) biosynthesis of 
bile acids has been observed. Unfortunately, Rawls et al. (2006) do not discuss 
the other ≈250 genes that the mouse host expresses differently depending on 
whether colonised with mouse or zebrafish microbiota (Rawls et al., 2006).  
Colonisation of the gut with bacteria has been shown to induce fucosylation of 
the epithelial surface proteins. Mono-colonisation with Bacteroides 
thetaiotaomicron is sufficient to maintain the fucosylation as long as the 
bacterium is capable of utilising L-fucose as a carbon source (Bry et al., 1996).  
Transplanting the gut microbiota from normal mice into germ-free recipients 
increases their body fat without any increase in food consumption. It is 
proposed that this is achieved by two complementary mechanisms: 1) the 
composition of the microbial community in the gut affects the amount of 
energy extracted from the diet and 2) microbiota alters the metabolic status of 
the host (Backhed et al., 2004). In addition, colonization of WT germ-free mice 
with microbiota from obese (ob/ob) mice results in a significantly greater 
increase in total body fat than colonization with a normal (lean) microbiota 
(Turnbaugh et al., 2006). 
As previously mentioned SFB are found in a very intimate interaction with the 
mouse epithelium and are “kept in check” by the secreted IgA. This raises the 
question whether they can be truly classified as commensals.  The findings so 
far indicate that SFB colonization leads to the maturation of the gut mucosal 
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lymphoid tissue, induces a strong and broad IgA response, stimulates the T-cell 
compartment, and upregulates intestinal innate defence mediators (Ivanov et 
al., 2009, Gaboriau-Routhiau et al., 2009). In addition, SFB colonization exerts an 
adjuvant effect on systemic responses. SFB colonisation can aggravate 
pathologic responses in mouse models of encephalitis and arthritis. On the 
contrary, SFB have been found protective against the development of type I 
diabetes in genetically predisposed mice (Lee et al., 2011, Wu et al., 2010, 
Chappert et al., 2013, Kriegel et al., 2011, Yurkovetskiy et al., 2013).  
Mice subjected to stress experience shift in the microbiota accompanied by 
increase in the circulating levels of IL-6 and MCP-1, which are significantly 
correlated with stressor-induced changes to three bacterial genera (i.e., 
Coprococcus, Pseudobutyrivibrio, and Dorea). Interestingly, when the mice are 
treated with an antibiotic cocktail exposure to stress fails to increase IL-6 and 
MCP-1. Therefore stress exposure significantly affects bacterial populations in 
the intestine but also suggest that the microbiota are necessary for stressor-
induced increases in circulating cytokines (Bailey et al., 2011). 
1.3. Diet, microbiota, metabolism & immunity 
Diet, microbiota, metabolism and immunity are clearly correlated but the 
pathways involved in their interplay are still unclear. It is likely that several 
determinants interact together to form certain community structure. For 
example, on one hand, diet is an important environmental variable and serves 
as both a source of colonizing bacteria and alters the gut nutritional 
environment, thus affecting the composition of the gut microbiota (Muegge et 
al., 2011, Wu et al., 2011). On the other hand, sex is a genetic trait, also known 
to influence the gut microbiota (Markle et al., 2013).  Interestingly, it has been 
shown that diet has a sex-specific effect on host gut microbiota (Bolnick et al., 
2014).  
Interaction between the immune system and the microbiota has been 
implemented in metabolic control. Genetic deficiency in TLR5 causes 
hyperphagia and development of metabolic syndrome, including 
hyperlipidemia, hypertension, insulin resistance, and increased adiposity in mice 
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as well as changes in the composition of the gut microbiota. Wild-type germ-
free recipients inoculated with gut microbiota from TLR5-deficient mice develop 
metabolic syndrome (Vijay-Kumar et al., 2010). 
It is likely that multiple pathways are engaged in the continuous interaction 
between immunity, metabolism, diet and the microbiota. Trompette et al. 
(2014) have proposed that the ratio of Firmicutes to Bacteroides is dependent 
on the fermentable dietary fiber which is metabolized by the microbiota and 
consequently leads to increase in the concentration of circulating short-chain 
fatty acids (SCFAs). High-fibre diet is associated with increased circulating levels 
of SCFAs and is protective against allergic inflammation. Treatment of mice with 
the SCFA propionate leads to generation and tissue infiltration of DCs with high 
phagocytic capacity but an impaired ability to promote T helper type 2 (Th2) 
responses, an effect dependent on G protein–coupled receptor 41. These 
results show that dietary fermentable fibre and SCFAs can shape the 
immunological environment and modulate allergic inflammation (Trompette et 
al., 2014). 
Propionate and butyrate have also been shown to activate intestinal 
gluconeogenesis which has beneficial effects on glucose and energy 
homeostasis. Butyrate activates intestinal gluconeogenesis gene expression 
through a cAMP-dependent mechanism, while propionate acts via a gut-brain 
neural circuit involving the fatty acid receptor FFAR3 (De Vadder et al., 2014).  
There is evidence that the three-way interaction between the immune system, 
the intestinal epithelium and the microbiota regulates gut metabolic state. In 
the absence of B cells/IgA, and in the presence of the microbiota, the intestinal 
epithelium engages its own protective mechanisms at the expense of its 
metabolic function thus resulting in decreased body fat due to lipid 





1.4. Role of the host in shaping its own gut microbiota 
To test how factors specific to host gut habitat shape microbial community 
structure, Rawls et al. (2006) performed transplantations of mouse microbiota 
into germ-free zebrafish and zebrafish microbiota into germ-free mice. It was 
found that in regards to the lineages present the transplanted community bared 
similarity with its community of origin. However, the relative abundance of the 
lineages changes to resemble the normal gut microbiota of the recipient host. 
Rawls et al. (2006) suggest that the differences in community structure between 
zebrafish and mice arise in part from distinct selective pressures imposed within 
the gut habitat of each host (Rawls et al., 2006).  
Another example of host effect on the microbiota are the ob/ob obese mice. 
Those  genetically obese (ob/ob) mice have 50% fewer Bacteroidetes, and 
correspondingly more Firmicutes, than their lean wild type (WT, +/+) siblings 
(Ley et al., 2005).  
In the intestines of mice with deficiency of activation-induced cytidine 
deaminase (AID), the absence of hypermutated IgA is partially compensated for 
by the presence of large amounts of non-mutated IgM and normal expression 
levels of defensins. Despite that, predominant and persistent expansion of SFB 
throughout the small intestine of AID–/– mice is observed. Reconstitution of 
lamina propria IgA production in AID–/– mice rescues the normal composition of 
gut flora (Suzuki et al., 2004). This opens the question to what extent are the 
SFB commensal, do they provide benefit to the host, is their overgrowth 
associated with aberrant effect, does other bacterial groups also change? Some 
of these questions are discussed in the section 1.2. of this chapter.  
There is some evidence that ageing of the host leads to reduced diversity of the 
gut microbiota but unfortunately the study in question (Claesson et al., 2012) 
fails to control appropriately and no clear discrimination can be made between 
the effect of ageing and the effect of diet. 
Pregnancy is another instance where dramatic alternation of the intestinal 
microbiota has been observed. As pregnancy advances, microbiota becomes 
more like that of people with metabolic syndrome. These changes seem not 
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damaging to maternal health and correspond with increase in blood glucose and 
fat deposition thought to help nourishing the fetus (Koren et al., 2012). 
If mice are exposed to a social stressor called social disruption, circulating 
cytokines increase and prime the innate immune system for enhanced reactivity 
associated with change in community structure of the microbiota. Most notably, 
the relative abundance of bacteria in the genus Bacteroides decreases, while 
that of Clostridium increases (Bailey et al., 2011).  
 
2. Hypothesis 
Main goal of this pilot study was to test the hypothesis that alteration of the 
lympho-epithelial cross-talk in the gut would result in altered microbial 
community structure, metabolite profile of the microbiota and the host. Mice 
deficient in molecules related to IL-12 signalling were supplied as part of the 
work described in Chapter 2 where we investigated the regulatory interplay 
between IL-12 and TSLP but this also provided an opportunity to look into the 
intestinal microbiota of these animals.  
3. Methods 
Animals 
Female mice from B6.12937-Ifngtrn1TS/J (IFNγ knockout), B6.12931-IL12btrn1Jm/J 
(IL-12p40 knockout), and B6.12931-IL12Rβ2trn1Jm/J (IL-12Rβ2 knockout) strains, 
along with the appropriate wild type C57BL/6J controls, were purchased from 
Jackson Laboratories. All animals were shipped simultaneously and allowed for 
acclimatisation at the DMU facility for two weeks before experimentation. Mice 
from the same strain were housed in microisolator cages (up to 5 animals per 
cage), maintained under 12 h light–dark regime and fed ad libitum standard 
chow. At eight weeks of age mice were sacrificed by cervical dislocation at the 
same time of day (±3 h) and samples were collected. All procedures were 
carried out in accordance with U.K. Home Office regulations, license conditions 





Immediately after the mice were killed, the gut tube was cut open longitudinally 
and gastrointestinal content was scraped from the terminal ileum (along 10–15 
mm of the ileum entering the cecum) or the colon (along 30–35 mm exiting the 
cecum). Those samples along with whole ceca were frozen in dry ice and stored 
at -80° C until used.  
DNA extraction 
From the scraped intestinal content 70(±30) mg were used for DNA extraction 
with FsatDNA Spin Kit for Soil (MP Biomedicals) according to the manufacturer’s 
instructions. 
16S PCR amplification and 454 sequencing 
PCR amplification of the 16S using the universal V4-V5 primers U515F 
GTGYCAGCMGCCGCGGTA and U927R CCCGYCAATTCMTTTRAGT (Tang et al., 
2014, Fabrice A, 2009) and consequent 454 sequencing was done by a crevice 
provider (Veterinary Laboratories Agency, UK).  
Sequencing data analysis 
Raw data from 454 sequencing (.sff format) was analysed with QIIME (Caporaso 
et al., 2010b). Briefly, de-multiplexing and initial filtering was done with the 
split_libraries.py script set to exclude reads outside 310-480 nucleotides length, 
window quality scores 50, with < 1 mismatched primers. Denoising with 
denoise_wrapper.py (Reeder and Knight, 2010) was performed on a high 
performance cluster. Picking of OTUs was accomplished using the QIIME 
workflow function pick_otus_through_otu_table.py with default settings 
including: clustering by uclust method (Edgar, 2010), cluster seed chosen as 
representative, PyNAST alignment (Caporaso et al., 2010a), conservative (97% 
similarity) rdp taxonomy assignment (Wang et al., 2007) according to the 
Greengenes database (McDonald et al., 2012, Werner et al., 2012), building 
phylogenetic tree with FastTree (Price et al., 2010). Chimeric sequences were 
removed with ChimeraSlayer (Haas et al., 2011). One sample from IL12p40 KO 
colon group, one from WT ileum, and one sample from WT colon group were 
removed from further analysis due to low sequence number. Before calculation 
119 
 
of diversity the OTU table was rarefied with upper limit of rarefaction depth 
seta at 2200. UniFrac was used for calculating beta-diversity (Lozupone and 
Knight, 2005).  
Sample preparation for metabolomics 
While still frozen ceca were cut longitudinally. Luminal content was gently 
separated from the host tissue. An average of 169 (±68) mg luminal content was 
mixed with 1 ml deuterated buffer (Le Gall et al., 2011) for 2 minutes. After 
centrifugation for 10 min at 800g supernatants were stored at -80° C until 
analysed the same week. Each sample of mouse tissue was washed with 10 ml 
PBS and transferred to tube with 10 glass beads 3 mm ø (VLR International). To 
an average of 60 (±15) mg of tissue was added 1 ml deuterated buffer and the 
samples were processed on FastPrep FR120 (BIO101 Thermo Savant) at 4 m/s 
three times 90 s bursts with 2 min rest on ice in-between. Samples were spun 
for 2 min at 6000 g. Supernatants transferred into fresh Eppendorf tubes and 
centrifuged for 15 min at 9000 g. Supernatants were stored at -80° C until 








4.1. Analysis of microbiota composition 
4.1.1. 16S metagenomics analysis 
4.1.1.1. Demultiplexing and initial filtering 
In the raw data the majority of the reads were 420 nucleotides long. After 
removal of the forward primer (18 nucleotides), the reverse primer (19 
nucleotides), and the barcode (10 nucleotides) the highest number of reads was 
around 370 nucleotides long. 
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Table 3 Metagenomics raw data. Number of reads combined for all 52 samples 
in the raw data and number of reads used for further analysis after selecting for 















long reads from 
all filtered (from 
all raw) 
310-480 430853 382445 365 88% (78%) 
 
The number of operational taxonomic units (OTUs) varied depending on 
whether the data were denoised or not and whether chimeric sequences were 
eliminated but this change had no effect on the way the samples clustered 
according to the multivariate analysis. If OTUs were assigned straight after the 
split_libraries.py there were 4359 OTUs. OTU number dropped to 1875 after 
denoising and was reduced even further to 633 if the chimeric sequences were 
removed. While the OTU number dropped by around 66% only 12.5% of the 
reads were removed as chimeric.  
4.1.1.2. Rarefaction and alpha diversity 
After rarefaction of the OTU table, rarefaction curves were constructed based 
on the calculated species richness. The number of species discovered is plotted 
as a function of the number of sequences. Steep slope indicates that a large 
fraction of the species diversity remains to be discovered. If the curve becomes 
flatter to the right, a reasonable number of individual samples have been taken 
meaning that more intensive sampling is likely to yield only few additional 
species. Amongst all groups higher species richness was observed in the colon 





Figure 23 Rarefaction curves for colon (top) and ileum (bottom) for the four 
groups. Higher species diversity was observed in the colon compared to the 
ileum. Flattening of the lines and particularly the ones for ileum suggests that at 
the current sequencing depth the majority of the species present had been 
detected. 
 
The highest number of observed species was evident in the IFNγ group whereas 
IL12Rβ2 group showed reduced species richness both in the colon and the ileum 
(Figure 23) but those differences did not reach statistical significance (p=0.635; 




4.1.1.3. Taxa summary 
Despite the interindividual variation, difference could be observed in the 
taxonomic distribution between the four groups (Figure 24).  
 
Figure 24 Relative taxonomic abundance at the level of class. The first bar in the 
colon group and the first bar in the ileum group were taken from the same 
mouse; the rest of the samples follow this order apart from the extra ileal 
sample marked with *.   
 
When looking at the level of phyla similar pattern could be observed in both 
colon and ileum samples. Actinobacteria and Bacteroidetes were most 
abundant in the IL12p40 KO mice and least abundant in the IL12Rβ2 group with 
the difference being more pronounced in the ileum (Figure 25). In the ileum the 
abundance of Actinobacteria was higher (mean 1.5%) compared to the colon 
(mean 0.9%) (p=0.0014; n=24; Wilcoxon matched-pairs signed rank test). On the 
contrary, there were more Bacteroidetes in the colon (mean 33.79% vs. ileum 





Figure 25 Actinobacteria and in particular representatives of the family 
Coriobacteriaceae were significantly more abundant in the ilea of IL12p40 KO 
mice compared to IL12Rβ2 KOs (p=0.0008; n=5 to 6; Kurskal-Wallis test; Dunn’s 
Multiple Comparison post-test). An unknown family of order Bacteroidales was 
responsible for the difference evident at phylum level for the Bacteroidetes. 
Again, IL12p40 KO group had pronouncedly higher relative abundance 
compared to IL12Rβ2 KO (n=5 to 6; one-way ANOVA; Bonferroni Multiple 
Comparison post-test; p<0.05=*, p<0.01=**, p<0.001=***, p<0.0001=****). 
 
Bacteria from phylum Firmicutes were more abundant in the ileum (mean 
74.72% vs. colon mean 64%) (p=0.0005; n=24; Wilcoxon matched-pairs signed 
rank test). For both colon and ileum, IL12p40 KO mice had the lowest 
abundance whereas the IL12Rβ2 KOs had the highest. This difference between 




Figure 26 The overall difference observed in the colon microbial communities 
for phylum Firmicutes was driven by difference in class Bacilli, more particularly 
in order Lactobacillales, family Lactobilacillaceae (n=5 to 6; one-way ANOVA; 





Finally, bacteria belonging to the phylum Tenericutes were also present but at a 
relatively low level (Figure 26). On average there were 1.23% in the colon and 
0.46% in the ileum (p=0.0016; n=24; Wilcoxon matched-pairs signed rank test). 
 
 
Figure 27 In the colon of IL12Rβ2 mice there were more bacteria from unknown 
family belonging to order RF39, class Mollinutes (n=5 to 6; Wilcoxon matched-




4.1.1.4. Beta diversity 
UniFrac (Lozupone and Knight, 2005) was used to calculate the distance 
measure between the microbial communities whilst incorporating phylogenetic 
information. Then Principal Coordinates Analysis (PCoA) was used to extract and 
visualize the most informative components of this multidimensional data 
(Figure 28). This transformation maps the samples present in the distance 
matrix to a new set of axes. The maximum amount of variation is explained by 
the first principal coordinate, the second largest amount of variation is 




Figure 28 Principal Coordinate Analysis (PCoA) of the unweighted (A) and 
weignted (B) UniFrac distance for all samples (n=49); the first three principal 




According to the unweignted UniFrac (Figure 28 A), gut microbial communities 
from IFNγ and IL12p40 KO were similar and the two groups clustered together 
when the first three coordinates were considered. When the microbial 
communities were analysed by weighted Unifrac (Figure 28 B) IFNγ and IL12p40 
KO groups again clustered together and were different from WT and IL12Rβ2 
groups.  
4.2. Metabolomics 
4.2.1. Metabolic profile of the luminal content 
Across all luminal content samples more than thirty metabolites have been 
identified. The overall profiles of the IL12p40 and IFNγ KO mice showed 
similarities and were different from WT and IL12Rβ2 (Figure 29). A number of 
amino acids (Figure 34, Figure 35) were contributing to the separation of 
IL12Rβ2 samples form WT along the first principle component (Figure 29, Figure 
30). Difference in some metabolites was predominant in only one group of mice 
(Figure 31, Figure 32, Figure 34), whereas other metabolites exhibited more 





Figure 29 Principle Component Analysis (PCA) on 30 1H NMR spectra of 
metabolites present in the luminal content. IL12Rβ2 KO is the group that differs 
the most from WT. IL12p40 KOs and IFN-γ KOs have similar metabolic profiles. 

















































Figure 30 Separation of the luminal content metabolic profiles is based on the 
difference in levels of the 30 metabolites selected for the PCA. Glucose, myo-
inositol, methylamine and ethanol levels are higher in WT while the levels of the 


























































Figure 31 Metabolites identified as different in IL12Rβ2 group (ANOVA or 





Figure 32 Metabolites identified as different in WT group (ANOVA/Kurskal-












Figure 33 Metabolites that were low in two of the groups and high in the other 







Figure 34 Five of the identified amino acids had highest NMR intensity in the 
IL12Rβ2 group; lower in the IFNγ and IL12p40 which were not significantly 
different between each other but were significantly different from WT group 











Figure 35 For another five of the identified amino acids and taurine, again the 
highest intensity was seen in the IL12Rβ2 group and the lowest in the WT but 
the difference was significant only for the comparison of WT against the other 




4.2.2. Metabolic profile of the host intestinal tissue 
We were interested to know whether the deficiency in IL-12 related genes will 
have an effect on metabolic profile of the gut and whether metabolic status of 
the luminal content will be reflected in the host intestinal tissue.  
In contrast to the PCA of the luminal metabolites (Figure 29), the PCA of the 
mouse gut tissue (Figure 36) showed separation between IL12Rβ2 and IFNγ on 
one side against WT and IL12p40 on the other. The group that differed most 
was IL12p40 (Figure 37, Figure 38).  
 
 






























































Figure 37 Metabolites differentially abundant in the gut tissue of IL12p40 KO 

















Figure 38 Examples of metabolites that were significantly different between 
IL12p40 and IFNγ/IL12Rβ2 KO mice (ANOVA/Kurskal-Wallis p<0.05=*, 
p<0.01=**, p<0.001=***, p<0.0001=****). 
 
 
Figure 39 Similarly to the findings for the luminal content, ethanol as well as 
methanol were elevated in the WT group (ANOVA/Kurskal-Wallis p<0.05=*, 




Figure 40 Most of the amino acids were similar between IFNγ and IL12Rβ2 KO 
groups whilst differing from IL12p40 and WT (ANOVA/Kurskal-Wallis p<0.05=*, 











Figure 41 Examples of metabolites that have different patterns of abundance 
between the groups depending on whether the lumen or the host tissue have 
been analyzed (ANOVA/Kurskal-Wallis p<0.05=*, p<0.01=**, p<0.001=***, 












In the past decade sequencing technology has become widely affordable 
allowing for bloom in the field of microbiota research (Figure 22). In addition, 
gut microbiota has been recognised as a contributor in both health and disease. 
Conditions such as IBD, obesity, and metabolic syndrome had been associated 
with intestinal dysbiosis. These factors lead to increased interest in how 
microbiota modulates the mammalian host. It is likely that the host-microbiota 
interaction is a reciprocal process and the host is also capable of driving changes 
in the bacterial communities resident in the gut. Therefore we hypothesised 
that alternation in the host’s immune status leads to altered intestinal 
microbiota.  
The choice of KO mouse strains in this study was opportunity driven. The 
IL12Rβ2-/-, IL12p40-/-, IFNγ-/- and WT mice were available as a part of the work 
described in Chapter 3.  
The results so far suggest that IL12p40 and IFNγ KO mice harbour relatively 
similar microbial communities (Figure 25, Figure 26, Figure 29). At phylum level 
the differences between IL12p40 and IL12Rβ2 KO mice were with highest 
statistical significance (Figure 25, Figure 26,).  IL12Rβ2 and IL12p40 KO mice are 
both deficient in IL12p70 signalling but due to subunit sharing in the IL-12 
cytokine family IL12Rβ2 KOs are also lacking IL-35 whereas IL12p40 KOs have no 
IL-23 signalling. IL-12 and IL-23 are mainly proinflammatory cytokines involved 
in the development of the Th1 and Th17 subsets of helper T cells, respectively  
(Vignali and Kuchroo, 2012). On the other hand, IL-35 is a potent inhibitory 
cytokine involved in tolerance possibly via suppression of Th17 (Shen et al., 
2014). This establishes a functionally balanced dichotomy between IL-12/IL-23 
and IL-35 and possibly underlines the differences observed between the 
microbiota and metabolic profiles of IL12p40 and IL12Rβ2 KO mice. 
One of the limitations of the 16S metagenomics analysis is that while providing 
phylogenetic and abundance information about the bacteria present it does not 
give any indication of the function these microbes perform. There is possibility 
that remotely related (distant 16S) species occupy the same ecological niche. Or 
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alternatively, closely related species (similar 16S) may have very distinct roles. 
For that reason, the metabolic profile of the luminal content was also analysed. 
In this instance, again the IL12p40 and the IFNγ groups exhibited parallels in 
terms of their metabolic profiles (Figure 29).  
Consistent trend in the abundance of the detected amino acids was evident 
where the NMR intensity was highest in the IL12Rβ2 group and lowest in the 
WT, with IL12p40 and IFNγ being at intermediate level (Figure 26, Figure 35). 
We were also interested to know whether the metabolic compounds present in 
the associated host gut tissue would reflect the metabolic profile observed in 
the lumen. Similarly to the metabolic analysis of the lumen, intestinal tissue 
from the IL12Rβ2 group displayed elevated abundance of amino acids (Figure 
40). IL12Rβ2 are known to have increased protein in the urine and decreased 
protein in the blood (Airoldi et al., 2005). It is possible that microbiota capable 
of increasing the nutrient availability of amino acids is selected in those animals.  
A number of compounds, including butyrate and nicotinic acid (niacin), showed 
different patterns of abundance depending on whether lumen or tissues were 
analysed (Figure 41). Butyrate was elevated in the tissue of IL12p40 mice while 
being no different in the lumen. This could possibly suggest that these 
microbiota derived compounds (Singh et al., 2014) are not simply diffusing into 
the host tissue. Indeed, evidence from the literature indicates that there are 
specialised butyrate (Hadjiagapiou et al., 2000, Lecona et al., 2008) and nicotinic 
acid (Takanaga et al., 1996, Nabokina et al., 2005) transporters. For example, 
monocarboxylate transporter 1 (MCT1) transports butyrate across the apical 
membrane of colonocytes (Thibault et al., 2007) and it has been shown that 
immunological signals can influence its expression (Thibault et al., 2007). Both 
butyrate and nicotinic acid can activate GPR109A (encoded by Niacr1) receptor 
(Singh et al., 2014). GPR109A signalling promotes anti-inflammatory 
polarisation of colonic macrophages and DCs. Moreover, it is essential for 
butyrate-mediated induction of IL-18 in colonic epithelium (Singh et al., 2014). 
Our finding that IL12p40 deficiency is related to higher concentration of 
butyrate and nicotinic acid in the gut alongside the knowledge built about 
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transport and immunological function of these compounds establishes an 
exciting platform for further research.  
6. Concluding remarks 
The work described here represents a pilot investigation aiming at identifying 
suitable targets for future studies. One main issue that requires addressing is 
discrimination between the cage effect and the effect of the host genotype on 
the microbiota.  
With the advance in the microbiota field more and more evidence has 
accumulated in the literature in regards to the presence of cage effects. It has 
also been shown that transfer of disease-associated microbiota occurs when 
healthy WT mice are cohoused with colitic animals (Garrett et al., 2007). 
Coprophagy contributes to the exchange of microbiota between animals sharing 
the same cage. It has been suggested that stochastic differences in community 
assembly occur within each individual cage microenvironment. Attempts to 
eliminate cage effects by standardizing the initial microbial community within 
cages or with identical initial gavage to multiple animals are therefore likely to 
fail (McCafferty et al., 2013). Experiments where different mouse genotypes are 
compared require several micro-isolators, each housing a mixture of mice from 
the different genotypes. On the other hand, there are studies demonstrating 
that when cages containing only one mouse strain are compared with those 
containing two strains of mice, host genetics contributed to a greater extend to 
the differences in the microbiota. Campbell et al. have concluded that 
environmental effects are weaker than underlying host genetics in shaping 
cecum bacterial communities (Campbell et al., 2012) supporting the notion that 
the differences reported here possibly reflect the effect of IL-12 signalling 




Chapter 5: Extending the study of lympho-
epithelial cross talk - a new role for CX3CR1+ 
cells in the gut: pathogen exclusion 
 
1. Introduction  
One of the main tasks of the epithelium overlying the mucosal surfaces of the 
gut is to provide an efficient barrier to microorganisms present in the intestinal 
lumen. Firstly, this is achieved by the presence of tight junctions that allow 
passage of water and ions but provide an effective mechanical barrier to 
macromolecules and microbes (Turner, 2009). Secondly, a combination of 
mucus and secretory IgA provide an efficient gel that sequestrates harmful 
microorganisms and prevent them from crossing the epithelial barrier in a 
process known as immune-exclusion (Mantis et al., 2011, Johansson et al., 
2011). Furthermore, it has been recently shown that a few hours after infection 
the epithelium-intrinsic NAIP/NLRC4 inflammasone drives the expulsion of 
infected epithelial cells to restrict Salmonella replication in the mucosa (Sellin et 
al., 2014). Ultimately, the aim of these protective mechanisms is to prevent 
pathogens from traversing/colonizing the intestinal mucosa. We have previously 
reported that intestinal challenge with Salmonella Typhimurium induced, very 
shortly after infection, the migration of Salmonella-capturing CX3CR1+ cells into 
the intestinal lumen (Arques et al., 2009). Interestingly, in the occurrence of 
infection with Salmonella, CX3CR1+ cells display dual behaviour and these cells 
can also directly sample bacteria by using cellular extensions that protrude 
between epithelial cells and shuttle bacteria across the epithelium to initiate 
immune responses (Rescigno et al., 2001, Niess et al., 2005). Most importantly, 
presence of the CX3CR1 receptor is essential for both processes. To further 
investigate its role we have utilised a mouse model which was first described by 
Jung et al. in year 2000 (Jung et al., 2000a). They have replaced the CX3CR1 
gene with green fluorescent protein (GFP) reporter. This approach enabled them 
to assign CX3CR1 expression to monocytes, subsets of NK and dendritic cells, 
144 
 
and the brain microglia of mice. CX3CR1 is a seven-transmembrane receptor for 
fractalkine (FKN, CX3CR1L, neurotactin).  
FKN is produced in two isoforms: membrane bound and secreted. It allows for 
both adhesion and chemottraction (Jung et al., 2000a). Soluble FKN induces 
intracellular calcium fluxes but does not activate integrins (Haskell et al., 1999). 
FKN mediated cell adhesion in the presence of pertussis toxin indicates that 
CX3CR1 acts primarily as an adhesion molecule, rather than as a signalling 
molecule but mechanism of signalling independent of G-protein is possible 
(Haskell et al., 1999). 
FKN is expressed by activated endothelial cells in the vasculature (Haskell et al., 
1999), steady state neurons in the central nervous system (Harrison et al., 
1998), iris and retina of the eye (Silverman et al., 2003), steady state basal 
keratinocytes of the epidermis (Lucas et al., 2001), IFN-γ stimulated bronchial 
epithelial cells (Fujimoto et al., 2001), and steady state intestinal epithelial cells 
(Muehlhoefer et al., 2000). Expression of the FKN in the gut is at its highest level 
in IECs isolated from the terminal ileum (Niess et al., 2005). In both CX3CR1+/gfp 
and CX3CR1gfp/gfp the fluorescent cells form a net like structure under the IECs in 
the villi of the small intestine. The interaction of epithelial FKN with CX3CR1 on 
immune cells is a classic example of how the lympho-epithelial crosstalk could 
be mediated at a molecular level. 
The lamina propria (LP) CX3CR1+/gfp cells are interconnected and in a steady 
state situation there are 3.1 ± 0.8 connections per cell (Niess and Adler, 2010). 
These cells are also present in the PP and MLNs. Lamina propria CX3CR1+ cells 
from CX3CR1+/gfp and CX3CR1gfp/gfp mice also express major histocompatibility 
complex (MHC) class II, CD80, and CD86 at levels that are comparable to 
CX3CR1+/+.  
Germ free (GF) CX3CR1+/gfp mice have reduced number of CX3CR1 positive cells 
in the LP and the MLN, hence presence of commensal flora is required for the 
local accumulation of these cells (Niess and Adler, 2010) underlining the 
importance of the three-way cross-talk in the gut involving not only the IECs and 
the LP immune cells but also the resident microbiota.  
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There is a lot of controversy in regards to the role of CX3CR1+ cells in the 
process of antigen sampling and their interaction with the nearby CD103+ cells 
in the LP. Schulz et al. have reported that CD103 and CX3CR1 phenotypically and 
functionally characterize distinct subsets in the LP. CX3CR1+ cells represent a 
slow turnover, non-migratory gut-resident population, whereas the CD103+ DCs 
migrate into the MLNs. CX3CR1+ cells display poor T cell stimulatory capacity in 
vitro and in vivo and are less efficient at generating retinoic acid compared to 
the CD103+ DC. These findings indicate that CD103+ DCs serve as classic DCs, 
whereas CX3CR1+ populations are macrophage-like and might modulate 
immune responses directly in the mucosa and serve as first line barrier against 
invading enteropathogens.  
We have previously reported that intestinal challenge with S. enterica 
Typhimurium induced the migration of Salmonella-capturing CX3CR1+ cells into 
the intestinal lumen (Arques et al., 2009). The migration of CX3CR1+ cells was 
restricted to the small intestine in a flagellin/MyD88-dependent manner and did 
not affect the integrity of the epithelial barrier. Interestingly, in the occurrence 
of infection with Salmonella, CX3CR1+ cells display dual behaviour and these 
cells can also directly sample bacteria by using cellular extensions called trans-
epithelial dendrites (TEDs) that protrude between epithelial cells and shuttle 
bacteria across the epithelium to initiate immune responses (Rescigno et al., 
2001, Chieppa et al., 2006). Most important, the presence of the FKN receptor 
CX3CR1 appeared to be essential for both events (Niess et al., 2005, Nicoletti et 
al., 2010). We sought to investigate the biological relevance of these two 
CX3CR1-mediated events by using in vivo real time imaging and a combination 
of mouse strains that differed in their ability to undergo CX3CR1- mediated 
direct sampling and intraluminal migration during Salmonella infection  
Interestingly, while luminal sampling is a strain specific event observable only in 
mice on C57BL/6 but not Balb/c background (Vallon-Eberhard et al., 2006), 
luminal migration is a universal mechanism (Arques et al., 2009, Chieppa et al., 
2006). Formation of TEDs in first generation hybrid CX3CR1+/gfp mice with wild-
type CX3CR1 allele from Balb/c parent and CX3CR1GFP allele from the C57BL/6 
parent still occurs. Thus, the Balb/c allele encodes an active CX3CR1 receptor 
146 
 
and the absence of TEDs in Balb/c mice is a recessive phenotype not attributed 
to the CX3CR1 locus (Vallon-Eberhard et al., 2006).  
The availability of wild type C57BL/6 sampling-competent/migration-
competent, Balb/c sampling-deficient/migration-competent, and CX3CR1gfp/gfp 
sampling-deficient/migration-deficient mice provided an opportunity to 
investigate the biological relevance of the CX3CR1-mediated events.  
2. Hypothesis  
The observations described above prompted us to test the hypothesis that 
interaction between Salmonella and IECs drives pathogen-capturing CX3CR1+ 
cells to migrate rapidly into the intestinal lumen to limit the number of 
pathogens crossing the epithelial barrier. Main objective of this work was 
documenting the CX3CR1-mediated luminal migration by using in vivo real time 
imaging and to assess the differential contribution of sampling and migration to 
pathogen protection by comparing C57BL/6 sampling-competent/migration-




CX3CR1 GFP knock-in mice (Jung et al., 2000b) on Balb/c background were 
kindly provided by Prof Oliver Pabst. Six-week-old female CX3CR1+/gfp mice were 
used for experimentation. The genotype of the animals was confirmed with PCR 
analysis (Appendix 2). CX3CR1-/- (C57BL/6 background) were purchased from 
Taconic and 6-8 week old WT Balb/c and C57BL/6 were purchase from Charles 
River. Villin-Cre MyD88 (MyD88ΔIEC) (C57BL/6 background) were kindly provided 
by K. Hughes and originated from the Welcome Trust Sanger Institute, Hinxton, 
UK. Mice were maintained and bred under specific pathogen-free conditions. 
Experiments were approved by the University of East Anglia Welfare and Ethical 
Review Body (AWERB; ref: 70/7582) and conducted under the guidelines of 
Animals Scientific Procedures Act (1986) of the United Kingdom. Also, 
experimental protocols were approved by the Animal Care and Use Committee 
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of the University of Siena (no. G2007/11/2) under the “Guiding Principles for 
Research Involving Animals and Human Beings”. 
Bacteria 
InvA-AroA-, InvA+AroA- and InvA+AroA+ Salmonella Typhimurium SL1344 
bacterial strains were provided by P. Mastroeni and D. Pickard (Hoiseth and 
Stocker, 1981, Raffatellu et al., 2005).  
Bacterial challenge 
Isolated loops were injected with 1x107 non-invasive/non-replicating InvA-AroA- 
for intravital imaging experiment or invasive/non-replicating InvA+AroA- 
Salmonella for collecting intraluminal CX3CR1+/gfp cells for phenotypic and 
quantitative analysis. Oral challenges were performed by gavages that were 
delivered five to ten minutes after administration of a solution of NaHCO3 (10% 
wt/vol/200μl). In order to monitor intraluminal migration of CX3CR1+ cell or 
bacterial load in the gut within 5 h after infection mice received a single oral 
dose of 1x107 of either InvA+AroA-, InvA-AroA- or InvA-AroA+ Salmonella; to 
determine long-term (5 days post-infection) bacterial load mice received a 
single dose of 1x107 of InvA-Aro+ strain. To determine strain specific 
susceptibility to Salmonella infection mice received a single dose of 1x108 wt 
(InvA+AroA+) Salmonella; finally to investigate both humoral and cellular 
immunity to non-invasive Salmonella mice received three doses of 1x108 InvA-
AroA- Salmonella at three day interval. 
In order to monitor intraluminal migration of CX3CR1+ cells and faecal bacterial 
load mice received a single oral dose of 1x107 of InvA+Aro- Salmonella. To 
determine translocation of non-invasive InvA- Salmonella two approaches were 
undertaken. For short term experiments mice (n=8-10mice/group) were orally 
administrated with a single dose of InvA-AroA- Salmonella and sacrificed at 30, 
60, 180 and 270 minutes post-infection. For long term experiments mice 
received the same dose of InvA-Aro+ and mice were sacrificed 5 days post-
infection. Tissues (small intestine and PPs for short term experiments; PP, MLN 
and spleen for long term experiments) were harvested weighed and treated 
with gentamicin (1 h at 37° C). After repeated washings in PBS tissues were 
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homogenized. Serial dilutions of the homogenates were plated on LB agar and 
incubated overnight at 37° C.  
Surgical procedure 
Animals were starved for 6 h prior anaesthesia with isoflurane, opening of the 
abdominal cavity and ligation of the ileum. The lumen of the intestinal loop was 
injected with Salmonella as described before (Arques et al., 2009). An hour later 
a 15 mm longitudinal incision was made such that the intestinal tube was cut 
open without damaging the blood supplying vessels or the mucosa chosen for 
imaging. The tissue was washed gently with warm PBS to remove residual 
luminal content. On the glass window of the microscope stage a drop of 
Salmonella in PBS was used to immerse the exposed luminal side. The tissue 
was held in place by covering it with a 13 mm in diameter round glass coverslip 
clamped to the stage. Importantly the pressure used to hold the specimen in 
place was enough to prevent displacement of the view field by weak peristaltic 
movement but also allowing for efficient blood supply and preserving the 
structure and functional integrity of the gut. To prevent drying of the exposed 
tissue it was covered with a cotton pad soaked in PBS which was regularly re-
moisturised. During incubation and imaging the temperature of the animal was 
maintained by the enclosed microscope temperature control system (Life 
Imaging Services, Basel, Switzerland) part of the multiphoton setup.  
Multiphoton imaging  
The Multiphoton microscope System from LaVision BioTeC (Bielefeld, Germany) 
used consisted of TriM Scope II single beam 2-photon microscope system 
including Nikon Eclipse Ti optical inverted microscope; Chameleon Ultra II Ti: 
Sapphire laser and Chameleon Compact Optical Parametric Oscillator (OPO) 
(Coherent Inc., USA); holder (Life Imaging Services, Basel, Switzerland); 2-axis 
galvanometric XY-scanner; Multi-PMT adapter for up to 4 PMTs, containing 
dichroic beam splitters at 495, 560 and 625 nm. The system was controlled by 
Inspektor Pro 4.0 software.  
With the excitation laser output of 3380 mW split 5%:95% between the laser 
scanner and the OPO, the Ti:Sa laser power was 169 mW, and the OPO output 
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was ~300 mW at 1000 nm.  The attenuators setting for the Ti:Sa power was 
20.25%, and the OPO power 10.75%,  giving effective power values on the 
sample of 35 mW at 860 nm, and ~30 mW at 1000 nm. 
Imaging was done with the galvanometric scanner covering an area of 200x200 
microns with 1000*1000 pixels (nominal 0.2 micron) image resolution, using a 
Nikon CFI-Plan Apochromat “VC” 20X air lens; corrected for cover slips. 3-5 line 
averages were used to improve the signal/noise ratio.  Z-stacks were acquired 
with 1 micron steps. Selective imaging of the GFP+ cells was done with 860 nm 
excitation. 
Data analysis 
Image analysis was done with the Fiji/ImageJ package (Schindelin et al., 2012) 
The imaging data were saved as four individual ome.tif files from the 4 PMTs.  
For display, the intensities of the rgb channels were individually adjusted (low, 
high). To get a better signal/noise ratio a median filter was applied to the 
images. 3D displays and video clips of the data sets were made with the ImageJ 
3D viewer plugin. 
The TrackMate_ (Fiji) plugin (Authors: Nick Perry, Jean-Yves Tinevez, Johannes 
Schindelin) was used to follow the movement of individual cells.  Because of the 
irregular shapes of the CX3CR1+ the tracking points were placed manually on 
the centres of cells. To account for tissue movement/distortions during the 
imaging, the movement of single cells were determined relative to ‘fixed’ (i.e. 
not moving in the tissue) neighbouring cells. This gave more adequate results 
for local movements than global registering of tissue stacks. 
Flow cytometry and isolation of CX3CR1+ cells 
Following bacterial challenge, luminal contents were carefully recovered by 
gently flushing the intestine with PBS. Intraluminal CX3CR1+/gfp cells were 
isolated and characterized by flow cytometry as described in details elsewhere 
(Arques et al., 2009). Samples were analysed by BD FACSAria II (BD Biosciences). 
The following antibodies were used: CD11c (HL3) (BD Biosciences), CD103 
(M290) (BD Biosciences), CD103 (2E7) (eBioscience), F4/80 (BM8) (eBioscience), 
MHC II (M5/114.15.2) (eBioscience), SiglecF (E50-2440) (BD Biosciences). For 
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the isolation of CX3CR1+ cells intestinal tissue from CX3CR1+/gfp mice were 
collected and tissues repeatedly treated with HBSS containing EDTA (2mM). 
After each treatment tissues were shaken and supernatant discarded. After 
each wash an aliquot from the supernatant was analysed by microscopy to 
detect the presence of IEC; EDTA treatment was stopped (usually after 3-4 
treatments) when epithelial cells were not present in the supernatant. Tissues 
were then treated for 50 minutes in RPMI 1640 with 10% FCS, 0.24mg/ml 
collagenase VIII (Sigma) and 40 U/ml DNase I (Roche) (Schulz et al., 2009). After 
shaking cells suspensions were filtered and then purified by gradient separation 
as described before (Schulz et al., 2009). Cells were sorted (>95% purity), 
suspended in PBS and injected into the intestinal lumen for pathogen exclusion 
assay.  
Immunity to non-invasive Salmonella 
Salmonella specific IgG and IgA were detected in serum and faeces. Briefly, 
serum was obtained from blood after 1 h incubation at 37° C and collected after 
centrifugation. Faecal samples were weighed and resuspended in PBS in 
presence of proteases inhibitors (Sigma-Aldrich); debris-free supernatants were 
then collected after centrifugation. ELISA plates (Costar) were coated with 
lysate from wt Salmonella obtained as described before (Beal et al., 2004). 
Plates were blocked and then incubated with dilutions of both serum and faecal 
solution. After repeated washings plates were incubated with anti IgA- and anti 
IgG biotinylated antibody (Abcam); this was followed by incubation with 
Streptavidin Peroxidase (Abcam). Also, numbers of single IgA-antibody forming 
cells (AFC) were detected using a modified ELISPOT assay developed in our lab 
(Nicoletti et al., 2010). Briefly, 96-well membrane ELISPOT plates (Whatman) 
were coated with lysate from wt Salmonella. After blocking (2% FCS and 2% milk 
powder) PP-lymphocytes cells (106) were added in 5% FCS RPMI and incubated 
overnight at 37° C and 5%CO2. Plates were washed with PBS 10mM EDTA, rinsed 
with cold PBS and then incubated with goat HRP-labelled anti-IgA (Life 
Technology) antibody overnight at 4° C. This was followed with incubation with 
HRP colour development reagent (BioRad). ELISPOT assay was performed in 
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duplicate and spots enumerated by diaphanoscope. In vitro Salmonella-specific 
T cell proliferation was measured following co-culture of T cells from InvA-AroA-
infected CX3CR1+/gfp and CX3CR1gfp/gfp mice with T cell-depleted splenocytes 
from naïve wt syngeneic mice in presence or absence of Salmonella lysate and 
treated with mytomicin C. T cells and T-cell-depleted splenocytes were 
prepared using MACS Cytokine Secretion Assay (Miltenyi Biotec) following 
instructions provided by the manufacturer. T cell proliferation was measured 
after 72 hours by flow cytometry. Parallel recall challenge cultures were set to 
determine levels for IFNγ in the supernatant by ELISA (Biolegend). 
4. Results 
4.1. Salmonella-induced migration of CX3CR1+ macrophages occurred 
through paracellular channels in the epithelium. 
We used a genetically modified mouse strain (Abreu, 2010) in which CX3CR1+ 
cells are expressing GFP (Figure 42). With the help of intravital two-photon 
microscopy we imaged the transepithelial migration of the CX3CR1+ cells in 
these CX3CR1+/gfp mice shortly (2 h) after the introduction of InvA-AroA- S. 
enterica Typhimurium into isolated ileal loops.First, GFP-expressing CX3CR1+ 
cell protruded into the intestinal lumen from the surface of the intestinal 
epithelium (Figure 43 A) (Appendix 3 Figure S3 A) and progressed further into 
the lumen (Figure 43 B, C) (Appendix 3 Figure S3 B, C) before moving away from 
the entry site (Figure 43 D, E) (Appendix 3 Figure S3 D, E). It also appeared that 
the imaged cell was immediately followed by another CX3CR1+/gfp cell migrating 
via the same opening in the epithelium (Figure 43 D, E) (Appendix 3 Figure S3 D, 
E). The integrity of the tissue remained intact throughout the experiment 
(Figure 44) (Appendix 4 Figure S4, Figure 44). This migratory pattern was also 
seen by TEM (Figure 45). The cells migrating into the lumen, one of which was in 
close contact with Salmonella appeared to move through paracellular channels. 
The migration of CX3CR1+ cell is unidirectional; after collecting intraluminal GFP-
CX3CR1 cells and reintroducing them into freshly isolated intestinal ileal loop no 
GFP-CX3CR1+ cells traversing the epithelial barrier to migrate back into the 
intestinal tissue. The majority of intraluminal CX3CR1+ cells (Figure 46) at 5 h 
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post-infection displayed the phenotype of gut resident macrophages MHCII+ 
F4/80+ CD11c+ CD103- SiglecF- that in steady-state situations do not migrate to 
mesenteric lymph-node, display poor T cell stimulatory capability and possess 




Figure 42 Using in vivo multiphoton microscopy series of consecutive optical 
sections of CX3CR1+/gfp unchallenged mouse intestine were obtained, starting at 
the luminal surface of the epithelium (turquoise). Underneath the epithelium, at 
about 15 µm depth are situated a number of interconnected CX3CR1+/gfp cells 







Figure 43 Still images from real time imaging analysis of CX3CR1+/gfp cells 
migrating into the intestinal lumen. Images were obtained after short term (2 h) 
challenge with non-invasive InvA-AroA- Salmonella Typhimurium in CX3CR1+/gfp 
mice. CX3CR1+/gfp cell (arrow head) in progress of protruding into the intestinal 
lumen from the surface (XY plan) of the intestinal epithelium (A) and then 
continuing to move out into the lumen through an opening of the intestinal 
epithelium (B-C). The migrating cell did not act as antigen sampling cell and did 
not retract the sampling devise within the tissue; instead the cell moved entirely 
within the lumen and away (dotted line) from the entry site (white box) (D-E). 
This cell is immediately followed by another CX3CR1 +/gfp cell protruding into the 
lumen from the same opening (D-E) (white box). Orthogonal 3D sections are 




Figure 44 Throughout the in vivo multiphoton image acquisition the tissue 
remained intact. Epithelial layer integrity and three dimensional structure at the 
beginning of the experiment (A) are comparable to the ones observed at the 
end (B) of data acquisition.  
 
 
Figure 45 Migration pattern of CX3CR1+ cells was further investigated by TEM. 
Migrating cells (mC) move into the lumen (L) via paracellular space (arrow 
heads) between adjacent enterocytes (E). Also in (A) one migrating cell is in 




Figure 46 Phenotypic analysis of intraluminal CX3CR1+ cell population of 
CX3CR1+/gfp (Balb/c background) 5 hours following intestinal challenge with 
1x107 InvA+AroA- Salmonella. The vast majority of the cell population rapidly 
recruited into the intestinal lumen showed the phenotype of resident 
(stationary) macrophage with poor T cell stimulatory activity and high 
phagocytic activity. These cells were MHCII+ F4/80+ CD11c+ but did not express 
the canonical marker for gut-derived dendritic cells, CD103; also, these cells 
lacked the neutrophil marker SiglecF. Grey areas correspond to isotype control 
and white areas represent specific staining. (Experiment performed in triplicate, 





4.2. Intraluminal cell migration is absent in CX3CR1gfp/gfp and MyD88∆IEC 
mice and is higher in response to invasive Salmonella. 
Salmonella-induced migration of CX3CR1+ cells was further investigated in 
CX3CR1gfp/gfp, CX3CR1+/gfp and villin-Cre MyD88ΔIEC mice carrying targeted 
deletion of MyD88 in the IECs (Frantz et al., 2012). After the introduction of 
InvA-AroA- Salmonella Typhimurium into isolated intestinal loops of CX3CR1+/gfp 
mice the number of CX3CR1+ cells appearing in the gut lumen 30 minutes post 
infection (Figure 47 A) reached 0.71x104 ± 1.2x103 which was approximately >30 
fold higher than levels seen in CX3CR1gfp/gfp mice (1.3x102 ± 1x102). The numbers 
of intraluminal CX3CR1+ cells increased steadily between 90 and 270 minutes 
reaching 8.9x104 ± 5x103. In contrast, no increase in the number of intraluminal 
CX3CR1+ cells was observed in CX3CR1gfp/gfp mice at any time point after 
infection; thus, showing that, the migration is absent, and not simply delayed in 
mice lacking a functional fractalkine receptor. Furthermore, we show that 
lympho-epithelial cross talk is essential for this event. Indeed, IEC-derived 
signals are instrumental in triggering the migration of CX3CR1+ cells in response 
to InvA-AroA- Salmonella Typhimurium. The migration was completely 
suppressed in MyD88ΔIEC mice compared to WT counterparts (1.5x102 ± 1x102 
and 6.5x104 ± 1.1x104 respectively at 5 h post infection) (Figure 47 B). 
We then evaluated the CX3CR1+ cells migration in response to oral delivery of 
Salmonella strains that differed in their capacity to invade the host. Intraluminal 
migration in CX3CR1+/gfp mice (Figure 47 C), was significantly higher after 
infection with the invasive Salmonella strain (4.3.x102 ± 1.2x102) compared to 
non-invasive strain (2.1.x102 ± 1x102) already within 30 minutes post-infection. 
The number of intraluminal cells steadily increased with time and, after 5 h it 
reached 4.4x104 ± 9x103 and 1.7x104 ± 1.2x103 cells for invasive and non-
invasive Salmonella, respectively. Migration was significantly reduced in 
response to both Salmonella variants at 12 h post-infection consistent with 
intraluminal migration being restricted to the initial stage of infection. Cell 
migration was also significantly higher in InvA+-treated mice (1.1x103 ± 0.4x103 
and 4.1x102 ± 1.3x102 cells for InvA+ and InvA- respectively after 270 min). 
CX3CR1+ cells were the only intraluminal cell population harbouring intracellular 
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Salmonella shortly after infection (Arques et al., 2009) suggesting a possible role 
in pathogen-exclusion. In agreement with this interpretation we observed that 
at 5 h after infection migration-competent CX3CR1+/gfp mice had a significantly 
higher faecal bacteria load compared to migration-deficient CX3CR1gfp/gfp mice 
(Figure 47 D). 
 
 
Figure 47 The role of CX3CR1 in Salmonella-induced migration was assessed in 
mice with a functional (CX3CR1+/gfp) or non-functional (CX3CR1gfp/gfp) receptor. 
Intraluminal migration of CX3CR1+ cells was absent in CX3CR1-deficient mice (A) 
(7-8 mice/group) that had been challenged with 1x107 InvA-AroA- Salmonella 
Typhimurium. The lack of the fraktalkine receptor completely abolished, and 
not simply delayed the pathogen-induced migration. Salmonella-dependent 
intraluminal recruitment of CX3CR1+ cells was also absent in mice with a target 
deletion of MyD88 in the IECs (MyD88ΔIEC) (B) (5-6 mice/group). In (C) it is 
shown that intraluminal migration is significantly more pronounced in response 
to oral challenge (1x107) with invasive (InvA+) Salmonella variant (7-8 
mice/group). Migration appeared to be restricted at the initial stage of infection 
and it declined significantly 12 h after infection for both invasive and non-
invasive strains. The presence of intraluminal CX3CR1+ cells led to a significant 
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increase in faecal bacterial load (D) (7-8 mice/group) compared to CX3CR1gfp/gfp 
mice 5 h after oral delivery of invasive Salmonella as in (C). (Experiments 
performed in triplicate; two-way ANOVA in A, B and C, Bonferroni Multiple 
Comparison post-test, where significance (p<0.05=*) for the comparisons at 
each time point is indicated; t-test in D (p<0.05=*); error bars represent 
standard error of the mean (SEM)) 
 
4.3. Bacteria translocation is increased in CX3CR1-deficient mice 
Bacteria translocation is increased in CX3CR1-deficient mice. It has been 
suggested that non-invasive InvA- Salmonella traverse the epithelium exclusively 
via CX3CR1-direct sampling also known as indirect route (Martinoli et al., 2007); 
thus we asked whether translocation of InvA- Salmonella differed in mouse 
strains either able (C57BL/6) (Chieppa et al., 2006) or unable (Balb/c mice and 
CX3CR1-/-) (Niess et al., 2005, Vallon-Eberhard et al., 2006) to sample luminal 
bacteria via the indirect route. Following oral delivery of InvA- Salmonella 
antigen sampling-competent/migration-competent C57BL/6 and sampling-
deficient/ migration-competent Balb/c had similar numbers of Salmonella 
penetrating both the conventional and the specialized follicle-associated (FAE) 
epithelia of Peyer’s patches (PPs) (Figure 48 A, B) at any time point during the 
initial stages of the infection. By contrast, sampling-deficient/migration-
deficient CX3CR1-/- mice showed significantly higher numbers of bacteria after 
30 and 60 minutes post infection within the PPs and the small intestinal lamina 
propria that remained significantly higher throughout the experiment (Figure 48 
A, B). Increased bacterial translocation across the gut epithelium in CX3CR1-
deficient mice (both CX3CR1-/- and CX3CR1gfp/gfp) was not the result of increased 
permeability of the epithelial barrier as shown by using soluble tracer and 
microparticles (Appendix 5). Indeed, serum levels of orally delivered fluorescent 
FITC-dextran and numbers of orally delivered FITC-labelled latex microparticles 
were similar to wt mice. In addition, the number of replicating InvA- AroA+ 
Salmonella recovered from PP, mesenteric LN and spleen 5 days after oral 
delivery was higher in CX3CR1-/- mice compared to wt counterparts (Figure 48 
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C). Increased bacterial transport in the gut of CX3CR1gfp/gfp mice was also seen 
following infection with InvA+ AroA+ Salmonella. CX3CR1gfp/gfp mice succumbed 7 
days after oral delivery of lethal dose of invasive Salmonella at a significantly 
faster rate compared to their CX3CR1+/gfp counterparts (Figure 49 A) and 
showed higher bacterial load in their organs (Figure 49 B). These results taken 
together would suggest that the lack of Salmonella-induced CX3CR1+ cells 
intraluminal migration favours bacterial translocation. 
 
 
Figure 48 Role of CX3CR1-mediated sampling in the uptake of non-invasive InvA-
Salmonella. Numbers of Salmonella traversing the conventional (A) (small 
intestine, SI) and specialized (B) (Peyer’s patches, PP) epithelia did not differ in 
mouse strains that have been shown to be either sampling-
competent/migration-competent (C57BL/6) or sampling-deficient/migration-
competent (Balb/c). In contrast, Salmonella uptake was significantly higher in 
CX3CR1-/- mice that were both sampling-deficient and migration-deficient (8 
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mice/group). Similarly higher numbers of Salmonella were found in the GALT 
(PP and MLN) and spleen of CX3CR1-/- mice compared to wt mice (10 
mice/group), 6 days after a single oral delivery of non-invasive-replicating InvA-
AroA+ Salmonella (C). Asterisk (*) indicates significant statistical difference. 
(Experiments performed in triplicate; two-way ANOVA in A and B, Bonferroni 
Multiple Comparison post-test, where significance (p<0.05=*) for the 
comparisons at each time point is indicated; t-test in D, where each anatomical 
location was considered as an independent data set; error bars represent 





Figure 49 Survival of mice with functional (CX3CR1+/gfp) and non-functional 
(CX3CR1gfp/gfp) fraktalkine receptor after oral administration of 1x108 InvA+AroA+ 
Salmonella. CX3CR1-deficient mice succumbed within 7 days from infection at a 
faster rate compared to CX3CR1+/gfp mice (A) (12 mice/group). Also, in spite of 
lacking the ability to sample Salmonella via the indirect route CX3CR1gfp/gfp mice 
(black bars) showed significantly higher bacterial load in the gut and other 
organs compared to CX3CR1+/gfp (grey bars) (B). Furthermore, increased 
susceptibility of these mice to infection could not be attributed to reduced 
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immunity to Salmonella as shown in Figure 50, Figure 51. (In B experiments 
performed in triplicate, n=2 to 3 (in total n=8-10 mice/group); t-test, where 
each anatomical location was considered as an independent data set; error bars 
represent standard error of the mean (SEM)) 
 
4.4. Lack of CX3CR1-mediated sampling did not affect immunity to 
Salmonella. 
We next addressed the possibility that the lack of CX3CR1-mediated sampling 
impaired immunity to InvA-AroA- Salmonella. Levels of serum IgG was 
consistently higher in CX3CR1gfp/gfp mice compared to CX3CR1+/gfp mice starting 
at week 2 post infection (Figure 50 A) although it did not reach statistical 
significance. Instead, IgA production in CX3CR1gfp/gfp mice, albeit significantly 
lower than the one induced by invasive/non-replicating InvA+AroA- Salmonella 
(data not shown) was significantly higher compared to wt mice (Figure 50 B) 
starting from week 3 post-infection. The higher Salmonella-specific IgA response 
in CX3CR1-/- mice was confirmed by assessing the numbers of antibody forming 
cells (AFC) in the PPs (Figure 50 C). Also, we observed that Salmonella-specific T 
cell blastogenesis was increased in CX3CR1gfp/gfp mice compare to CX3CR1+/gfp 
(Figure 51 A-C) and secreted higher of levels of IFNγ (Figure 51 F). Thus, 
immunity to non-invasive Salmonella that specifically targets CX3CR1-mediated 





Figure 50 Humoral immunity to non-invasive Salmonella in CX3CR1-deficient 
mice. Mice (9-10 mice/group) received 3 consecutive doses of 1x107 of non-
invasive/nonreplicating InvA-AroA- at 3 day interval. Levels of serum IgG (A) and 
intestinal IgA (B) Salmonella-specific antibodies were determined by ELISA. Both 
responses appeared to be higher in CX3CR1gfp/gfp compared to CX3CR1+/gfp mice 
although only intestinal levels of IgA were significantly different starting from 
week 3 after infection (*). Higher mucosal IgA immunity in CX3CR1gfp/gfp mice 
was further confirmed by monitoring numbers of AFC in PPs (C). Asterisk (*) 
indicates significant statistical difference. (Experiments performed three times, 
each time n=3 to 4 mice/group; two-way ANOVA, Bonferroni Multiple 
Comparison post-test, where significance (p<0.05=*) for the comparisons at 






Figure 51 Cellular immunity to non-invasive Salmonella in CX3CR1-deficient 
mice. T cell blastogenesis was measured following in vitro recall challenge of T 
cells from CX3CR1+/gfp and CX3CR1gfp/gfp mice (9-10 mice/group) following oral 
delivery of Salmonella as for Figure 50. Lymphoblasts were recognized by flow 
cytometry based on size (side-scatter, SSC) and granularity (forward-scatter, 
FSC) (A-D). Blastogenesis in culture increased in presence of Salmonella lysate 
(C, D) compared to mock infected cultures (A, B) and it was significantly higher 
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in CX3CR1gfp/gfp mice (C) compared to CX3CR1+/gfp counterparts (D). Quantitative 
analysis is shown in (E). Also, parallel in vitro recall challenge cultures showed 
that CX3CR1gfp/gfp mice secreted higher levels of IFNγ compared to CX3CR1+/gfp 
(F). Asterisk (*) indicates significant statistical difference. (Experiments 
performed three times, each time n=3 to 4 mice/group; two-way ANOVA in E 
and F, Bonferroni Multiple Comparison post-test, where significance (p<0.05=*) 
is indicated; error bars represent standard error of the mean (SEM)) 
 
4.5. The presence of intraluminal CX3CR1+ cells reduced the number of 
Salmonella invading intestinal tissue. 
Finally, we tested the hypothesis that intraluminal CX3CR1+ cells limit 
Salmonella penetration of the epithelial barrier. At various intervals, shortly 
following oral delivery of 1x107 InvA+AroA- Salmonella, CX3CR1+ cells isolated 
from CX3CR1+/gfp donors were injected into the intestinal lumen of migration-
deficient CX3CR1-/- mice (Appendix 6 Figure S6). Four groups of mice were used 
and the number of adoptively transferred cells at any given time point was 
based on the time course experiment (Figure 47 C). The adoptive transfer of 
intraluminal CX3CR1+ cells in CX3CR1-/- mice significantly reduced the number of 
InvA+ Salmonella traversing the epithelial barrier (Figure 52). In the presence of 
0.5x103 CX3CR1+ cells the number of tissue CFU of InvA+AroA- Salmonella 
declined (from 1.2x103 ± 3.3x102 to 2.1x102 ± 1.4x102) at 30 minutes post-
infection (group I). Similarly, significant reductions in bacterial load in the 
intestinal tissues were observed in group II and III. Finally, group IV was 
passively transferred, fifteen minutes after Salmonella administration with a 
number of CX3CR1+ cells (1x104) that far exceeded the number of CX3CR1+ cells 
found in the small intestine at the beginning of the infection. In this case, the 
presence of intraluminal CX3CR1+ cells almost completely abolished Salmonella 
invasion of intestinal tissue (CFU tissue <40). These results suggest that CX3CR1+ 
cells migrate rapidly into the lumen to prevent Salmonella from penetrating the 





Figure 52 Role of intraluminal CX3CR1+ cells in pathogen-exclusion. CX3CR1gfp/gfp 
mice (6 mice/group) were infected with a single oral dose (1x107) of 
invasive/non replicating InvA+Aro- Salmonella. Salmonella infecting the intestinal 
tissue were determined in the absence (CX3CR1-/-, grey bars) or presence (AT-
CX3CR1-/-, black bars) of CX3CR1+ cells that were adoptively transferred (AT) 
directly into the intestinal lumen. A significant decline of Salmonella CFU 
g/tissue was observed in group I 30 minutes after infection following adoptive 
transfer of 0.5x103 CX3CR1+ cells. Significant reduction in the number of 
pathogens invading the host was also seen in group II and III that received 
increasing numbers of CX3CR1+ that were determined according to the time 
course study shown in (Figure 47 C). In group IV the introduction in the lumen 
of larger, non-physiologically high number of intraluminal CX3CR1+ cells (1x104) 
(20 fold increase compared to the number of cells usually found in the gut 15 
minutes after infection) nearly completely abolished Salmonella infection. 
(Experiment performed three times, each time n=2 mice/group; two-way 
ANOVA, Bonferroni Multiple Comparison post-test, where significance 





Preventing pathogen invasion is, together with absorption of nutrients the main 
task of the intestinal epithelium. Indeed, the presence of a thick layer of mucus 
and secretion of IgA ensures that harmful microorganisms do not breach the 
intestinal epithelium. We report that when this barrier is breached by invasive 
pathogenic bacteria the host rapidly responds by sending into the intestinal 
lumen pathogen (Salmonella)-capturing CX3CR1+ cells to limit the number of 
bacteria penetrating the epithelium. The rapid migration is triggered by the 
initial interaction of pathogens with IEC since this migration is absent in mice 
lacking the adaptor molecules MyD88 solely within the epithelium. Interaction 
of Salmonella and the IEC-associated TLR may lead to two different events. 
CX3CR1+ cells can directly sample bacteria and shuttle them across the 
epithelium (Rescigno et al., 2001); alternatively these cells could also move 
through the epithelium and migrate into the lumen where they capture 
Salmonella (Arques et al., 2009). However, while it was suggested that CX3CR1-
sampling was relevant to mounting pathogen-specific response the role and 
biological relevance of the rapid migration of Salmonella-capturing CX3CR1+ 
cells in the lumen remained to be determined. CX3CR1-sampling and -migration 
showed some differences the most notable being that, while CX3CR1-migration 
in response to Salmonella takes place in different mouse strains, such as 
C57BL/6 and Balb/c (Arques et al., 2009) the ability to sample luminal bacteria 
via the indirect route is strain-specific (Chieppa et al., 2006, Vallon-Eberhard et 
al., 2006). We exploited this feature to investigate the biological relevance of 
these two CX3CR1-mediated events during the initial stage of Salmonella 
infection. We observed that, in spite of lacking the ability to sample bacteria via 
the indirect route, Balb/c mice showed very similar uptake of non-invasive 
Salmonella in the gut compared to sampling-competent wt C57BL/6. This 
observation is of particular relevance when examined in the context of 
Salmonella uptake in CX3CR1-deficient mice that lacked both indirect sampling 
(Niess et al., 2005) and intraluminal migration (Nicoletti et al., 2010). We 
observed that CX3CR1-deficient mice showed a significantly higher bacterial 
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load both at mucosal level and systemically compared to both C57BL/6 and 
Balb/c. Increased pathogen uptake in CX3CR1-deficient mice did not depend on 
intrinsic alteration of the integrity of the epithelial barrier in these mice (both 
CX3CR1-/- and CX3CR1gfp/gfp) since permeability to either soluble or particulate 
tracers was similar to wt counterparts. Overall these results would suggest that 
sampling via the indirect route does not play a significant role in pathogen 
uptake through the intestinal epithelium. Instead they point to the lack of rapid 
intraluminal migration of CX3CR1+ cells as the critical event favouring bacterial 
translocation. This hypothesis is further strengthened by the observation that 
intraluminal migration of CX3CR1+ cells in CX3CR1+/gfp mice was associated with 
increased faecal bacterial counts compared to CX3CR1gfp/gfp mice. Furthermore, 
CX3CR1-deficient mice are more susceptible to Salmonella infection, as seen by 
us and others (Niess et al., 2005); however, the reason for this remained to be 
determined. One possibility was that the lack of CX3CR1-mediated sampling led 
to an impaired immunity to Salmonella. Surprisingly, the absence of CX3CR1-
mediated sampling does not appear to be critical for adaptive anti-Salmonella 
response. In these mice, oral delivery of non-invasive/non-replicating InvA-AroA- 
Salmonella mutant that specifically target the indirect route induced similar 
levels of anti-Salmonella-specific IgG and higher spleen T cell proliferation. Also, 
CX3CR1-deficient mice developed a significantly higher mucosal (IgA) response 
to non-invasive Salmonella that is characterized by poor mucosal antigenic 
properties (Martinoli et al., 2007). It is likely that this could be attributed to 
higher numbers of Salmonella reaching the PPs, the inductive sites of IgA-
mediated immunity, in CX3CR1-deficient mice. Taken together these results 
strongly suggest that increased susceptibility to Salmonella infection in CX3CR1- 
deficient mice (Niess et al., 2005) could be due, partly to the lack of protection 
afforded by CX3CR1- mediated pathogen exclusion early in infection. As a 
parallel observation, these data also confirmed previous reports suggesting that 
Salmonella type III secretion system (InvA) facilitates up-take by FAE-microfold 
(M) cells but its absence does not totally compromise the ability of Salmonella 
to target this entry route (Galán and Curtiss, 1989, Jepson and Clark, 2001, 
Martinez-Argudo and Jepson, 2008). Intraluminal migration of CX3CR1+ cells is 
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unidirectional and once into the lumen they do not traverse back the intestinal 
epithelium. Determining the fate of intraluminal Salmonella-capturing CX3CR1+ 
cells was prompted by the important finding that in mice T. gondii-infected 
neutrophils that had migrated into the intestinal lumen at a later stage (one 
week post-infection) during the infection can move back into the intestinal 
tissue (Coombes et al., 2013). The opportunity to utilize GFP-CX3CR1+ cells (Jung 
et al., 2000a) provided us with the tool to address this issue by using a more 
reliable system compared to the one we previously used that involved 
membrane-labelling with Dil dye (Arques et al., 2009). The observation that 
CX3CR1+/gfp in contrast to infected neutrophils undertake a one way journey 
suggested that, neutrophils may be intrinsically different from CX3CR1+ cells in 
their ability to traverse back the epithelium. Alternatively, in contrast to 
Salmonella, T. gondii may trigger the secretion/expression of cytokine/surface 
molecules in infected cells that favour this event. The unidirectional migration 
of CX3CR1+ cells into the lumen very early during Salmonella infection 
contributes to pathogen-exclusion. Direct introduction of these cells into the 
lumen of migration-deficient CX3CR1-/- mice shortly after oral delivery of 
invasive Salmonella significantly reduced the number of pathogens traversing 
the epithelial barrier. Furthermore, although at this time we cannot rule out the 
possibility that other cell types may participate to this protective response at a 
later stage in infection the previous observation that CX3CR1+ cells was the only 
intraluminal cell population harbouring intracellular Salmonella (Arques et al., 
2009) strongly suggested that these cells are the main player in the very early 
stages of infection. We would like to propose that the CX3CR1-mediated 
pathogen-exclusion is part of a defensive strategy that includes multiple players. 
In addition to the already known protection barriers present at the intestinal 
mucosa such as the mucus layer, antimicrobial peptides, and sIgA information is 
emerging about new defence mechanism. For example, recently it has been 
shown that intraepithelial Salmonella Typhimurium population expands through 
a combination of de novo invasion and intraepithelial replication. The latter is 
counteracted by epithelium-intrinsic NAIP(s) and the NLRC4 inflammasome 
promoted removal of infected epithelial cells (Sellin et al., 2014). The work 
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presented in this chapter describes another mechanism of defence against 
intestinal pathogens (Figure 53). If the other lines of defence are breached IEC-
derived signals readily trigger the intraluminal migration of CX3CR1+ cells that 
are present in large number in the subepithelial area where they form an 
intricate cell network. 
 
Figure 53 Several defence mechanisms are in place to prevent pathogen 
invasion of the intestinal mucosa. Mucus layer containing IgA and antimicrobial 
peptides covers the intestinal epithelium and protects it against potential 
pathogens. If this defence is breached, at the early stages of infection, CX3CR1-
positive cells migrate into the lumen where they capture pathogens. If epithelial 
cells get infected they are eliminated by expulsion in order to minimise 
pathogen proliferation and spread. Elements of this figure are based on 








Appendix 1  
 
Confirming the genotype of IL-12Rβ2-/- mice 
Primers used for confirming the genotype of IL-12Rβ2
-/-
 mice (Wu et al., 2000): 
Mutant (M): 
5’-GAAGCGGGAAGGGACTGGCTGCTA-3’ (PGK-1 neo/ Neo-specific 
forward primer);  
5’-CGGGAGCGGCGATACCGTAAAGC-3’ (PGK-1 neo/ Neo-specific reverse 
primer); 
5’-GTGTGCAAGCTTGGCACTGTGACCGTCCAG-3’ (exon 3/ IL-12R β2 
exon 3 forward primer); 
Wild type (WT): 
5’-GTTTAGCTTGCAGACAAACAAGGTCATACC-3’ (exon 3/ IL-12R β2 






Wild type (WT) product: 265 bp 
Transgenic/mutant (M) product: 500 bp 
 
PCR programme (Techne Flexigene): 
 
Heated lid: 105°C 
Loo1: 1 cycle 
Seg: 95°C/2 min 
Loop2: 35 cycles 
Seg: 95°C/35 sec 
Seg: 51°C/30 sec 
Seg: 72°C/35 sec 

















Confirming the genotype of CX3CR1gfp/gfp and CX3CR1gfp/+ mice  
Primers used for genotyping of the CX3CR1 colony (NYCSM): 
Wild type: 5’-AGCCGGAAGCCCAAGAGCATC-3’ 
Common: 5’-CCGCCCAGACGCCCAGACTA-3’ 
Mutant: 5’-TGCTGCTGCCCGACAACCAC-3’ 
Wild type (WT) product: 291 bp 
Transgenic/mutant (M) product: 650 bp 
PCR parameters: 
Hotstart: 10 min at 95° C 
35 cycles: 
Denaturating: 30 sec at 94° C 
Annealing: 30 sec at 60° C 
Extension: 45 sec at 72° C 
 
 
Figure S1 Example of PCR products from genotyping mice №86 to №98 along 
with wild type control “a”. For each mouse there are two lanes - one with 
combination of primers detecting the wild type version of the CX3CR1 allele 













Figure S2 Intraluminal migration of CX3CR1gfp/+ cell following challenge with 
Salmonella: orthogonal cross-sections through the 3D stacks in successive time-
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frames. In (A) CX3CR1gfp/+ cell is slightly protruding from the epithelial surface 
(dotted line); the outward movement being more pronounced in (B) and (C). 
The cells then moves away from the exit site (D) and (E). Scale bar = 10 µm. (see 
Supplementary Video S1 and S2)  
 
 
Video S1 Intraluminal migration of CX3CR1gfp/+ cell following challenge with 
Salmonella. The video footage on which Figure 47 and Figure S3 were based.  
 
Video S2 Intraluminal migration of CX3CR1gfp/+ cell following challenge with 
Salmonella. The cells are marked with yellow tracking points. There are four 
reference cells that are inside the tissue and remain relatively stationary (they 
move along with the whole tissue due to peristaltic movement but are 
otherwise not participating in intraluminal migration). The migrating CX3CR1gfp/+ 
cell in the first two frames moves outward into the lumen and then away from 




















Intestinal permeability to dextran: in vivo multiphoton imaging  
Staining with fluorescent dextran was also used to validate the tissue integrity 
during the multiphoton procedures. Before mounting on the imaging glass slide 




Figure S3 Tissue integrity was preserved during multiphoton procedure. 
Fluorescent Dextran (red) could be seen in the space between individual villi. 
The epithelium (blue) was intact and therefore impermeable to the Dextran 
none of which was observed inside the villi. A three dimensional reconstruction 
of the tissue in this figure is provided in (Supplementary Video S3) 
 
Video S3 Tissue integrity was preserved during multiphoton procedure. 3D 












Intestinal permeability to dextran: oral admiration  
Intestinal permeability to dextran was measured in 6-8 week old CX3CR1gfp/gfp, 
CX3CR1gfp/+ and syngeneic WT mice (4 mice/group). FITC-labelled dextran 
(Sigma-Aldrich) was dissolved in PBS at a concentration of 100 mg/ml and 
administered to each mouse (44 mg/100 g body weight) by oral gavage. Blood 
samples were collected after 6 hours and the plasma analysed using 
fluorescence spectrometer at excitation wavelength of 490 nm and emission 
wavelength of 520 nm. Standard curves to calculate fluorescent dextran 
concentration in the samples were prepared from dilutions in PBS. This work 




Figure S4 Intestinal permeability in CX3CR1-deficient mice. Oral delivery of a 
single dose of either FITC-dextran (A) or yellow-green fluorescent polystyrene 
microparticles (B) showed that intestinal permeability to both soluble and 
particulates tracers was not affect by the lack of functional fraktalkine receptor 
(4 mice/group). This shows that the higher bacterial load in the intestine as 
shown in Figure 48 could not be attributed to an intrinsic “leaky” gut in CX3CR1-










Figure S5 Schematic summary of pathogen-exclusion assay in CX3CR1-/- mice. 
Four groups of mice (6 mice/group) received a single oral delivery of 1x107 
invasive/nonreplicating InvA+AroA- at T0. The number of CX3CR1+ cells for the 
adoptive transfer of intraluminal cells in Gr I, II and III at any given time (T15, 
T30 and T90) was established according to the results of the time course 
experiment illustrated in Figure 47. Group IV received a number of CX3CR1+ 
cells (1x104) that far exceeded the number of cells observed in the lumen 15 
minutes (T15) after infection. At the end of the experiments mice were 










AFC IgA-antibody forming cells  
AID activation-induced cytidine deaminase 
APC allophycocyanin 
APCs antigen presenting cells 
BALT  broncho associated lymphoid tissue 
BMP bone morphogenic protein 
CD cluster of differentiation 
CP cryptopatches 
CPE ground crude peanut extract 
CSR class-switch recombination 
CT cholera toxin 
CT* cycle threshold (not to be confused with cholera toxin*) 
DC dendritic cell 
DGGE denaturing gradient gel electrophoresis 
DMEM Dulbecco’s modified Eagle’s medium  
DPBS Dulbecco’s phosphate-buffered saline 
DTT dithiothreitol 
EAE experimental autoimmune encephalomyelitis 
EDTA ethylenediaminetetraacetic acid 
ELISA enzyme linked immunosorbent assay 
FAE follicle-associated epithelium 
FCS foetal calf serum 
FITC fluorescein isothiocyanate 
FKN fractalkine (CX3CR1L, neurotactin) 
FM follicular mantle 
Foxp3 factor forkhead box P3 
GALT gut associate lymphoid tissue 
GC germinal center 
GENALT genital associated lymphoid tissue 
GF germ free 
GFP green fluorescent protein 
GI gastro intestinal 
HBSS Hank’s Balanced Salt solution 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRP Horseradish peroxidase 
IBD inflammatory bowel disease 
IEC intestinal epithelial cell 
IEL  intra-epithelial lymphocyte 
IFN interferon  
Ig immunoglobulin  
IL interleukin  
ILC Innate lymphoid cells 
ILF isolated lymphoid follicles 
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Lactococcus lactis LAB 
LI large intestine 
LP lamina propria 
LT lymphotoxin  
LTi lymphoid tissue-inducer 
M cell microfold cell 
MALT mucosal associated lymphoid tissue 
MAMPs microbe associated molecular patters 
MAPK mitogen-activated protein kinase 
MDP muramyl dipeptide 
MHC major histocompatibility class 
mHPP m-hydroxyphenylpropionic acid 
MLN mesenteric lymph nodes 
MΦ macrophage 
NALT nasal associated lymphoid tissue 
NF-kB nuclear factor kappa-light-chain-enhancer of activated B 
cells 
NK natural killer 
NMR nuclear magnetic resonance 
OTU operational taxonomic unit 
OVA ovalbumin 
PBS phosphate-buffered saline 
PBSAFE Phosphate-buffered saline, azide, foetal calf serum, 
ethylenediaminetetraacetic acid 
PCA Principle Component Analysis 
PCoA Principal Coordinates Analysis 
PE phycoerythrin 
PMN polymorphonuclear leukocytes 
PP Peyer’s patch 
PPL Peyer’s patch lymphocytes 
RPMI Roswell Park Memorial Institute medium 
SB saponin buffer 
SCFAs short-chain fatty acids 
SED subepithelial dome 
SFB segmented filamentous bacteria 
SHM somatic hypermutation 
SI small intestine 
TCR T cell receptor 
TEDs thransepithelial dendrites 
TEM transmission electron microscopy 
TGF transforming growth factor 
Th T helper 
TLR Toll-like receptor 
TNF tumour necrosis factor 
TRITC tetramethylrhodamine 
TSLP thymic stromal lymphopoietin 
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